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Abstract 
Ribonucleic acid (RNA) has long been thought of as the bearer and the machinery of translating 
the genetic code. It is now known that RNA is capable of diverse functions both in a cellular and in 
a synthetic context which have highlighted RNA as an important biological molecule to be studied 
and as a potential toolkit for the researcher. Research into RNA has uncovered a wealth of 
subgroups of RNA with different functions including the bacterial small non-coding RNAs (sRNAs). 
These sRNAs and other RNA subgroups are now known to be key cellular regulators of important 
activities such as virulence and stress response and thus emphasise their importance in antibiotic 
research. Many RNAs regulate their function and the function of other biomolecules by specific 
interactions with other RNAs, proteins, small molecules and even ions. 
However, identifying specific meaningful RNA interactions and their consequences is troublesome 
and methods to study these interactions are slow and laborious. This work has focussed on 
developing protocols for applying existing and novel techniques to studying important RNA 
interactions which has led to the invention of a new technology for creating functional multi RNA 
arrays. 
Initial work employed structural and binding analyses to investigate the details of three important 
sRNA interactions with divalent ions or the chaperone protein Hfq, which provided clarity on 
previous data. Subsequently, efforts were made to develop methods to studying RNA interactions 
in detail but with medium throughput with surface plasmon resonance imaging, not previously 
used for studying RNA interactions. Finally, protocols were developed to create stable and 
functional, multi RNA arrays that were subsequently validated for use in screening RNA 
interactions in high-throughput with the demonstration of specific RNA-RNA, RNA-protein and 
RNA-small molecule interactions. This work sets the precedent for the utilisation of higher 
throughput methods in studying RNA interactions towards the greater understanding and 
exploitation of RNA functions and capabilities. 
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Definitions and Abbreviations 
In this thesis, the following words are used as defined below: 
Probe - labelled or otherwise inherently fluorescent molecule which is used to detect an 
interaction with an immobilised RNA 
Print - the process by which an RNA array is generated from a DNA template array 
Template side - microarray slide containing an array of immobilised DNA templates which encode 
the RNA of interest 
Capture slide - microarray slide containing immobilised aptamer ligand molecules which allow the 
capture of RNA fused with relevant immobilisation components 
 
The following abbreviations have also been used: 
A   adenine 
A260  absorbance at 260 nano metres 
aa   amino acid 
AGO2  argonaute 2 
Am/Um  2'O-methyl adenosine or uridine 
APP  Actinobacillus pleuropneumoniae 
APS   ammonium persulphate 
ATP   adenosine triphosphate 
AU   absorbance unit 
bp   base pair 
c   concentration 
C  cytosine 
Ca2+  calcium ion 
CaCl2   calcium chloride 
CdSO4  cadmium sulphate 
CFM  continuous flow microspotter 
CLIP  cross-link immunoprecipitation 
cm   centi metre 
CTR   carboxyl terminal region 
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cv   column volume (s) 
Da   dalton (s) 
DNA   deoxyribonucleic acid 
DNase  deoxyribonuclease 
dNTP   deoxynucleotriphosphate 
ds   double stranded 
E. coli   Escherichia coli 
EcHfq   Escherichia coli Hfq 
EDTA   ethylenediaminetetraacetic acid 
EMSA   electrophoretic mobility shift assay 
EtBr   ethidium bromide 
EV71  enterovirus 71 
Fab  antibody fragment 
FF   fast flow 
FWHM  full width at half maximum 
g   g-force 
g   gram 
G  gibbs free energy 
G  guanine 
GMP  guanosine monophosphate 
gRNA  guide ribonucleic acid 
GTP  guanosine triphosphate 
HBS   Hepes-buffered saline 
HCl   hydrochloric acid 
HIGS  host-induced gene silencing 
His-tag   6 histidine tag 
HPLC   high performance liquid chromatography 
hr   hour 
I  inosine 
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IPTG   isopropyl-β-D-thiogalactopyranoside 
IRES  internal ribosome entry site 
IVT  in vitro transcription 
KCl   potassium chloride 
KD   dissociation constant 
kDa   kilo-Daltons 
L   litre 
LB broth  luria-Bertani broth 
M   molar 
m32,2,7Gppp hypermethylated g-cap 
m6A  N6-methyladenosine 
mAU   milli absorbance unit 
mg   milli gram 
MG  malachite green 
Mg2+   magnesium ion 
MgCl2   magnesium chloride 
MgSO4   magnesium sulphate 
MicAstab  MicA in a stabilised conformation 
min   minute 
miRNA   micro ribonucleic acid 
ml   milli litre 
mM   milli molar 
mm  milli metre 
Mn2+  manganese ion 
mol   mole 
mRNA   messenger ribonucleic acid 
MW   molecular weight 
MWCO   molecular weight cut off 
NaCl   sodium chloride 
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ncRNA  non-coding ribonucleic acid 
NEB   New England Biolabs 
ng   nanogram 
NHS   N-hydroxysuccinimide 
nL  nano litre 
nm   nano meter 
nM   nano molar 
nt   nucleotide 
NTD  amino terminal domain 
NTP   nucleoside triphosphate 
OD   optical density 
OH   hydroxyl 
OH   hydroxyl 
ORF   open reading frame 
P   phosphate 
pA  polyadenylation signal 
PAGE   polyacrylamide gel electrophoresis 
PAPI   poly (A) polymerase I 
PBS  phosphate buffered saline 
PBST  phosphate buffered saline with Tween 20 
PCR   polymerase chain reaction 
PDB   protein data bank 
pET   expression plasmid 
pg   picogram 
PMT  photo multiplier tube 
PNPase  polynucleotide phosphorylase 
pre-miRNA precursor micro ribonucleic acid 
pre-mRNA precursor messenger ribonucleic acid 
pri-miRNA primary micro ribonucleic acid 
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qRT-PCR quantitative reverse transcription polymerase chain reaction 
RBS  ribosome binding site 
RISC   ribonucleic acid-induced silencing complex 
RNA   ribonucleic acid 
RNAi  ribonucleic acid interference 
RNAP   ribonucleic acid polymerase 
RNase  ribonuclease 
RNA-seq ribonucleic acid sequencing 
RNP  ribonucleoprotein 
ROI  ribonucleic acid of interest 
rpm   revolutions per minute 
rRNA  ribosomal ribonucleic acid 
RT-PCR  reverse transcription polymerase chain reaction 
RU   response unit 
s   second (s) 
S. aureus  Staphylococcus aureus 
S. enterica  Salmonella enterica 
S. typhimurium Salmonella typhimurium 
SA   streptavidin 
SANS  small angle neutron scattering 
SAXS  small angle X-ray scattering 
SDS   sodium dodecyl sulphate 
SELEX  systematic evolution of ligands by exponential enrichment 
siRNA   small interfering RNAs 
snoRNA small nucleolar ribonucleic acid 
snoRNP  small nucleolar ribonucleoprotein 
snRNA  small nuclear ribonucleic acid 
snRNP  small nuclear ribonucleoprotein 
SPR   surface plasmon resonance 
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SPRi  surface plasmon resonance imaging 
sRNA   small ribonucleic acid 
ss   single stranded 
T  thymine 
T7 RNAP  T7 RNA polymerase 
TBE   Tris, Boric acid and EDTA 
TBIO-PCR thermodynamically-balanced inside-out polymerase chain reaction 
TEMED   N, N, N’, N’ - tetramethylethylenediamine 
Tm  melting temperature 
tob  tobramycin 
Tris   Tris (hydroxymethyl)-aminomethane 
tRNA   transfer RNA 
TXN  transcription buffer 
U   uracil 
UTP  uridine triphosphate 
UTR   untranslated region 
UV   ultraviolet 
V   volts 
v   volume 
V. cholerae  Vibrio cholerae 
VcHfq   Vibrio cholerae Hfq 
WT  wild type 
α   alpha 
β   beta 
γ   gamma 
Δ   change in 
δ   delta 
ε   extinction coefficient 
λ   wavelength 
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μg   microgram 
μl   micro litre 
µm  micro meter 
μM   micro molar 
σ   sigma 
ψ  pseudouridine 
°   degree 
Å   Ångström (s) 
(NH4)2 SO4  ammonium sulphate 
_SA  streptavidin aptamer fused 
_tob  tobramycin aptamer fused 
5'-SS  five prime splice site 
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Chapter 1 
1 Introduction 
 
1.1 Diverse roles of regulatory non-coding RNAs 
Since the elucidation of the double helical structure of DNA in 1953 (Watson & Crick, 1953) and 
the publication of the celebrated central dogma by Crick in 1958 (Crick, 1958), the concepts that 
were established and the research which followed immediately consigned RNA to be the template 
(mRNA, (Brenner, Jacob, & Meselson, 1961)) and the infrastructure (referring to tRNA (Hoagland, 
Stephenson, Scott, Hecht, & Zamecnik, 1958)and rRNA (Palade, 1955)) for protein synthesis, RNA 
predominantly continues to be interpreted this way by many people. 
However, new classes of non-coding RNAs (ncRNAs) with diverse functions related to and beyond 
protein synthesis have since been discovered and the list is constantly growing. With an 
expanding index of RNAs comes the enhanced need to increase the through-put of techniques 
available for characterising the function of these RNAs and their interactions. The RNAs and their 
respective roles outlined below provide a synopsis of the current 'catalogue' of RNAs which are 
reviewed in greater depth in (Cech & Steitz, 2014; Morris & Mattick, 2014). 
1.1.1 RNA processing 
1.1.1.1 snRNAs and mRNA maturation 
In eukaryotes, the majority of protein-coding genes exist as a mosaic of coding sequences 
interrupted by non-coding sequences known as introns. During transcription the entire gene, 
including its introns, is transcribed into precursor mRNAs (pre-mRNAs). The introns are excised 
and the exons spliced together to form mature mRNA with continuous protein-coding sequences 
by a large ribonucleoprotein (RNP) assembly called the spliceosome (reviewed in (Papasaikas & 
Valcárcel, 2016; Wahl, Will, & Lührmann, 2009)). The spliceosome can be thought of as a complex 
that chaperones pre-mRNAs and small nuclear (sn) RNAs into conformations resembling the RNA 
catalytic core of group II introns (Hang, Wan, Yan, & Shi, 2015) (Section 1.1.2). 
Splicing expands the diversity of transcripts generated through the repurposed introns that are 
further processed (reviewed in (Hesselberth, 2013)) to become small nucleolar RNAs (snoRNAs, 
Section 1.1.1.2), micro RNAs (miRNAs, Section 1.1.5), and long non-coding RNAs (lncRNAs, not 
discussed, reviewed in (Mercer, Dinger, & Mattick, 2009)). Additionally, ambiguity in exon/intron 
boundaries allows alternative patterns of intron removal, called alternative splicing. More than 
90 % of human genes are alternatively spliced and disruption of the processes involved caused by 
mutations has been linked to a variety of pathologies, including cancer, metabolic and 
neurodegenerative diseases (Singh & Cooper, 2012). Therefore, greater understanding of splicing 
mechanisms promises advances in biology; medicine, for example in therapeutics; and 
biotechnology, in the form of novel gene modulation tools (Sophie Bonnal, Vigevani, & Valcárcel, 
2012). 
Human U1 snRNA is 164 nt long with a well-defined structure consisting of four stem loops (Figure 
1.1) (Krol et al., 1990; Pomeranz Krummel, Oubridge, Leung, Li, & Nagai, 2009). U1 usually forms 
the scaffold of an RNP complex (termed U1 snRNP) containing seven Sm proteins as well as U1A, 
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U1C and U1-70k (Abad et al., 2008). U1 snRNA is best known for its conventional function in 
splicing (Schellenberg, Ritchie, & MacMillan, 2008). Specifically, U1 is required at the very first 
stage of the splicing process (Reed, 1996). The 5' single stranded region of U1 snRNA contains a 
short sequence that is generally complementary to the 5'-SSs (5'-splice sites) of introns. Marking 
the 5'-end of an intron by base pairing between these U1 and the 5'SS plays a key role in the 
initiation of splicing (Horowitz & Krainer, 1994). 
The observation that there is an overall excess of U1 in human cells led to the subsequent 
discovery that U1 is also involved in processes other than splicing. One of the most studied 
functions of U1, other than its role in splicing, is in the regulation of 3'-end processing, specifically 
by suppression. U1 has been shown to differentially affect how pA (polyA) signals present in 
endogenous and viral pre-mRNAs are interpreted by interacting with 5'-SS like sequences near pA 
signals resulting in alternative polyadenylation (Jia & Zheng, 2009). In Bovine and Human 
papillomaviruses (BPV/HPV) and HIV, U1 snRNP binding to 5'-SSs upstream of pA signals inhibits 
polyadenylation as a result of interaction between U1 snRNP with polyA polymerase and likely 
leads to subsequent degradation, whilst binding to 5'-SSs downstream of pA signals inhibits the 
cleavage of RNA that occurs before polyadenylation (Vagner, Rüegsegger, Gunderson, Keller, & 
Mattaj, 2000).  
The mechanism of how alternative polyadenylation is used to regulate gene expression in viruses 
is still unknown and there is much information still missing on the RNA interactions involved in 
splice site recognition, conformational state transitions, and exon/intron boundary definition. The 
U1A spliceosomal protein interaction with U1 snRNA stem loop II is reported to have an affinity KD 
of approximately 0.1 nM (van Gelder et al., 1993). It has therefore found a place as an RNA affinity 
tag as well as other molecular biology uses (Ferré-D’Amaré & Doudna, 2000). 
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1.1.1.2 RNA modifications 
As well as pre-mRNA splicing, post-transcriptional alterations are known to occur in diverse 
organisms from bacteria to humans, with a range of over 140 currently known chemical 
modifications at distinct sites (Machnicka et al., 2013). These modifications have an effect on RNA 
base pairing, conformational and protein binding possibilities, consequently expanding the 
regulatory potential of cellular RNA (Sakurai et al., 2014; Schwartz et al., 2014; Yue, Liu, & He, 
2015).  
Most snoRNAs are pieces of intron approximately 70 nt long that acquire another role after their 
release from excised introns through exonucleolytic processing (Liu & Maxwell, 1990; Watkins & 
Bohnsack, 2012). snoRNAs are found to be localised to the nucleolus associated with proteins as 
snoRNPs and function by guiding the methylation and pseudouridylation of rRNAs, tRNAs and 
snRNAs (Henras, Dez, & Henry, 2004; Meier, 2005).The role of snoRNAs is to provide a scaffold 
onto which partner proteins assemble and tether specific target RNAs, thereby specifying the 
Figure 1. 1 Structure and protein binding regions of U1 snRNA 
The secondary structure of human U1 snRNA and the sites at which the protein components of the 
U1snRNP (U1-70k, U1-A and the Sm core) associate. Stem-loops 1-4 are marked and protein association 
sites are highlighted in colour. U1C is thought to associate mostly through protein-protein interactions. The 
5' end of the RNA (boxed) contains several modifications and is responsible for recognising the 5' Splice Site 
(5'-SS) and is required but not sufficient for spliceosome assembly. 
m32,2,7Gppp, hypermethylated 5' cap; Am/Um, 2'-O'Me modification; ψ, pseudoUridine.   
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modification site. Hundreds of mammalian snoRNAs have functions yet to be revealed and 
numbers of what are referred to as 'orphan' molecules are increasing (Bratkovič & Rogelj, 2014) 
indicating a requirement for tools and methods to investigate these RNA interactions (Bazeley et 
al., 2008). 
Bioinformatic prediction of snoRNA targets carries with it unreliability issues (Bartschat, Kehr, 
Tafer, Stadler, & Hertel, 2014; Kehr, Bartschat, Tafer, Stadler, & Hertel, 2014) highlighting a need 
for development of experimental methods to solve the issue of functional elucidation (Bratkovič 
& Rogelj, 2014). Often, there are numerous copies of specific snoRNA genes, while some modified 
positions are predicted to be targeted by more than a single snoRNA (Kehr et al., 2014; Lestrade & 
Weber, 2006). Consequently, the targets of most snoRNAs have not been experimentally verified 
(Xiao, Yang, Schattner, & Yu, 2009), creating a gap in the knowledge of snoRNAs. Additionally, 
new functions of snoRNAs are being discovered, such as its role in alternative splicing (Kishore & 
Stamm, 2006) indicating there is much more about snoRNAs to learn. 
Short ncRNAs (40-80 nt) called guide RNAs (gRNAs) also participate in RNA editing events, a form 
of transcript maturation prevalent in kinetoplastid protozoa (Sloof & Benne, 1997). RNA editing 
can be carried out by insertion/deletion of Uracil (U) residues (Alfonzo, Thiemann, & Simpson, 
1997; Hajduk & Ochsenreiter) or by deamination from Cytosine (C) to U (Su & Randau, 2011) and 
Adenine (A) to Inosine (I) (often referred to as the inosinome, (Wulff, Sakurai, & Nishikura, 2011)). 
RNA modifications do not just exist as a means of RNA machinery maturation but appear to be 
much more widespread in what is becoming known as the epi-transcriptome (Meyer & Jaffrey, 
2014).  
N6-methyladenosine (m6A) is the most widespread modification that occurs in the mRNAs of most 
eukaryotes (Figure 1.2 B), yet despite its widespread distribution in the mammalian transcriptome 
(three m6A/mRNA on average), functional characterisation is scarce, possibly as a result of the low 
abundance of m6A mRNA and technical difficulties in global detection (Yue et al., 2015). 
Current results indicate that m6A serves as a marker on a large number of mRNAs and lncRNAs, 
which facilitates dynamic response and/or adaptation to external signals and stimuli including 
cap-independent translational control (Meyer et al., 2015) and heat-shock response (Jun Zhou et 
al., 2015). It was also demonstrated in human cells that m6A alters the local structure in mRNAs 
and lncRNAs, termed an 'm6A-switch', to facilitate binding of a nuclear RNA binding protein 
(Figure 1.2 A) (Liu et al., 2015). Emerging evidence suggests there is also an abundance of 
modifications in bacteria which indicates there may be a new era of epitranscriptomics on the 
horizon (Marbaniang & Vogel, 2016). 
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1.1.2 Catalytic RNAs 
RNA itself is capable of enzymatic catalysis, as was first demonstrated with autoexcision and 
autocyclisation of the ribosomal RNA intervening sequence of the single-celled protozoan, 
Tetrahymena (Kruger et al., 1982). It has since been demonstrated that RNA catalysis exists and 
has persisted in other roles, notably at the core of RNA splicing by the spliceosome (Fica et al., 
2013) and mRNA translation by the ribosome (Steitz & Moore, 2003). Growing evidence suggests 
that catalytic RNA may be conserved throughout many genomes, including humans, and that 
these RNAs may have a range of functions yet to be discovered (de la Peña & García-Robles, 2010; 
Webb, Riccitelli, Ruminski, & Lupták, 2009). 
1.1.3 Riboswitch-like RNAs and aptamers 
Riboswitches are structured non-coding RNA domains that specifically recognise and bind small 
molecules, often metabolites, in order to affect gene expression (Coppins, Hall, & Groisman, 2007; 
Mandal & Breaker, 2004). These RNA modules are most common in bacteria but some have been 
discovered in eukaryotes including plants (Sudarsan, Barrick, & Breaker, 2003). The key feature of 
riboswitches is their molecular architecture which enables them to carry out their two main 
functions: molecular recognition and conformational switching (Figure 1.3). A typical riboswitch 
consists of two modules which act out these functions; an aptamer that senses a single ligand and 
an expression platform, usually downstream of the aptamer that assesses the state of the 
aptamer and controls gene expression accordingly (Barrick & Breaker, 2007; Mandal & Breaker, 
2004). The most common mechanisms of riboswitches in bacteria are transcription termination 
(Figure 1.3 A) and translation initiation (Figure 1.3 B). There is considerable application for the 
practical exploitation of riboswitches; existing riboswitches can be used in conjunction with 
RNA-binding protein 
A 
Methylation 
Demethylation 
Concealed RNA binding motif Liberated RNA binding motif 
m6A 
A 
B 
Figure 1. 2 m6A methylation and how the 'm6A switch' alters RNA structure and binding 
A) m6A alters local RNA structure, consequently exposing RNA binding motifs (labelled) and allowing 
subsequent protein binding (red block). B) m6A modification is reversibly regulated by many proteins which 
methylate (writers) and demethylate (erasers). Proteins that are directly recruited to m6A modifications are 
called 'readers' , whereas proteins that bind to the RNA motifs revealed by m6A switches are referred to as 
indirect readers of m6A. 
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coding regions to create new ligand-controlled genetic constructs. Natural riboswitches can be 
reverse-engineered in order to create new synthetic designer riboswitches for genetic studies 
(Suess & Weigand, 2008). Also, existing riboswitches and their associated metabolic pathways can 
be targeted with suitable ligand analogs serving as a class of antibiotics (Blount & Breaker, 2006; 
Breaker, 2009). 
 
 
 
 
 
 
 
 
 
 
 
Included in the riboswitch-like RNAs definition are those that respond to changes in temperature, 
called RNA thermometers (Johansson, 2009). They are located mostly in the 5'UTR of messenger 
RNAs and commonly regulate heat shock proteins as in the 'repression of heat shock gene 
expression' (ROSE) (Nocker et al., 2001) and 'FourU' thermosensors (Waldminghaus, Heidrich, 
Brantl, & Narberhaus, 2007). RNA thermometers basepair to the Shine-Dalgarno site on the 
mRNA at low temperatures creating a weak hairpin structure - often with non-canonical base 
pairing - which melts at high temperatures increasing access of the ribosome for translation 
initiation. 
Synthetic aptamers (single-stranded nucleic acids with tertiary structures that confer high affinity 
binding and specificity to a ligand) are selected in vitro from a library of random sequences by a 
UUUU 
RNA 
DNA 
RNAP 
Ligand Terminator 
Aptamer 
Anti-terminator 
? 
AUG 
RNA 
Ligand 
R
B
S 
aptamer 
Ribosome 
A 
B 
Figure 1. 3 Mechanism of riboswitch-mediated gene regulation 
A) Transcription termination. RNA (orange) being transcribed from DNA (brown) by RNA polymerase (green) 
folds into an upstream aptamer element and a downstream stem loop terminator which causes premature 
termination. Ligand (blue circle) binding causes a structure change which causes refolding of the terminator 
stem loop with an anti-terminator sequence and consequently allowing transcription reed-through of the 
terminator sequence. B) Translation initiation. mRNA (orange) in the absence of ligand (blue circle) folds 
into the ligand-recognising aptamer and a stem loop containing the ribosome binding site (RBS) which 
inhibits recognition by the ribosome (pink) and subsequent translation. Ligand binding causes a structural 
rearrangement of the inhibitory stem loop, liberating the previously obscured RBS and allowing translation. 
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process called SELEX (Systematic evolution of ligands by exponential enrichment, Figure 1.4) 
(Ellington & Szostak, 1990; Green, Ellington, & Szostak, 1990; Tuerk & Gold, 1990). Since its initial 
description, SELEX has undergone countless changes and improvements such that selection of a 
new aptamer now takes only hours instead of weeks (Darmostuk, Rimpelova, Gbelcova, & Ruml, 
2015) and aptamers have been produced against a wide range of targets ranging from ions (Kim 
et al., 2009) to whole cells (Savory et al., 2013). 
Aptamers have found uses as affinity tags, for example the streptavidin aptamer (SA) (C Srisawat 
& Engelke, 2001; Chatchawan Srisawat & Engelke, 2002) has been used extensively to purify 
ribonucleoprotein complexes from RNA extracts in order to study the RNA binding partners 
involved. Another aptamer, popular due to its high affinity for the aminoglycoside antibiotic 
tobramycin (tob) (Hamasaki, Killian, Cho, & Rando, 1998; Y. Wang & Rando, 1995), was among the 
first to be structurally characterised (Jiang & Patel, 1998), demonstrating how RNA can fold into 
shapes that endow high affinities towards their ligands. 
The high affinity and specificity of aptamers has also been exploited in order to produce aptamers 
which exhibit fluorescence when bound to their ligand, allowing detection of RNAs in vivo 
(Filonov, Moon, Svensen, & Jaffrey, 2014; Paige, Wu, & Jaffrey, 2011). These aptamers have been 
employed to study 'toxic RNAs' associated with disease (Strack, Disney, & Jaffrey, 2013) and in 
modified form as sensors to detect metabolite and protein expression levels in cells (Paige, 
Nguyen-Duc, Song, & Jaffrey, 2012; Song, Strack, & Jaffrey, 2013; You, Litke, & Jaffrey, 2015). 
Other key proposed applications are the use of aptamers in biosensors (Jayasena, 1999; Tombelli, 
Minunni, & Mascini, 2005) and as therapeutics such as the licensed drug Macugen, an anti-
angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration 
(AMD) (Vavvas & D’Amico, 2006). 
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1.1.4 Viral RNAs 
Internal Ribosome Entry Sites (IRES) are distinct nucleotide sequences often used by viruses as a 
means to permit 5'cap-independant initiation of translation in the middle of mRNAs and ensure 
that viral translation is active. It is common for IRESs to be located in the 5' UTR of RNA viruses 
and some viruses contain multiple IRESs which allow translation of multiple open reading frames 
(ORFs). These RNA regions were discovered in 1988 in the poliovirus (Pelletier & Sonenberg, 1988) 
and encephalomyocarditis virus (Jang et al., 1988), RNAs and have since been shown to be 
essential for viral infection by many medically and economically important viruses such as 
hepatitis C (HCV), coxsackievirus-B3, hepatitis A, foot-and-mouth disease, polio, rhinovirus, and 
HIV-1 (Pfingsten, Costantino, & Kieft, 2006). 
SELEX 
Pool generation 
Target 
Binding 
Wash 
Elute 
Amplification 
Regenerate pool 
Sequence 
and analyse 
Figure 1. 4 Systematic evolution of ligands by exponential enrichment (SELEX) 
The process begins (top) with the generation of a large pool of RNA sequences transcribed from random 
sequences of fixed length flanked by constant 5' and 3' ends that serve as primers. The RNA pool is exposed 
to the target (blue circle) and allowed to bind (green and red) whilst those sequences that do not bind (blue 
and purple) are washed away. Successfully bound sequences are eluted and amplified by RT-PCR and 
transcribed to regenerate the pool (top). This process is repeated with increasingly stringent washes to 
sequentially select for increasingly higher affinity interactions. Finally, once high affinity sequences have 
been isolated they are amplified and sequences (top left) and the sequences analysed for structure, 
conservation etc. 
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The role of specific viral RNA domains in internal entry of ribosomes has not been fully clarified 
because IRES sequences are very diverse. An IRES can be as short as 9 nt-long (Chappell, Edelman, 
& Mauro, 2000) or can be a large highly structured 600 nt-long sequence (Bonnal, 2003).  
Enterovirus 71 (EV71) was the infectious agent in several large-scale outbreaks of severe 
neurological disorders worldwide. EV71 infections typically cause hand foot and mouth disease 
(HFMD) and serious neurological complications with mortality (McMinn, 2002). Understanding of 
viral RNA interactions, such as those in enterovirus 71 (EV71), with cellular components is 
therefore key to comprehending how a virus is able to control host cell machinery and underlies 
the efforts in tackling viral infections (Huang et al., 2011). These IRESs also present themselves as 
unique tools for molecular biologists, for example as components of polycistronic expression 
vectors (Gurtu, Yan, & Zhang, 1996). 
1.1.5 Regulation of mRNAs in Eukaryotes - RNA interference (RNAi) 
RNA interference (RNAi) is a natural cellular process that silences gene expression through the use 
of non-coding RNAs by promoting the degradation of mRNA (Williams et al., 2008). In eukaryotes 
there are two types of non-coding RNAs used in RNAi; microRNAs (miRNAs) and small interfering 
RNAs (siRNAs). These RNAs both bind to regions of complementarity in the 3’ UTR of mRNA 
targets resulting in the silencing of gene expression (Figure 1.5).  
siRNAs (Figure 1.5 left) are either transcribed or artificially introduced as precursor double 
stranded RNAs (dsRNAs). These double stranded structures are then processed by Dicer (an RNase 
III-like enzyme) into single stranded siRNAs of about 20-25 nt, with overhangs at the 5’P and 3’ OH 
(Elbashir, Lendeckel, & Tuschl, 2001; Elbashir, Harborth, et al., 2001; Zamore, Tuschl, Sharp, & 
Bartel, 2000). Upon loading into the RNA-induced silencing complex (RISC) one strand of the RNA 
(the passenger strand) is degraded by the argonaute 2 (AGO2) component (Hammond, Bernstein, 
Beach, & Hannon, 2000) leaving the other strand (the guide strand) intact. The guide strand then 
guides this complex to select a target mRNA through full complementarity, and the catalytic part 
of RISC (argonaute) cleaves the mRNA and consequently silences gene expression. 
Genomically-encoded primary-micro RNAs (pri-miRNAs, Figure 1.5 right) are transcribed in the cell 
as long hairpins which require processing into a 70 nt stem loop structure (pre-miRNA) by the 
RNase III like enzyme, Drosha (Denli, Tops, Plasterk, Ketting, & Hannon, 2004; Han et al., 2004; 
Lee et al., 2003). The pre-miRNA stem loop is transported by Exportin 5 to the cytoplasm where it 
is processed by Dicer (like the siRNAs) into short 20-25 nt miRNA which is incorporated into the 
RISC complex where the passenger strand is discarded. However, unlike siRNAs, miRNAs only 
interact with a short region of partial complementarity (~2-7 nt) allowing the miRNAs flexibility to 
bind and silence multiple targets (Brennecke, Stark, Russell, & Cohen, 2005; Lewis, Shih, Jones-
Rhoades, Bartel, & Burge, 2003). The target mRNA is inhibited via translational repression, 
degradation or cleavage. 
Not only can RNA control gene expression of the cell within which it was transcribed, it appears 
that miRNAs are able to travel outside their cell of origin and enter different cells of the same 
organism (Sarkies & Miska, 2013). RNA silencing signals travelling between organisms of the same 
species is thought to occur in breast-feeding infants (Melnik, John, & Schmitz, 2013), whilst plants 
parasitized by other plants is an example of RNA-mediated gene regulation between different 
species (Tomilov, Tomilova, Wroblewski, Michelmore, & Yoder, 2008). Recently, both animals and 
plants have been observed to exchange RNA with closely interacting pathogenic, parasitic, or 
symbiotic organisms (Cheng, Luo, Hu, Cao, & Jin, 2013; Garcia-Silva et al., 2014; Liang, Zen, Zhang, 
Zhang, & Chen, 2013). 
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Exploitation of RNA signal transfer has been proposed whereby pathogen genes can be silenced 
by plant-produced RNAs. The idea of host-induced gene silencing (HIGS) in which plant expressed 
RNAs directed against pathogen genes has the potential to become an important disease-control 
method in the future, such systems have been described to work in an increasing number of 
species (Cheng et al., 2013; Helber et al., 2011; Ibrahim et al., 2011; Nowara et al., 2010; Nunes & 
Dean, 2012). 
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Figure 1. 5 Regulation of mRNAs in Eukaryotes - RNA interference (RNAi) 
Processing pathways of siRNAs (left) and miRNAs (right). Primary miRNA is transcribed in the nucleus before 
being cleaved by Drosha and subsequently exported to the cytoplasm. In the cytoplasm, both dsRNA and 
pre-miRNA are processed by Dicer into siRNA and miRNA, respectively. These RNAs are loaded into the RISC 
complex after the cleavage or discarding of the passenger strand. The remaining guide strand RNA guides 
the activated RISC or miRISC complexes towards the target mRNA whereupon full or partial complementary 
pairing leads to the destruction or repression of mRNA translation. 
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1.2 Gene regulation by sRNAs in bacteria 
In bacteria, the major type of non-coding RNA that contributes to regulation are the small RNAs 
(sRNAs; reviewed in (Gottesman & Storz, 2011)). sRNAs are highly structured transcripts that are 
individually transcribed in response to specific environmental stresses and typically range from 
50-400 nt in size. The major families of sRNAs include the true antisense RNAs which are 
transcribed from the strand complementary to the RNA they regulate (referred to as cis-encoded 
sRNAs) (Georg & Hess, 2011), and the sRNAs that are encoded at a different genomic location to 
their targets (referred to as trans-encoded sRNAs) (Storz, Vogel, & Wassarman, 2011; Updegrove, 
Shabalina, & Storz, 2015). The cis-encoded antisense RNAs pair to their target RNAs with full 
complementarity whereas the trans-encoded RNAs base pair with limited complementarity 
bringing about diverse regulatory effects. The latter group of trans-encoded RNAs (hereafter 
referred to as sRNAs) are the main focus of this work and the following review. 
1.2.1 Discovery of sRNAs 
The first chromosomally encoded small RNA regulator to be reported in 1984, was the 174 
nucleotide Escherichia coli RNA MicF (Mizuno, Chou, & Inouye, 1984). The first small RNA 
regulators were identified through gel analysis due to their abundance, by multicopy phenotypes, 
or by serendipity (Wassarman, Zhang, & Storz, 1999). 
Slow identification of sRNAs was attributed to the difficulty in locating sRNA encoding regions by 
traditional genetic methods. As the large majority of sRNAs do not encode for proteins, they are 
therefore resistant to inactivation by single mutations which cause frame shifts and also do not 
have open reading frames (ORFs) that can easily be found by bioinformatic searching methods.  
However, various computational and bioinformatic approaches have been successful in locating 
more sRNAs by searching for co-localisation of genetic features that are commonly associated 
with sRNA-encoding genes such as intergenic regions, putative promoters and Rho-independent 
terminators (Argaman et al., 2001; Rivas, Klein, Jones, & Eddy, 2001; Wassarman, Repoila, 
Rosenow, Storz, & Gottesman, 2001) have resulted in over 100 sRNAs being identified in multiple 
bacteria species (Brantl & Brückner, 2014). 
1.2.2 Functions of sRNAs 
sRNAs most commonly interact with regions in the 5’UTR of mRNAs and pair with incomplete 
complementarity. This allows for increased flexibility and often a single sRNA will bind with many 
mRNA targets as well as permit several sRNAs to act on a single mRNA (Viegas & Arraiano, 2008). 
The majority of sRNAs are induced in response to specific environmental cues such as oxidative 
stress, cell envelope stress or cell density (Hoe, Raabe, Rozhdestvensky, & Tang, 2013; Storz et al., 
2011) and bring about changes in gene expression to help the cell adapt or even regulate 
virulence genes (Han, Liu, Fang, Yang, & Zhou, 2013; Toledo-Arana, Repoila, & Cossart, 2007). 
Broadly speaking there are two main outcomes associated with sRNA-mRNA pairing (Figure 1.6); 
namely mRNA translation repression (and degradation, Figure 1.6 A) and mRNA translation 
activation (and stabilisation, Figure 1.6 B) which are discussed below. 
1.2.2.1 Repression of mRNA translation 
The generic mechanism of repression by sRNAs (Figure 1.6 A) involves base pairing interactions 
that directly inhibit translation initiation because the sRNA sequesters mRNA sequences required 
for stable ribosome binding, known as the ribosome binding site (RBS), in the approximate region 
from 20 nt upstream of the start codon (Beyer, Skripkin, Wadzack, & Nierhaus, 1994; Hüttenhofer 
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& Noller, 1994). As more studies of sRNA regulatory mechanisms have been performed, variations 
to this theme have been demonstrated. Binding of sRNAs to mRNA sequences outside the region 
recognized by the ribosome can still inhibit translation initiation (Bouvier, Sharma, Mika, 
Nierhaus, & Vogel, 2008; Darfeuille, Unoson, Vogel, & Wagner, 2007; Holmqvist et al., 2010; 
Sharma, Darfeuille, Plantinga, & Vogel, 2007), for example, by recruitment of Hfq to bind the RBS 
(Desnoyers & Massé, 2012) or by sequestering mRNA sequences that are possible translational 
enhancer elements (Bandyra et al., 2012; Desnoyers, Bouchard, & Massé, 2013). 
sRNA-mediated translational repression is often coupled to mRNA degradation by an RNase E 
degradosome-dependent pathway and many sRNAs have been shown to promote mRNA 
degradation upon interaction (Guillier & Gottesman, 2008; Papenfort et al., 2006; A. A. 
Rasmussen et al., 2005). Translating ribosomes protect mRNA from RNase E degradation (Dreyfus, 
2009), therefore inhibition of translation by sRNAs exposes RNase E recognition sites and renders 
mRNAs susceptible to degradation (Prévost, Desnoyers, Jacques, Lavoie, & Massé, 2011). Though 
translational repression and mRNA degradation are typically coupled, this is usually not obligatory 
for gene silencing as in some cases sRNA-mediated translational repression has no significant 
effect on mRNA turnover (Møller, Franch, Udesen, Gerdes, & Valentin-Hansen, 2002). Conversely, 
sRNAs have been shown to specifically target mRNAs for degradation rather than directly affect 
translation (Desnoyers, Morissette, Prévost, & Massé, 2009; Pfeiffer, Papenfort, Lucchini, Hinton, 
& Vogel, 2009). Recent research suggests sRNAs are destroyed in conjunction with their 
counterpart mRNAs, to ensure the sRNA signal is removed post-function (Viegas, Silva, Saramago, 
Domingues, & Arraiano, 2011). 
1.2.2.2 Activation of mRNA translation 
Two general mechanisms of activation by sRNA binding have been reported. The first is the so-
called anti-antisense mechanism (Majdalani, Cunning, Sledjeski, Elliott, & Gottesman, 1998), 
which involves an intrinsic inhibitory structure, such as a stem loop being present in the target 
mRNA that blocks translation. Activation is achieved by the sRNA pairing to the inhibitory 
structure and freeing the RBS (Figure 1.6 B i). For this mechanism, the primary outcome of 
activation is enhancement of translation via accessibility of the ribosomes. The second general 
mechanism of activation is interruption of degradation by ribonucleases either due to the 
protection from the translating ribosomes, or from structural changes caused by sRNAs that 
occlude previously exposed RNase cleavage sites (Lease & Belfort, 2000; Ramirez-Peña, Treviño, 
Liu, Perez, & Sumby, 2010)(Figure 1.6 B ii).  
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1.2.3 Structure of sRNAs 
sRNAs are typically highly structured, being composed of one or several stem-loops or even 
complex secondary structures such as pseudoknots (Antal, Bordeau, Douchin, & Felden, 2005), 
interspersed with single-stranded regions, which often contain AU-rich sequences thought to be 
involved in Hfq binding (Zhang, Wassarman, Ortega, Steven, & Storz, 2002). At the 3′-end they 
typically contain GC-rich (Guanine and Cytosine) Rho-independent terminator stem-loops, often 
followed by uridine-rich sequences. Common to all sRNAs is the region of base-pairing recognition 
with its target mRNA, often referred to as the 'seed' region. Although all base-pairing sRNAs have 
a seed region, typically located in the 5' region of the sRNA, its single/double-strandedness varies 
from one to another and with it its requirement for structural arrangement. Seed regions may 
even be located in loops of secondary structures leading to loop-loop base-pairing interactions 
called kissing complexes (Argaman & Altuvia, 2000). 
Studies of several sRNAs have indicated that the RNA chaperone protein, Hfq (Section 1.3), 
requires this polyU tail in order to bind sRNAs. However, it remains unclear whether this tail is a 
direct binding site for Hfq or whether polyU may act as an entry site for a more stable internal site 
(Otaka, Ishikawa, Morita, & Aiba, 2011). Interestingly, several sRNAs characterised in Gram-
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Figure 1. 6 sRNA functions 
A) Translation repression by sRNAs. sRNAs (orange) bind to the 5' untranslated region (5' UTR) of the mRNA 
(green) typically on or near the ribosome binding site (RBS). sRNA binding blocks access to the RBS by the 
ribosome (pink) which consequently down-regulates translation and may lead to degradation of the mRNA 
(and sRNA). B) Translation activation. i) An mRNA with a stem loop in its 5' UTR containing the RBS inhibits 
translation by blocking ribosome access. sRNA binding to the anti-RBS sequence refolds and releases the 
RBS and consequently allows access of the ribosome to initiate translation and increase protein levels. This 
is often associated with stabilisation of the mRNA. ii) An mRNA containing a degradation site (cross) is 
degraded by RNases such as RNase E (purple). sRNA binding blocks the degradation site thereby inhibiting 
recognition by the RNase and allowing translation. 
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positive bacteria such as Staphylococcus aureus and Bacillus subtilis do not require Hfq for 
function, even when Hfq is encoded in the organism (Boisset et al., 2007; Heidrich, Moll, & Brantl, 
2007; Silvaggi, Perkins, & Losick, 2005). It is not yet completely clear why Hfq is required in some 
cases of limited base pairing and not others. 
Several sRNA structures have been predicted or experimentally verified using RNA 
degrading/modifying techniques (Chevalier, Geissmann, Helfer, & Romby, 2009) that indicate 
secondary structures. There is however, little information on the tertiary folds of these RNAs and 
quarternary structures of their complexes with their targets that might facilitate design of 
inhibitors towards novel antibiotics (Toledo-Arana et al., 2007). Low resolution scattering data 
(Ribeiro et al., 2012) and dynamic modelling (Peng, Curtis, Fang, & Woodson, 2014) have given 
insight into structural changes of RNAs interacting with binding partners but as of yet, detailed 
high resolution structures of whole intact sRNAs and their complexes do not exist although some 
recent results have made advances on this front (see Section 1.3.3 and Figure 1.9). 
In some cases, compact RNA conformations involve the negatively charged phosphates being 
brought into close proximity. Such arrangements require small structure modulating molecules 
such as polyamines (Lightfoot & Hall, 2014) and more prevalently, inorganic cations (Bowman, 
Lenz, Hud, & Williams, 2012). Mg2+ is the dominant inorganic cation in biological systems so it is 
not surprising that sRNAs have previously been observed to require Mg2+ for correct conformation 
or to form oligomeric structures (Cayrol, Geinguenaud, et al., 2009; Cayrol, Nogues, et al., 2009; 
Lease & Woodson, 2004). 
1.3 Role of Hfq in association with sRNAs 
1.3.1 Identification of Hfq 
Research on Hfq began in the 1960s when it was discovered to be an essential host factor for the 
replication of RNA bacteriophage Qβ in E. coli (the name Hfq derives from Host factor for 
Qβ)(Franze de Fernandez, Eoyang, & August, 1968). It is thought that it enhances the  replication 
efficiency by melting the RNA 3' end structure (Schuppli, Georgijevic, & Weber, 2000). It was 
characterised to be extraordinarily heat-resistant and bound nucleic acids with a strong 
preference for AU-rich single -stranded RNA (Carmichael, Weber, Niveleau, & Wahba, 1975; de 
Haseth & Uhlenbeck, 1980a, 1980b; Franze de Fernandez, Hayward, & August, 1972; Hori & 
Yanazaki, 1974; Senear & Steitz, 1976). In the 1990s, a Hfq insertion mutation strain of E. coli was 
used to discover and characterise pleiotropic phenotypes, generally caused by impaired stress 
response. Even reduced virulence in pathogenic Brucella abortus was observed indicating a broad 
set of physiological functions for Hfq (Robertson & Roop, 1999; Tsui, Leung, & Winkler, 1994). 
1.3.2 Hfq facilitates sRNA-mRNA pairing, stabilises RNAs and recruits processing 
enzymes 
In vitro data (Geissmann & Touati, 2004; Møller, Franch, Højrup, et al., 2002; Morita, Mochizuki, & 
Aiba, 2006; Papenfort et al., 2006; Vecerek, Moll, & Bläsi, 2007; Zhang et al., 2002) generally 
suggests that the engagement between Hfq, sRNAs and their cognate mRNAs leads to a tripartite 
Hfq–sRNA–mRNA complex. However, it is not clearly defined whether the ternary complex is 
stable in vivo and some have suggested that the sRNA–mRNA duplex is released from Hfq (Vogel 
& Luisi, 2011). This could possibly be explained by the rapid turnover of Hfq-RNA complexes 
driven by the high competition for Hfq binding between cellular RNAs (Fender, Elf, Hampel, 
Zimmermann, & Wagner, 2010; Wagner, 2013). The rate of pairing between the 87-nt sRNA, DsrA 
and the 5’-UTR of one of its target mRNAs, rpoS, was seen to increase two-fold in the presence of 
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Hfq (Lease & Woodson, 2004) and 30-fold when the rpoS construct was extended to include the 
newly identified full determinants (Soper & Woodson, 2008). This demonstrates the role of Hfq in 
facilitating RNA-RNA duplex formation, particularly in the case of sRNA-mRNA interactions (Figure 
1.7 A). 
There are several possible routes for Hfq to aid sRNA–mRNA duplex formation. First, Hfq could 
increase the on-rate for sRNA annealing to a target (Fender et al., 2010; Holmqvist et al., 2010; 
Kawamoto, Koide, Morita, & Aiba, 2006). Secondly, Hfq could favour the release of sRNA–mRNA 
as a stable pair (Soper, Mandin, Majdalani, Gottesman, & Woodson, 2010). Thirdly Hfq has been 
shown to induce changes in RNA structure which could favour duplex formation (Geissmann & 
Touati, 2004; A. Zhang et al., 2002). 
Another important function of Hfq is its stabilisation of RNAs by protecting them from nuclease 
digestion (Figure 1.7 B). sRNAs: DsrA, RhyB and SgrS sRNAs have all been stabilised against 
RNase E cleavage in the presence of Hfq (Moll, Afonyushkin, Vytvytska, Kaberdin, & Bläsi, 2003; 
Møller, Franch, Højrup, et al., 2002; Sledjeski, Whitman, & Zhang, 2001). RNase E typically cleaves 
RNA at AU-rich regions adjacent to stem loops (McDowall, Hernandez, Lin-Chao, & Cohen, 1993; 
McDowall, Lin-Chao, & Cohen, 1994; Melefors & von Gabain, 1988; Prévost et al., 2011; Zhang et 
al., 2002), similar to the preferred RNA binding sites of Hfq. This highlights the possibility that Hfq 
stabilises sRNAs by binding to, and blocking the RNase E cleavage sites (Figure 1.7 B). 
Hfq has been co-purified with other proteins that act on RNA, such as polynucleotide 
phosphorylase (PNPase)and poly(A) polymerase (PAP) from E. coli (Mohanty, Maples, & Kushner, 
2004). The exoribonuclease PNPase has previously been linked as a major functional partner for 
Hfq in mediating sRNA turnover and activity (De Lay & Gottesman, 2011), as well as RNase E 
(Carabetta, Silhavy, & Cristea, 2010; Caron, Lafontaine, & Massé), implying Hfq may recruit other 
proteins to ternary complexes (Figure 1.7 C). 
41 
 
 
 
 
 
 
 
1.3.3 Hfq structure: Hfq has three RNA-binding faces and unstructured C-terminal 
regions (CTRs) 
Greater understanding of Hfq function was made possible when the first crystal structures of Hfq 
from S. aureus (6-70 aa), E. coli (6-71 aa) and Pseudomonas aeruginosa organisms (6-65 aa) were 
solved (Nikulin et al., 2005; Sauter, 2003; Schumacher et al., 2002) (Figure 1.8).  
These structures revealed similarity to the Sm core proteins of the spliceosome (See Section 
1.1.1.1 (Weichenrieder, 2014)) and therefore designated Hfq as a member of the (L)Sm protein 
superfamily (Khusial, Plaag, & Zieve, 2005; Wilusz & Wilusz, 2005). This ancient family of proteins 
are found in all three domains of life and are characterised by the presence of the conserved LSm-
domain protein fold (Achsel, Stark, & Lührmann, 2001). The LSm fold consists of an N-terminal α-
helix (α1) followed by five β-strands (β1-5) separated by five loops. The Hfq polypeptides 
assembles into homohexameric 'doughnuts' (Papenfort & Vogel, 2009; Sonnleitner, Moll, & Bläsi, 
2002). The interface between two subunits comprises residues from the β4 and β5 strands 
creating a ring in which all N-terminal α-helices are located on the same face. The hexamer face 
where the α-helix resides is termed the ‘proximal’ face, whilst the opposing face is termed the 
sRNA 
mRNA 
mRNA sRNA 
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mRNA 
sRNA 
mRNA 
PAP1 RNase E 
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Figure 1. 7 Possible outcomes of Hfq's interaction with mRNA and sRNAs 
Ternary complex formation is thought to lead to one of three genera outcomes: A) Stabilisation of the 
sRNA-mRNA duplex and subsequent repression/activation effects on translation. B) Persistence of the Hfq 
binding to either the sRNA or the mRNA results in protection from RNases and increased stability. C) Hfq 
facilitates hetero-duplex formation between sRNA-mRNA pairs and suitably recruits processing enzymes 
which polyAdenylate and/or degrade the mRNA and/or sRNA. 
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‘distal’ face. The overall protein has a diameter of ~ 65 Å, a thickness of ~ 28 Å and a central pore 
of ~11 Å. 
 
 
 
 
 
 
 
 
The ring-like architecture of Hfq exposes three regions for potential interaction with nucleic acids 
each with their respective specificities (Figure 1.8 (Sauer, 2014)). The structural basis for the 
preference for binding purine-rich sequences at the distal RNA binding site was provided by 
several crystal structures of Hfq hexamers bound to short, purine-rich oligonucleotides 
(Horstmann, Orans, Valentin-Hansen, Shelburne, & Brennan, 2012; Link, Valentin-Hansen, & 
Brennan, 2009; Someya et al., 2012). Further structures revealed Hfq proteins from gram-negative 
bacteria comprise a tripartite binding motif for poly-(ARN)n repeats (Link et al., 2009), while Hfq 
homologs from gram-positive species are likely to interact with poly-(AN)n sequences via bipartite 
binding sites (Horstmann et al., 2012). It was therefore implicated that Hfq interacts with internal 
adenine-rich sequences of mRNAs (Salim, Faner, Philip, & Feig, 2012; Salim & Feig, 2010) and with 
poly(A)n tails of RNAs tagged for degradation (Hajnsdorf & Régnier, 1999, 2000). These proposals 
were later corroborated by data showing that the adenosine-rich motif 5'-AAYAA-3' (A, adenine; 
Y, pyrimidine) is important for Hfq-dependant regulation of an mRNA by sRNAs (Soper & 
Woodson, 2008). 
The Proximal RNA binding site of Hfq was shown to preferably bind uridine-rich sequences and 
has been implicated in sRNA recognition where it was assumed that the proximal site of Hfq 
would bind to internal A/U-rich sequences. S. aureus Hfq was later co-crystallised with an A(U)5G 
RNA substrate which revealed the first six nucleotides were bound to the protein whilst the 3'-
terminal guanine was exposed, adding further evidence to this theory (Schumacher et al., 2002). 
The crystal structure of Salmonella enterica serovar Typhimurium Hfq in complex with the U6 
oligonucleotide indicated the specificity and affinity of Hfq for RNA U-rich sequences could be 
linked to recognition of the U-rich tail of the Rho-independent terminator by identification of the 
3' hydroxyl group by the proximal face (Sauer & Weichenrieder, 2011). 
Recently a crystal structure of the S. Typhimurium sRNA, RydC with the full length E. coli Hfq gave 
further gave insight in to how Hfq interacts with sRNAs  whilst presenting them for interaction 
with mRNAs (Figure 1.9 (Dimastrogiovanni et al., 2014)). The structure reveals the ~60 nt RNA 
binding to the Hfq proximal face via its 3'-end (Figure 1.9 B) whilst the pseudoknot structure 
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Figure 1. 8 Secondary structure and quarternary fold of the E. coli Hfq hexamer 
The hexameric ring-shape of Hfq. Each monomer consists of a single N-terminal α-helix (α, red), 5 β-sheets 
(β1-5, yellow) with connecting loops (green) and a flexible CTR of variable length from species to species. 
The protein presents two main RNA binding surfaces, the distal and the proximal face. RNA is also known to 
be able to interact with residues on the lateral edges of the protein. Images were produced in Pymol using 
PDB accession code: 4v2s. 
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(Figure 1.9 C) 'leans' across the lateral surface of Hfq and extends outwards away from Hfq (Figure 
1.9 A). The residues contacting the 3'-end include: base-stacking with F42; 2' OH hydrogen 
bonding with K56 and H57; and base hydrogen bonding with Q8 and Q41. These residue contacts 
are consistent with the crystal structure of S. Typhimurium Hfq with polyU (Sauer & 
Weichenrieder, 2011). Whilst this structure provides the first higher resolution information on 
large RNAs binding to Hfq there are a few problems. The limiting 3.48 Å resolution consequently 
meant that the model of the RNA was only partially mapped to the electron density, thereby not 
providing unequivocal alignment of RydC sequence with structure. The authors also point out that 
the 'distorted sandwich' of the RNA bridging two Hfq hemaxers in the crystal lattice is not likely to 
be the biologically relevant species. The authors subsequently used related biochemical data to 
infer a binding model of the RydC RNA's interaction with Hfq encompassing both RNA-Hfq 
contacts seen in the crystal structure with a single Hfq hexamer. It may also be relevant to point 
out the uncommon pseudoknot structure of RydC may require an altogether unique binding 
mode to Hfq, not entirely representative of other RNAs based on other data (see Figure 1.10). 
 
 
 
 
 
 
 
 
 
 
After some time the lateral surface of the Hfq hexamer was discovered to be an additional RNA-
binding surface thought to bind the sRNA body (Sauer, Schmidt, & Weichenrieder, 2012). The 
lateral RNA binding surface consists of six patches (one per monomer) of conserved polar residues 
(R16, R17, R19 and K47) which catalyse base pair formation and exchange (Panja, Schu, & 
Woodson, 2013). 
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Figure 1. 9 E. coli Hfq co-crystal structure with S. Typhimurium RydC RNA 
A) Lateral view of RydC binding. RydC sRNA (orange) can be seen extending vertically away from the 
proximal face whilst 'leaning' over the Hfq (purple and blue) lateral face (black arrow) contacting the N-
terminal residues (blue monomer). The RydC 3'-end contacts the proximal face (red arrow, not visible). B) 
Proximal zoomed view of the 3'-end contacting the proximal face residues. Key protein residues are labelled 
in white, RNA residues in red. C) Schematic model illustrating the pseudoknot structure of RydC and how it 
contacts Hfq. Black and red arrows illustrate the same binding areas as in A). Images were produced in 
Pymol using PDB accession code: 4v2s. 
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The accumulated biochemical and structural data has consistently implied that Hfq promotes 
sRNA/mRNA duplex formation by simultaneous interactions with poly-(ARN)n sequences of 
mRNAs via its distal face and with polyU sequences of the sRNAs via its proximal face (Vogel & 
Luisi, 2011). It is, however, not yet known how this data relates to full length sRNAs interacting 
with Hfq and how that interaction facilitates ternary complex formation with a full length mRNA. 
So far, the general consensus for specific binding of sRNAs by Hfq is that the sRNA 3' end is 
recognised by the proximal face of the hexamer, whilst additional internal U-rich sequences 
stabilise the interaction by associating with up to six of the lateral RNA binding sites of Hfq (Sauer, 
2014). It is also useful to note that detailed interaction studies involving multiple Hfq and sRNA 
constructs have confirmed that the three RNA binding sites of Hfq are independent and can be 
used simultaneously in any combination, further demonstrating the dynamic nature of Hfq (Sauer 
et al., 2012). 
What remains to be shown is the role that the Hfq CTR plays in recognition of RNAs. In many 
bacterial species, Hfq has CTR extensions in addition to the conserved core (Attia et al., 2008; 
Schilling & Gerischer, 2009). For example, the CTR of E. coli Hfq comprises approximately one 
third of the protein. The length of the CTR can vary significantly for example the CTR for E. coli is 
30 amino acids, the CTR of Vibrio cholerae is 15 amino acids and the CTR of Herbaspirillum 
seropedicae is 7 amino acids. Although structures of Hfq from many various bacterial species have 
been solved (Nikulin et al., 2005; Sauter, 2003; Schumacher et al., 2002), none have been able to 
resolve the CTR, most likely due to its inherent disorder and flexibility. Low resolution scattering 
analysis of the full-length E. coli Hfq provided a molecular envelope that resembled a six-pointed 
star indicating the CTRs extend out radially from the core (Figure 1.10 A (Beich-Frandsen, Vecerek, 
et al., 2011; Vincent, Henderson, Ragan, et al., 2012)). Low resolution scattering experiments 
performed by group members also provided the first low resolution insights into a large sRNA 
binding to a full length Hfq (Figure 1.10 B (Vincent, Henderson, Stone, et al., 2012)). Interestingly, 
the sRNA, Qrr1, appears to bind across the face of the Hfq proximal face interacting with lateral 
surfaces and the CTRs on opposite ends. It would appear that the RNA binds in a similar manner 
as shown in the RydC structure described above (Figure 1.9) whereby single-stranded regions bind 
the proximal face and duplex stems 'lean' across the lateral surface (Figure 1.10 B, lateral view). 
The importance of the Hfq CTR in relation to RNA binding is not clearly defined to date. Studies 
have produced contradicting data: one study showed the E. coli Hfq core to be proficient in sRNA 
binding in vitro and its over-expression to have minimal impact on target mRNA regulation in vivo 
(Olsen, Møller-Jensen, Brennan, & Valentin-Hansen, 2010). By contrast, prior studies indicated E. 
coli Hfq CTR deletions reduced fitness due to impaired sRNA-mediated responses, indicating 
inadequate RNA-binding capacity of the Hfq core without CTRs (Sonnleitner et al., 2004; Vecerek, 
Rajkowitsch, Sonnleitner, Schroeder, & Bläsi, 2008). 
The three interaction faces of Hfq are known to bind single-stranded RNA (see above) and have 
low affinity for double stranded RNA (Hopkins, Panja, & Woodson, 2011), whilst the CTR 
extensions are very flexible (Beich-Frandsen, Vecerek, et al., 2011; Salim et al., 2012) and contain 
several polar and aromatic residues that could interact with the grooves of an RNA helix. 
Therefore it has been suggested that the CTRs could play a role in finding RNAs (Vecerek et al., 
2008) by effectively increasing the capture radius of the protein (Wright & Dyson, 2009) and 
interacting with stem loops. 
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1.4 Investigating RNA - transcriptomics 
Regulatory RNAs, both as dual function coding RNAs and non-coding RNAs appear to be a 
universal feature of the transcriptomes of all organisms. Efforts to find and characterise them 
resulted in the continued development of new and improved techniques. This section will focus 
on the application of techniques to the study of prokaryotic transcriptomes and specifically 
bacterial sRNAs. However, the techniques used in identifying and characterising prokaryotic 
transcriptomes are generally applicable to eukaryotic systems as well. 
1.4.1 Discovery of non-coding RNAs 
The initial experimental approaches used to identify sRNAs in prokaryotes were laborious and 
often purely serendipitous. The first bacterial sRNAs were found by a number of approaches 
including labelling of abundant small RNAs separated by gel fractionation (Griffin, 1971; Hindley, 
1967); bioinformatics searches of intergenic regions conserved between the sequenced genomes 
at the time (Argaman et al., 2001; Rivas et al., 2001; Wassarman et al., 2001); shotgun cloning of 
small-sized RNAs in E. coli (RNomics, (Kawano, Reynolds, Miranda-Rios, & Storz, 2005; Vogel et al., 
2003)); and microarray analysis (Selinger et al., 2000). Whilst these methods were successful in 
finding sRNAs they were inefficient, yielding relatively few of the sRNAs now known to exist.  
Technical advances in tiling arrays (Tjaden et al., 2002) and next-generation sequencing (Kröger et 
al., 2013; Tree, Granneman, McAteer, Tollervey, & Gally, 2014) have increased the number of 
proven and putative sRNAs such that E. coli and S. enterica are currently thought to express 300 
unique sRNAs (Barquist & Vogel, 2015). Comparable numbers of sRNAs have now been detected 
in a wide range of other bacterial species (Hess, Berghoff, Wilde, Steglich, & Klug, 2014; Mellin & 
A 
B 
Proximal face Lateral face Distal face 
Figure 1. 10 Low resolution structures of V. cholerae Hfq indicating CTR shape and Qrr1 binding 
A) Homology model of the VcHfq core (dark purple cartoon) docked in to the low resolution small angle X-
ray scattering (SAXS) envelope (light purple spheres). CTRs not visible in the homology model appear to 
extend radially outwards from the core making an overall six-pointed star shape. B) Low resolution SAXS 
and SANS (small angle neutron scattering) structure of VcHfq (gray) in complex with the sRNA Qrr1 
(orange). Qrr1 binds across the proximal face (supported by mutational analysis) and appears to contact 
lateral surfaces and CTRs on opposite ends. Taken from Vincent et al 2012. 
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Cossart, 2012; Toffano-Nioche et al., 2012). Transcriptomics using microarrays or RNA-seq in wild 
type versus hfq deletion strains or specific growth conditions is an approach used to find sRNAs 
and mRNAs involved in post-transcriptional regulation (Kröger et al., 2013). However, these 
approaches can be laborious, whilst it is also unrealistic to expect the researcher to assay all 
possible growth conditions exhaustively. Additionally, continued development of 
immunoprecipitation (IP) protocols has resulted in a variety of techniques (e.g. cross-linking IP 
(CLIP) (Ule et al., 2003), photo-activated ribonucleoside CLIP (PAR-CLIP) (Favre, Saintomé, Fourrey, 
Clivio, & Laugâa, 1998) and high-throughput sequencing CLIP (HITS-CLIP) (Chi, Zang, Mele, & 
Darnell, 2009; Licatalosi et al., 2008)) to discover RNA-protein interactions in vivo (Zhang, Xie, Xu, 
& Qu, 2015). These methods have continually been used to study non-coding RNAs, yet the key 
problem with these techniques is the use of the protein as the subject. These techniques have 
typically been used with Hfq to discover bacterial sRNAs but not all non-coding sRNAs bind Hfq 
(Silvaggi et al., 2005) meaning many sRNAs go unidentified. 
1.4.2 Characterisation of novel RNAs 
The development of methods for functional characterisation of sRNAs has lagged behind those of 
discovery. RNA-RNA interaction prediction software has become increasingly developed in an 
attempt to uncover more about the vast number of novel RNAs discovered by sequencing 
technology. The potential of using RNA-RNA interaction predictors in identifying ncRNA targets 
may help reduce the work needed to determine RNA-RNA networks and functions in the cell (Lai 
& Meyer, 2015). However, such prediction software still have a relatively poor accuracy (Pain et 
al., 2015), likely due to the current incomplete understanding of how these sRNAs interact with 
targets and additional factors that affect associations (Beisel, Updegrove, Janson, & Storz, 2012; 
Papenfort, Bouvier, Mika, Sharma, & Vogel, 2010). It is therefore necessary to use experimental 
approaches to validate both targets and interactions (Cynthia Mira Sharma & Vogel, 2009). 
The traditionally used approach for elucidating the function of an sRNA is to manipulate its 
expression. This will involve one or more of: over expression, pulse expression and knockouts. The 
concept of these experiments is that changing the expression of an sRNA will lead to changes in 
transcript levels, protein levels or changes in phenotype. A proteomics approach would be to 
analyse protein extracts of the affected cells with 2D-PAGE and/or MALDI-TOF (Udekwu et al., 
2005). However, this approach suffers from the inability to differentiate between direct and 
indirect changes. Disrupting the balance of the sRNA network has its own drawbacks in that it can 
lead to confusing results (Faner & Feig, 2013). Another popular approach would be to create 
reporter gene fusions for the prospective binding partner if one is known (Urban & Vogel, 2007). 
This technique can fall prey to false positives or inadvertently report an indirect mechanism of 
regulation such that ultimately it is necessary to further validate these results with classical low-
throughput techniques such as northern blots (Alwine, Kemp, & Stark, 1977) and (quantitative) 
reverse transcription PCR ((q)RT-PCR) (Rappolee, Mark, Banda, & Werb, 1988). 
Another important factor involved in target analysis of the putative sRNAs is its structure (see 
Section 1.2.3). Many different approaches have been used in determining sRNA and mRNA 
structure both alone and in complex with binding partners such as Hfq, which include: using 
digestion by RNases with various specificities to determine paired identity of bases (Geissmann & 
Touati, 2004), using ions such as Tb3+ or Pb2+ to cleave all single-stranded nucleotides (Desnoyers 
et al., 2009) and more recently, selective 2'-hydroxyl acylation analysed by primer extension 
(SHAPE) which utilises a hydroxyl-selective electrophile in reacting with flexible/accessible 
nucleotides (Merino, Wilkinson, Coughlan, & Weeks, 2005). Recently, SHAPE and other secondary 
structure determination methods have been adapted to integrate analysis by RNA-seq for massive 
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parallel comparison of RNA structures in vivo to elucidate what is now being referred to as the 
'RNA structurome' (Kwok, Tang, Assmann, & Bevilacqua, 2015). These methods have already 
revealed some very interesting findings, such as the indication that mRNAs are much less 
structured in vivo than in vitro and are more comparable to in vitro structures determined at 
higher temperatures (Ding et al., 2014; Rouskin, Zubradt, Washietl, Kellis, & Weissman, 2014). 
1.4.3 Interaction and biophysical characterisation 
Modern transcriptomics techniques have increased the throughput for discovery of novel 
transcripts. However, established methods for functional characterisation are unsuitable for 
characterising the large numbers of non-coding transcripts being discovered in the different 
organisms being studied for scientific, medical, and industrial purposes. Low throughput 
techniques such as electrophoretic mobility shift assays (EMSAs) and surface plasmon resonance 
(SPR) have proven useful tools in investigating RNA interactions and have been deployed 
extensively. Whilst advances in throughput, such as for SPR imaging (SPRi), promise to improve 
the situation it is evident that lack of high-throughput methods to study RNA interactions is an 
area where more research is needed.  
One approach that would be suitable would be to generate high-density functional RNA 
interaction arrays. Such a construction would allow the high-throughput parallel analysis of RNA 
interactions of broad types of RNA, both known and novel, for characterising and discovering 
interactions. 
Current efforts towards this end are rather limited, although attempts have been made. One 
method for immobilising RNA aptamer arrays involves the immobilisation of biotinylated RNA 
aptamers to a streptavidin-coated slide (Collett, Eun, & Ellington, 2005). The RNAs are in vitro 
transcribed (IVT) with a 5'-biotin-GMP modified nucleotide and spotted on to the slide for 
immobilisation. Unfortunately this technique requires multiple processing steps as the RNAs are 
purified from the IVT mix and refolded before immobilisation. This is undesirable due to the well 
known sensitivity of RNA to degradation. Also the 5'-biotin label would result in premature 
terminated products being immobilised together with the full length RNA, creating a 
heterogeneous surface. Alternatively, others have attempted to create RNA arrays by hybridising 
RNAs with a polyA tail or other complementary sequence to an immobilised DNA oligonucleotide 
(Li, Lee, & Corn, 2006; Martin et al., 2012). A recent approach has also used an in vitro 
transcription reaction to create the RNA from an immobilised DNA primer. Unfortunately an extra 
DNase step for removing the DNA is required to create a homogeneous RNA surface. Also, the 
RNAs are encoded by relatively short templates and consequently the RNA products are only 
approximately 20 nts which is not representative of the majority of RNAs (Wu, Holden, & Smith, 
2014). 
With much current research being done to understand RNAs and with many efforts being directed 
at developing methods to study interaction methods in high-throughput, there is clearly a need to 
create a more robustly constructed RNA array with larger, more biologically relevant RNAs of the 
nascently transcribed structure. 
1.5 Project aims 
The broad aim of this thesis was to investigate the molecular interactions of RNAs; particularly in 
the context of bacterial non-coding RNAs, allowing a greater understanding of the roles of sRNAs 
in gene regulation and to inform future exploitation for biological, industrial and medicinal 
purposes. Specifically this involved: 
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1. Investigating the role that primary and secondary RNA structures play in the regulation of 
sRNA activity by dissecting the specifics of RNA interactions with ions and Hfq by using 
biophysical and structural analyses. (Chapter 4) 
2. Optimising and developing an efficient method for incorporating a biotin tag onto the 3’ 
end of biologically relevant RNAs to facilitate their immobilisation to streptavidin surfaces 
for monitoring interactions using low to medium throughput approaches. (Chapter 5) 
3. Exploring a novel approach for generating functional RNA arrays for parallel high-
throughput interaction testing. (Chapters 6 and 7)  
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Chapter 2 
2 Methods and Materials 
 
2.1 Introduction 
This chapter details the materials and methods used throughout this study. Standard methods 
were adhered to throughout however, when necessary, changes were incorporated to provide 
improvement and are detailed in the relevant sections. Please note that when using fluorescently 
labelled molecules they were protected from light as much as possible for example by using 
amber test tubes. With respect to microbiology procedures, aseptic technique was observed to 
avoid contamination. As appropriate when working with protein and RNA, the necessary 
precautions were taken to ensure reagent stability and purity. 
2.2 Production of DNA templates  
DNA templates were prepared by using temperature-optimised overlapping primers with the 
thermodynamically balanced inside-out polymerase chain reaction strategy (TBIO-PCR) (Gao, 
2003). An alternative PCR strategy was used to prepare DNA templates amplified from plasmid 
source (Section 2.2.2) and to prepare labelled DNA templates (Section 2.2.3). The specific 
refinements for each strategy are detailed below. 
The KOD hot start DNA polymerase kit (Merck) components were used to assemble each PCR 
mixture. All kit components, plasmid and oligonucleotide primers were thawed on ice. Reactions 
were assembled at room temperature to the volumes and concentrations recommended by the 
kit manual, except where indicated. In all cases, except for when stated, forward and reverse 
primers were included to 2 µM final concentration and DNA template was added to 1 ng total. 
Fisherbrand 0.3 mL thin-walled PCR tubes were used and reactions carried out in an Applied 
Biosystems GeneAmp PCR system 9700 thermal cycler using the cycle parameters stated in the 
relevant sections. 
DNA templates were purified from PCR reagents by Macherey Nagel nucleospin columns using the 
specified protocol. The UV absorbance spectrum of the DNA samples were measured using a 
Nanodrop 2000c spectrophotometer (Thermo). The concentration was determined from the A260 
and the purity of the nucleic acid by the A260/A280 and A260/A230 ratios. The DNA samples were 
further analysed for purity of the correct size product by agarose gel electrophoresis (Section 
2.5.4). See Appendix 1 for all sequences and primers. 
2.2.1 Thermodynamically Balanced Inside-Out Polymerase Chain Reaction (TBIO-
PCR) production of DNA templates 
TBIO-PCR involves complementation between an outside pair of primers with the ends of a fully 
synthesised inside fragment. TBIO bidirectional elongation must be completed for a given outside 
primer pair before the subsequent round of bidirectional elongation can take place. A schematic 
illustration of the principle of TBIO-PCR is shown in Figure 2.1 with example primers shown in 
Table 2.1. 
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Table 2. 1 Example primers for DNA template synthesis by TBIO-PCR of Qrr1_tob 
The 5′-blue- and 3′-red-coloured regions of each primer correspond to the blue- and red-coloured regions 
of primer overlap indicated in Figure 2.1. 
Name Sequence: 'Sense' (S) primers 5'→3' and 'Antisense' (AS) primers 3'←5' 
S3 5' - TAATACGACTCACTATAGGGTGACCCGCAAG - 3' 
S2 5' - ACTATAGGGTGACCCGCAAGGGTCACCTAGCCAACTGACGTTGTTAGTGAATAATC - 3' 
S1 5' - CCAACTGACGTTGTTAGTGAATAATCAATGTTCACAAATAACAGCCAATAGACTCA - 3' 
AS1 3' - AGTGTTTATTGTCGGTTATCTGAGTAAGATAACCGATAAAAAAAAAAAAAAAAAGG - 5' 
AS2 3' - AAGATAACCGATAAAAAAAAAAAAAAAAAGGGGGGGGGGCCGAATCATATCGCTCC - 5' 
AS3 3' - GGGCCGAATCATATCGCTCCAAATCGATGTGAGCACGACTCGG - 5' 
 
2.2.1.1 In silico DNA template design 
DNA templates for in vitro transcribing (IVT) the RNA of interest (ROI) were constructed in silico 
before designing the overlapping primers for TBIO-PCR synthesis of the DNA template. For this, 
the sequences for the ROIs were appended with an upstream T7 bacteriophage RNA polymerase 
(RNAP) promoter sequence to facilitate subsequent RNA transcription. The constructed DNA 
template sequence was then used to design overlapping primers using a computer program called 
DNAworks (Hoover & Lubkowski, 2002). This program automates the design of overlapping 
primers for synthetic gene construction with highly homogeneous melting temperatures (Tm) and 
minimal mispriming opportunity. 
Identical DNAworks parameters were used when designing overlapping primers for all DNA 
construct sequences allowing multiple DNA templates to be synthesised using a single 
thermocycler program with TBIO-PCR. Some of the DNA templates described in this thesis were 
previously designed for past projects and therefore have slightly different thermocycler programs 
due to differences in the design parameters used. The TBIO-PCR parameters for the synthesis of 
DNA templates designed for this project are shown in (Table 2.3) and those designed for previous 
projects are shown in Appendix 2. The parameters set for the DNAworks program were: annealing 
temperature of 62 to 64 °C, to keep a consistent thermocycler annealing stage; and oligo length 
between 40 and 60 nt, to reduce down the number of lower sized variations of oligo length and to 
avoid excessive length oligos which can be costly and may need extra purification steps. The 
program outputs a report on the possible variations of primers. These variations were screened 
manually for the most suitable set based on: minimal mispriming opportunity, overlap greater 
than 18 nt, lowest Tm range of overlaps, smallest number of primers in the set and the shortest 
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Figure 2. 1 Schematic illustration of DNA template synthesis by TBIO-PCR for Qrr1_tob 
Generation of the double-stranded DNA fragment from the three pairs of the TBIO primer set, S1 and AS1 
to S3 and AS3. The 5′-blue- and 3′-red-coloured regions of each primer correspond to the blue- and red-
coloured regions of primer overlap indicated in Table 2.1. The inside to outside concentration gradient of 
the sense and antisense primer pairs is indicated on the left. Also, the size of the DNA fragment generated 
after bidirectional elongation with each outside primer pair is indicated on the right. PCR generates the full 
length DNA fragment in a single step. Adapted from Gao et al, 2003. 
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length primers to reduce the cost as well as primer structure. Primers were ordered from Life 
Technologies. 
2.2.1.2 TBIO-PCR 
The aforementioned TBIO-PCR mixtures were assembled as in Table 2.2 and the reactions carried 
out with thermal cycler parameters as shown in Table 2.3. 
Table 2. 2 Reaction mixture assembly for TBIO-PCR synthesis of DNA 
Reagent Volume (µl) [Final] 
Nuclease-free H2O Up to 50 - 
10 × KOD hot start buffer 5 1 × 
2 mM (each) dNTPs 5 200 µM (each) 
25 mM MgSO4 3 1.5 mM 
100 µM S3 primer 1 2 µM 
10 µM S2 primer 1 0.2 µM 
1 µM S1 primer 1 0.02 µM 
1 µM AS1 primer 1 0.02 µM 
10 µM AS2 primer 1 0.2 µM 
100 µM AS3 primer 1 2 µM 
1.0 Unit/µl KOD hot start DNA polymerase 1 0.02 U/µl 
TOTAL 50  
 
Table 2. 3 PCR thermal cycler parameters for generic TBIO-PCR 
Temperature (°C) Time (mm:ss) Number of cycles 
95 2:00 1 
95 0:20 
25 60 0:10 
70 0:20 
70 1:00 1 
4 ∞ 1 
 
2.2.2 PCR amplification of rpoS and rpoS_SA templates from plasmid template 
Plasmid DNA containing the rpoS mRNA 5' UTR (-576 to +10) sequence was previously prepared 
by Dr Charlotte Henderson and kindly provided for use in this project. Amplification of rpoS was 
performed as described in (Charlotte Anne Henderson, 2012) (Table 2.4). 
Table 2. 4 rpoS construct amplification parameters 
Temperature (°C) Time (mm:ss) Number of cycles 
95 07:00 1 
95 00:20 
40 60 00:10 
70 00:09 
72 07:00 1 
4 ∞ 1 
 
For the synthesis of the rpoS_SA construct the plasmid insert was amplified by PCR and 
subsequently extended by two rounds of overlapping primer extension to include the linker and 
SAapt sequences (Table 2.5). 
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Table 2. 5 rpoS_SA construct PCR thermal cycler parameters 
Temperature (°C) Time (mm:ss) Number of cycles 
95 02:00 1 
95 00:20 
25 60 00:10 
70 00:20 
70 01:00 1 
4 ∞ 1 
 
2.2.3 PCR amplification of labelled DNA templates 
The synthesis of DNA templates with functional groups incorporated at either 5'-end of dsDNA 
was achieved by PCR amplification of the previously prepared DNA template with 5'-
functionalised primers thus incorporating the functional group at the relevant 5'-end. 
Three functional groups were incorporated into DNA templates used in this study: upstream 
biotin or aminohexyl linker to facilitate surface-immobilisation of the DNA and downstream Alexa 
Fluor 647 fluorescent dye to report for the presence of the DNA and allow quantification. Forward 
primers with a 6 nt overlapping 5' linker sequence and the upstream functional groups were 
designed to anneal to the T7 RNAP promoter which is present on all constructs. Reverse primers 
containing the downstream Alexa Fluor 647 dye were used for the MicA and MicA_SA constructs 
and therefore were designed to anneal to the downstream end of MicA and MicA_SA, 
respectively. The PCR parameters for creating labelled DNA templates are shown in Table 2.6. 
 
Table 2. 6 Thermal cycler parameters for labelling DNA by PCR 
Temperature (°C) Time (mm:ss) Number of cycles 
95 02:00 1 
95 00:20 
25 53 00:30 
70 00:30 
70 05:00 1 
4 ∞ 1 
 
2.2.4 Considerations for fluorescently labelled nucleic acids 
To accurately determine the concentration of fluorescently labelled nucleic acid samples by UV 
spectrophotometry, a Nanodrop 2000c spectrophotemeter program was used which 
automatically calculates nucleic acid concentration with the following strategy: The A260 value 
used to calculate the nucleic acid concentration takes into account any appropriate dye correction 
factors, the absorbance correction due to the selected analysis correction wavelength, the 750 
nm baseline and the relevant nucleic acid extinction coefficient (NanoDrop 2000 / 2000c 
Spectrophotometer User Manual, 2009). 
2.3 Production of RNAs 
RNAs were transcribed by run-off IVT of PCR products with the T7 Megascript kit (Ambion) using 
standard methods. It was important to add the buffer last before the enzyme to avoid 
precipitation of any nucleic acid by the spermidine in the buffer. Reactions were incubated in a 
heat block at 37 °C for 4 hours unless otherwise stated. The reactions were quenched whilst 
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simultaneously removing the DNA template by the addition of 1 µl Turbo DNase for every 20 µl of 
reaction mix and further incubating the reaction mixture at 37 °C for a further 15 min. 
RNAs were purified from IVT reactions by using either the Megaclear kit or the NucAway kit 
(Ambion) and re-suspended in 10 mM Tris-HCl ph 8.0 unless otherwise mentioned. The UV 
absorbance spectrum of the RNA samples were measured using a Nanodrop 2000c 
spectrophotometer (Thermo). The concentration was determined from the A260 and the purity of 
the nucleic acid by the A260/A280 and A260/A230 ratios. The RNA samples were further analysed for 
purity of the correct size product by denaturing PAGE (Section 2.5.3). Accurate concentration 
determination of fluorescently-labelled RNA was carried out as in Section 2.2.4. 
2.3.1 IVT of unlabelled RNA 
All unlabelled RNAs were made by IVT reactions prepared as described in Table 2.7. IVT reactions 
were purified and analysed as mentioned in Section 2.3. 
 
Table 2. 7 IVT reaction mix for making unlabelled RNAs 
Reagent Volume (µl) [Final] 
Nuclease-free H2O Make up to final volume - 
DNA template Make up to 200 nM 200 nM 
75 mM ATP 5 7.5 mM 
75 mM CTP 5 7.5 mM 
75 mM GTP 5 7.5 mM 
75 mM UTP 5 7.5 mM 
10 × Megascript buffer 5 1 × 
10 × T7 RNA polymerase 5 1 × 
TOTAL 50  
2.3.2 Fluorescently-labelling RNA internally by IVT 
Fluorescently labelled RNAs were produced by IVT incorporating either Cy3 or Cy5 UTP (GE, Figure 
2.2). The IVT reaction described in Table 2.7 is altered to include NTPS at a final concentration of 5 
mM and supplemented with 0.5 mM final concentration of Cydye-UTP. 
 
 
 
 
 
 
Figure 2. 2 Structure of Cy3/5-UTP (GE) 
For Cy3-UTP, n=1. For Cy5-UTP, n=2. 
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2.3.3 Post-transcriptional tagging of RNA by ligation of biotin/fluorescent 
nucleotides 
p-U-biotin (uridine 5’,3’-(bis)phosphate with biotin linked through the 3’ phosphate via an 
extended organic linker; Fig. 2.4, Dharmacon) was ligated to RNA 3' ends using T4 RNA Ligase 
(NEB). Methods used were based on previous work (Charlotte Anne Henderson, 2012). Reactions 
(detailed in Table 2.9) were assembled at room temperature and incubated at 37 °C for 60 mins 
when testing ligation efficiency or 16 °C overnight for reagent preparation. To achieve high 
ligation efficiencies, the 3’ end of the RNA was appended with adenine nucleotides, as noted in 
Chapter 5. Subsequent separation of the RNA and biotin-RNA conjugate from the other reaction 
components was achieved by purification with Micro Bio-Spin P-6 size exclusion columns (Bio-
Rad). 
 
Table 2. 8 Reaction mixture for tagging RNAs by ligation with T4 RNA ligase 
Reagent Volume (µl) Final concentration 
RNA   10 µM 
Nuclease-free H2O  Make up to final volume 
10 mM ATP  2 1 mM 
100 µM p-U-Biotin 4 20 µM 
10 × ligase buffer 2 1 × 
100 % DMSO 2 10 % 
10 Units/µl ligase 4 2 Units/µl 
TOTAL 20  
 
To assess for biotin-labelling success, the method described in Section 2.3.4 was used. RNA 
identified as only partially biotin-labelled was further purified using gel extraction. Specifically, the 
biotin-labelled RNA band was excised, placed inside dialysis tubing (10 kDa molecular weight cut 
off, MWCO) in 1 x TBE and placed in an agarose gel tank containing the same buffer and electro-
eluted at 120 v for 1 hour, followed by briefly reversing the direction for a further 30 seconds. 
 
 
 
 
 
Figure 2. 3 Chemical structure of p-U-biotin (Dharmacon) 
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For fluorescently tagging RNAs at the 3' end using p-U-U-Dy547/Dy647 (Cy3/Cy5 equivalents, 
respectively, Figure 2.5) the same methods as above were used for ligation reactions. 
 
 
 
 
 
2.3.4 Biotinylated-RNA streptavidin (SA) capture assay 
To assess for biotin-labelling success and yield, 50 ng RNA samples were incubated with an excess 
of SA (1 µg) for 30 mins at room temperature in SA capture buffer (10 mM Tris (pH 8.0), 100 mM 
NaCl and 0.5 mM EDTA). Reactions were then analysed by denaturing PAGE (section 2.5.3) but the 
samples were loaded without heating. Biotin-labelled RNA was identified as bands migrating 
slower through the gel due to the larger size of the SA-biotin RNA complex. 
2.4 Protein Expression and purification 
2.4.1 E. coli Hfq (EcHfq) 
EcHfq protein purification was performed as previously described in (Charlotte Anne Henderson, 
2012). E. coli BL21 (DE3) cells transformed with pEH10 plasmid containing the gene encoding E. 
coli Hfq (wt) in a pET22b vector were provided by Dr. Charlotte Henderson (the sequence can be 
found in Appendix 3). Cells were grown at 37 °C in LB media containing 100 μg/ml ampicillin to an 
OD600 of 0.6, before protein production was induced with 1 mM IPTG. Cells were harvested after 3 
hrs by centrifugation (5,000 g, 20 mins, 4 °C) and the pellets re-suspended in 50 ml lysis buffer (50 
mM Tris-HCl (pH 8.0), 1.5 M NaCl, 250 mM MgCl2 and 1 mM EDTA). The cells were then lysed by 
sonication (10 mins, 0.5 s pulses) followed by centrifugation to clarify the lysate (53,000 g, 20 
mins, 4 °C). The supernatant was isolated and heated to 85 °C for 20 mins before centrifuging 
(53,000 g, 40 mins, 4 °C) and making up to 1.7 M (NH4)2SO4. The sample was finally centrifuged 
(53,000 g, 20 mins, 4 °C) before loading onto a HiTrap Butyl-S FF column (GE Healthcare) 
equilibrated with Buffer A (50 mM Tris-HCl, (pH 8.0), 1.5 M NaCl, 1.7 M (NH4)2SO4). The column 
was washed with a 5 column volume (cv) step gradient of 17.6 % buffer B (50 mM Tris-HCl (pH 
8.0) before eluting Hfq over a 20 cv linear gradient of 17.6 % - 100 % buffer B. UV absorbance was 
monitored at 280 nm and the peak fractions containing protein were collected and concentrated 
using Sartorius Vivaspin 2 ml concentrators with a 10 kDa MWCO. The concentrated protein was 
then loaded onto a Superdex 200 10/300 GL size exclusion column equilibrated with 20 mM Tris, 
(pH 8), 500 mM NaCl, 0.5 M EDTA and 10 % glycerol and eluted over 1.5 cv. The peak fractions 
were collected and concentrated as above and the protein stored at -80 °C. SDS-PAGE (Section 
Figure 2. 4 Chemical structure of p-U-U-Dy547/647 (Dharmacon) 
For Dy547, n=1. For Dy647, n=2. 
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2.5.1) was used to analyse samples from each purification step and the final activity was assessed 
by MicA sRNA binding (Section 2.5.2). 
2.4.2 V. cholerae Hfq (VcHfq) in E. coli 
VcHfq protein purification was performed as previously described in (Vincent, Henderson, Stone, 
et al., 2012). V. cholerae Hfq expressing cells were provided by Dr. Helen Vincent. E. coli BL21 
(DE3) cells transformed with pET28 vector containing the gene encoding VcHfq (pET28[VcHfq]; 
sequence can be found in Appendix 3) were grown in LB supplemented with 50 μg/ml kanamycin 
at 37 °C to an OD600 of 0.6, before protein production was induced with 1 mM IPTG. Cells were 
harvested after 3 hrs by centrifugation (5,000 g, 20 mins, 4 °C) and the pellets re-suspended in 50 
ml of Lysis buffer (20 mM Tris, (pH 7.4), 500 mM NaCl, 10 mM MgCl2) supplemented with 1 U/ml 
Turbo DNase (Ambion) and 1 mg/ml lysozyme (Sigma). Cells were disrupted by sonication and the 
lysate clarified by centrifugation at 40,000 g for 30 mins at 4 °C. After addition of imidazole to 20 
mM, the supernatant was loaded onto a HisTrap HP column (GE Healthcare) equilibrated in 20 
mM Tris, (pH 7.4), 500 mM NaCl and 20 mM imidazole at 4 °C using an ÄKTAxpress (GE 
Healthcare). Protein was eluted with a linear gradient over 10 column volumes to 1 M imidazole. 
His6-tagged VcHfq containing fractions were buffer-exchanged into 20 mM Tris, (pH 8.0), 500 mM 
NaCl, 2.5 mM CaCl2 and 10 % glycerol using a PD10 columns (GE Healthcare) and incubated with 1 
U/ml Thrombin (Sigma) at room temperature over 16 h. Following addition of imidazole to a final 
concentration of 20 mM, the thrombin-cleaved VcHfq was loaded onto a HisTrap column 
equilibrated in 20 mM Tris, (pH 7.4), 500 mM NaCl and 20 mM imidazole at 4 °C using an 
ÄKTAxpress. Protein was eluted with a linear gradient over 30 column volumes to 1 M imidazole. 
VcHfq-containing fractions were buffer-exchanged into 20 mM Tris, (pH 8), 1 M NaCl, 1M 
(NH4)2SO4 and 0.5 mM EDTA using a PD10 column and loaded onto a HiTrap Butyl-S FF column (GE 
Healthcare) equilibrated in 20 mM Tris, (pH 8.0), 1 M NaCl, 1M (NH4)2SO4 and 0.5 mM EDTA at 4 
°C using an ÄKTAxpress. Protein was eluted with a linear gradient over 15 column volumes to 0 M 
(NH4)2SO4. VcHfq-containing fractions were buffer-exchanged into 20 mM Tris, (pH 8.0), 500 mM 
NaCl, 0.5 mM EDTA and 10 % glycerol using a PD10 column, concentrated to ~ 10 mg/ml using a 
VivaSpin 2 centrifugal concentrator with a MWCO of 10 kDa and loaded onto a Superdex 200 
10/300 GL size exclusion column (GE Healthcare) equilibrated in 20 mM Tris, (pH 8.0), 500 mM 
NaCl, 0.5 mM EDTA and 10 % glycerol using an ÄKTA purifier (GE Healthcare). VcHfq-containing 
fractions were pooled, concentrated to ~ 5 mg/ml using a VivaSpin 2 centrifugal concentrator with 
a MWCO of 10 kDa and stored at -80 °C. Samples from each purification step were analysed by 
SDS-PAGE (Section 2.5.1) and the final activity assessed by monitoring binding to a VcHfq sRNA 
target Qrr1 (section 2.5.2). 
2.5 Gel electrophoresis 
Gel electrophoresis is an analytical technique used to assess the separation of molecules. Under 
native conditions separation is based on size, shape and charge, whilst under denaturing 
conditions molecules are separated based on size only. There are four common gel 
electrophoresis methods used throughout this work and each is outlined below. 
2.5.1 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
SDS (sodium dodecyl sulfate) is a detergent that unfolds and denatures the native structure of a 
protein. SDS-acting gels therefore separate proteins based only on size. These gels were used to 
assess the size and purity of Hfq proteins to ensure they had been correctly expressed and 
purified. Protein molecular weights (MW) were compared to standard MW markers to confirm 
their size. Monitoring for contaminating proteins after the final purification step assessed the 
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purity of the sample. SDS-PAGE gel reagents (National Diagnostics; Table 2.10) were used to 
prepare the required gel solutions (Table 2.11). 
 
Table 2. 9 SDS-PAGE gel reagents (National Diagnostics EC-890) 
ProtoGel™ 
Acrylamide 30 % w/v 
Bis-acrylamide 0.8 % w/v 
ProtoGel™ stacking buffer 
Tris-HCl, (pH 6.8) 0.5 M 
SDS 0.4 % w/v 
ProtoGel™ resolving buffer 
Tris-HCl, (pH 8.8) 1.5 M 
SDS 0.4 % w/v 
 
Table 2. 10 SDS-PAGE gel solutions 
Resolving solution (12 %) 
ProtoGel™ 4 ml 
Resolving buffer 2.6 ml 
dH2O 3.3 ml 
TEMED   10 μl 
10 % w/v APS 100 μl 
Stacking solution (4 %)   
ProtoGel™ 650 μl 
Stacking buffer 1.25 ml 
dH2O 2.5 ml 
TEMED 5 μl 
10 % w/v APS 25 μl 
 
Table 2. 11 SDS-PAGE additional stock reagents 
10 x SDS running buffer 
Tris (pH 8.0) 0.25 M 
Glycine 1.92 M 
SDS 1 % w/v 
2 x SDS loading dye 
Tris-HCl, (pH 6.8) 0.16 M 
SDS 4 % 
Glycerol 20 % 
β-mercaptoethanol 10 % 
Bromophenol blue 0.2 % 
 
To prepare the gel, resolving solution (6 ml; Table 2.11) was poured into a plastic gel cassette 
(Invitrogen). Water-saturated butanol (0.5 ml) was layered on top to achieve a flat interface. After 
~ 30 mins the butanol was removed and the interface washed with dH2O. Stacking solution (2 ml; 
Table 2.11) was then poured on top and a comb placed inside the top of the gel cassette. The gel 
was kept upright for 30 mins until set. The cassette was then placed into an XCell SureLock™ Mini-
cell and clamped into place. The tank was filled with 500 ml of 1 x SDS running buffer diluted from 
the 10 × stock (Table 2.12)and the comb removed. Samples were prepared for gel loading by 
adding SDS loading dye to 1 x final concentration (Table 2.12) then heating at 95 °C for 5 min. 5 μl 
of BenchMark™ protein ladder was used for size standards to calibrate the gels (Invitrogen). Gels 
were run at 150 V for ~ 1 hr, until the dye had reached the bottom of the gel. Gels were stained 
with SimplyBlue™ Safestain (Invitrogen). 
2.5.2 Native PAGE and Electrophoretic Mobility Shift Assay (EMSA) 
Native gels use gentle conditions that allow the quaternary structure of molecules to remain 
intact, therefore this gel type separates molecules based on size, charge and shape, enabling 
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molecular composition to be investigated. Native gels were used to assess the interactions of the 
proteins, RNAs and their subsequently formed complexes. Analysis conducted using these gels 
may also be referred to as Electrophoretic Mobility Shift Assays (EMSAs). Native-PAGE gel 
reagents (National Diagnostics; Table 2.13) were used to prepare the required gel solution (Table 
2.14). 
 
Table 2. 12 Native PAGE gel reagents (National Diagnostics EC-852) 
AccuGel™ 
Acrylamide 29 % w/v 
Bis-acrylamide 1 % w/v 
10 x TBE 
Tris-HCl, (pH 6.8) 0.89 M 
Boric acid, (pH 8.3) 0.89 M 
EDTA 20 mM 
 
Table 2. 13 Native PAGE gel solution 
AccuGel™ (6 %)  
AccuGel™ 1.5 ml 
10 x TBE 1 ml 
dH2O 7.5 ml 
TEMED 8 μl 
10 % w/v APS 100 μl 
 
Table 2. 14 Native PAGE additional stock reagents 
10 x TBE running buffer 
Tris-HCl, (pH 8.0) 0.89 M 
Boric acid (pH 8.3) 0.89 M 
EDTA 20 mM 
4 x native loading dye 
Tris-HCl, (pH 6.8) 0.25 M 
Glycerol 40 % 
Bromophenol blue 0.02 % 
 
To prepare the gel, the gel solution (Table 2.14) was poured into a plastic gel cassette (Invitrogen) 
and a comb placed inside the top of the cassette to generate sample wells. The gel was left for 30 
mins to set before the cassette was then placed into an XCell SureLock™ Mini-cell and clamped 
into place. The tank was filled with 500 ml of 1 x TBE running buffer diluted from the 10 × stock 
(Table 2.15) and the comb removed. 
Typically, sample buffers were used that contained > 10 % glycerol to ensure the sample could be 
loaded into the wells without using loading dye. This was done to prevent the bromophenol blue 
within the loading dye interfering with detection. One control lane containing 1 x loading dye 
(Table 2.15) was used to measure how far the gels had run. Gels were run at 100 V for 1.5 hr. To 
detect non-labelled RNAs, gels were stained for 5 mins with SYBR Gold™ (Invitrogen) before 
visualising under UV trans-illuminescence. To detect Cy5 and Cy3 labelled samples (or alternative 
dyes with equivalent spectral properties) a Fujifilm imager (FLA-5000) was used with lasers set at 
632 nm and 532 nm (respectively).  
2.5.3 Urea (denaturing) PAGE 
Urea polyacrylamide gels use 6-8 M Urea to denature the secondary structure of folded RNA 
molecules, resulting in a gel that separates the nucleic acid based only on size. These gels were 
used to determine the purity of RNA samples following IVT and for assessment of RNA size 
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following tagging experiments. Denaturing-PAGE gel reagents (National Diagnostics; Table 2.16) 
were used to prepare the required gel solution (Table 2.17). 
Table 2. 15 Denaturing PAGE gel reagents (National Diagnostics EC-830) 
UreaGel™ concentrate 
Acrylamide 19 % w/v 
Bis-acrylamide 1 % w/v 
Urea 7.5 M 
UreaGel™ diluent Urea 7.5 M 
UreaGel™ buffer 
Tris-Borate, (pH 8.3) 0.89 M 
EDTA 20 mM 
Urea 7.5 M 
 
Table 2. 16 Denaturing PAGE gel solutions 
UreaGel™ (8 %)  
UreaGel™ conc 3.2 ml 
UreaGel™ diluent 5.8 ml 
UreaGel™ buffer 1 ml 
TEMED 4 μl 
10 % w/v APS 80 μl 
 
Table 2. 17 Denaturing PAGE additional stock reagents 
10 x TBE running buffer 
Tris- Borate, (pH 8.3) 0.89 M 
EDTA 20 mM 
2 x denaturing loading dye 
Formamide 95 % 
EDTA 18 mM 
SDS 0.025 % 
Xylene Cyanol 0.02 % 
 
To prepare the gel, the gel solution (Table 2.17) was poured into a plastic cassette (Invitrogen) 
and a comb placed inside the top of the cassette to produce sample wells. The gel was left for 30 
mins to set before the cassette was placed into an XCell SureLock™ Mini-cell and clamped into 
place. The tank was filled with 500 ml of 1 x TBE running buffer prepared from the 10 × stock 
(Table 2.18), the comb removed and the gel pre-run at 200 V for 30 mins to heat the gel. Samples 
were prepared by adding loading dye (Table 2.18) to 1 x final concentration and heating at 95 °C 
for 5 mins prior to loading. Gels were run at 200 V for 1 hr before staining for 5 mins with SYBR 
Gold™ (Invitrogen). Gels were visualised under UV trans-illuminescence. 
2.5.4 Agarose gel electrophoresis 
Agarose is an alternative gel matrix to polyacrylamide (used in PAGE, described above). This gel 
separates molecules based on their size and was used throughout this work to assess DNA purity 
before RNA transcription. Agarose gel reagents were used to prepare the required gel solution 
(Table 2.19). 
Table 2. 18 Agarose gel solution 
Agarose 1.8 % 
Agarose 0.72 g 
1 × TBE 40 ml 
Ethidium bromide 0.5 µg/ml 
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Table 2. 19 Agarose additional stock reagents 
10 x TBE 
Tris- Borate, (pH 8.3) 0.89 M 
EDTA 20 mM 
6 x Loading dye 
Tris-HCl, (pH 8.0) 3.3 mM 
Ficoll 400 2.5 % 
EDTA 11 mM 
SDS 0.017 % 
Bromophenol Blue 0.015 % 
 
To prepare the gel, the gel solution (Table 2.19) was mixed and boiled for 2 min. Ethidium 
bromide (Table 2.19) was added and the solution poured into the casting tray and combs were 
inserted to create the wells. The gel was left to set for 30 mins before adding 500 ml 1 x TBE 
running buffer prepared from the 10 × stock (Table 2.20) supplemented with 0.5 µg/ml Ethidium 
bromide and removing the combs. To prepare the samples, loading dye (Table 2.20) was added to 
a final concentration of 1 x. 1 μl of low MW DNA ladder (NEB) was used to calibrate the gels. Gels 
were run at 120 V for 30 mins and imaged under UV trans-illuminescence. 
2.6 Crystallisation and X-ray diffraction 
X-ray crystallographic studies were undertaken in collaboration with Dr John McGeehan and Dr 
Richard Martin (University of Portsmouth). Crystallisation trials of VcHfq protein with and without 
the sRNA Qrr1 were performed in an attempt to obtain atomic resolution information. VcHfq in 
size exclusion buffer (see Section 2.4.2) was deposited into crystal trays at initial concentrations of 
17.3 - 28.2 mg/ml. VcHfq-Qrr1 complexes were prepared to equimolar concentrations with the 
equivalent concentration of 5 mg/ml VcHfq before being deposited into crystal trays. A summary 
of the process is shown in Figure 2.6.  
Firstly, sparse matrix and systematic crystallisation screens were trialled. Sitting drops were set up 
in a 96-well MRC-style two shelf plates using the Cartesian dispensing system (Genomic Solutions) 
run with Honey Bee software (Digilabs). The robot dispensed 100 nL of sample and 100 nL of the 
well solution. The trays were stored at 16°C and checked at regular intervals using polarizing light 
microscopy. 
Once diffracting crystals were obtained, they were cryo-cooled in liquid nitrogen and X-ray 
diffraction studies were conducted using our home X-ray source and also at the Diamond Light 
Source.  
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2.7 Surface Plasmon Resonance (SPR) 
SPR monitors the interaction between molecules in real time allowing a range of interaction 
characteristics to be determined such as the specificity, on/off rates (kinetics) and the binding 
strength (affinity) of interacting partners. The approach involves attaching one interacting partner 
(termed the ligand) to the surface of a sensor chip, and then passing sample containing other 
interaction partner(s) (termed the analyte) over the surface. Binding of analytes to ligands 
immobilised on the sensor surface generates a response which is proportional to the bound mass.  
SPR is a phenomenon that occurs in thin conducting films (gold layer) at the interface of two 
media of different refractive index (glass of the sensor chip and the sample solution in the flow 
cell). Incident light reflected off the gold film leaks an electric field intensity (evanescent wave 
field) across the interface into the medium of lower refractive index (flow cell solution). At a 
certain combination of wavelength and angle, incident light excites plasmons (electron charge 
density waves) in the gold film. SPR is seen as a drop in intensity of reflected light due to a 
characteristic absorption of energy via the evanescent wave field. Because the evanescent wave 
field penetrates the flow cell solution, changes in refractive index caused by change in mass at the 
surface of the sensor chip are measured as changes in SPR conditions. 
Only changes in refractive index near the sensor surface (within 150 nm) affect the SPR signal. 
Sensorgrams are then produced that display the changes in refractive index (response units (RU)) 
as a function of time, with one RU representing the binding of ~ 1 pg/mm2. A summary of the 
process is shown in Figure 2.7. 
Figure 2. 5 Flow diagram of the main steps involved in X-ray crystallography 
Macromolecules such as protein and/or RNA are purified and are subjected to crystallisation trials. 
Diffraction quality crystals are used to collect X-ray diffraction data at an X-ray source, either in-house or at 
a synchrotron. To solve a structure, diffraction data must be coupled with phase information obtained 
experimentally or from molecular replacement if suitable. When an electron density map has been created 
the 3D model can be built and refined. 
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In this work data was collected on a Biacore T200 (GE) using a number of approaches, including 
both qualitative and single-cycle kinetics approaches in which ranges of analyte concentrations 
were consecutively flowed over the ligand and the association and dissociation phases monitored 
over time (Figure 2.8). To analyse the data Biacore T200 evaluation software (GE) was used. 
 
 
 
 
 
 
 
 
2.7.1 SPR Immobilisation SA chip 
The surface of the SA chip carries a dextran matrix to which SA has been covalently attached. SA is 
a tetrameric protein with a high affinity for biotin (equilibrium dissociation constant KD ~ 10-15 M), 
so the surface is prepared for high affinity capture of biotinylated ligands. The interaction of biotin 
with SA is so strong that the biotinylated ligand cannot normally be removed to regenerate the SA 
surface, and capture of a biotinylated ligand on Sensor Chip SA, is in practical terms, almost 
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Figure 2. 6 Schematic representation of a SPR setup 
Incident light is reflected off the top side of the gold layer of a sensor chip. This gold layer is the scaffold to 
which ligands (orange) can be immobilised onto via various surface chemistries. The bottom side of the gold 
surface is encased in a flow cell through which analyte molecules (violet) can be flown over the immobilised 
ligands to measure their interaction. When a binding event occurs on the flow cell sensor chip surface, the 
mass change alters the refraction index which is detected as a change in the reflection angle (I and II) of the 
polarized light needed for SPR. 
Figure 2. 7 Illustrative sensorgram for a single-cycle kinetics experiment using SPR 
During single-cycle kinetics analysis, the analyte is injected over the immobilised ligand in increasing 
concentrations followed by injects of running buffer with no analyte (indicated above), all in a single cycle. 
The surface is not regenerated between injections. Analyte injections and buffer injections represent the 
association and dissociation phases of binding, respectively (indicated below). 
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equivalent in stability to covalent immobilization of the ligand. SA chips were used to immobilise 
biotinylated RNAs for analysis of interaction with RNA binding partners and Hfq. 
2.8 Surface Plasmon Resonance imaging (SPRi) 
The principles of SPRi technology are the same as SPR in how they exploit the SPR phenomenon. 
The design of SPRi includes a video CCD camera to visualise the whole of the biochip sensor 
surface as a difference image of binding meaning immobilisation of ligands can be performed in 
an array format providing SPR information for up to 400 spots simultaneously in real time. A 
schematic illustration of an SPRi flowcell including the sensorgram and difference image outputs is 
shown in Figure 2.9. 
 
 
 
 
 
 
 
 
 
 
 
2.8.1 SPRi system 
The experiment was carried out using a SPRi-PLEX II™ instrument. This semi-automatic system is 
equipped with a degassing unit, a continuous pump and an injection valve (100 μl sample loop). 
The working temperature was set at 20 °C. 
A B 
C 
2 
4 
D 
Figure 2. 8 Schematic illustration of the experimental setup for SPRi and illustrative results 
A) Flow cell represented during binding of analyte (Hfq, violet) to array of ligand spots (RNA, orange; spots 
are shown in different colours to represent different RNAs or different concentrations of the same RNA) 
immobilised to the Gold biochip. B) Schematic key for A). C) Schematic sensorgram output expected from 
the flow cell in A), sensorgram trace colour corresponds to RNA ligand spot colour. Greater binding is 
represented by a higher signal as demonstrated with the purple trace. D) Schematic difference image 
expected from the flow cell in A), spot position corresponds to the RNA ligand spot positions in A). Greater 
binding is represented by a brighter signal as demonstrated in the bottom left spot. 
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2.8.2 Biochip functionalisation 
A carboxymethyl dextran coated SPRi biochip (CMD) was coated with Extravadin (Horiba 
Scientific) and was used to immobilise biotin-tagged RNAs.  
2.8.3 Ligand immobilisation with SPRi-CFM printer 
The Continuous flow microspotter (CFM) printer (Figure 2.10) uses flow to print biomolecules on 
the SPRi-Biochip surface. Printing with flow enables better spot uniformity and homogeneity and 
facilitates immobilisation of up to 48 spots (in a 4 x 12 matrix) simultaneously in a single run. The 
biotin-RNA, positive and negative control molecules were prepared in 10 mM Hepes, 150 mM 
NaCl buffer at pH 7.4 and immobilised on the SPRi-Biochip at appropriate concentrations and 
conditions. The SPRi signal obtained on buffer reference spots accounts for the non-specific 
interaction signal measured and is subtracted from the signal obtained on RNA spots. 
 
 
 
 
 
 
 
2.8.4 Interaction studies 
Experiments involved injecting 100 µl of test molecules (analyte) at 50 µl/min in 10 mM Hepes, 
150 mM NaCl buffer at pH 7.4 over the prepared ligand-immobilised surface and monitoring the 
change in refractive index (reflectivity). Data was analysed using Scrubbergen software (Horiba 
Scientific). Between injections, the surface was regenerated by flowing over 100 µl of 0.5 M NaCl 
at 50 µl/min.  
2.9 Array format studies 
Nexterion H slides were equilibrated to room temperature if stored frozen. A template was used 
to pipette spots on the slides and ensure symmetry if needed for transcription printing (Section 
6.5.1). Sterile filtered solutions were used whenever contact with RNA was expected. Protective 
equipment and clean tools were used to minimise contamination of slides. 
Figure 2. 9 SPRi-CFM printer 
The SPRi-CFM is an automatic printer that uses flow deposition for immobilising molecules. Samples are 
cycled over the surface and captured from solution, leading to higher density immobilisation and better 
spot uniformity which yield improvements in assay sensitivity. 
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2.9.1 Biotin-RNA array 
Aliquots (10 µL) of 1 mg/mL SA in phosphate buffered saline pH 7.4 (PBS) were pipetted onto 
NHS-activated slides (Nexterion H, Schott), incubated for 30 mins at 37 °C in a humidified 
chamber. 
Slides were washed 3 x with 5 ml PBST (1 x PBS + 0.05 % Tween 20) and 1 x with 5 ml filtered dH2O 
and dried with pressurised air. Slides were covered with 5 ml of 50 mM ethanolamine-HCl pH 8.5 
and incubated for 30 mins at room temperature prior to washing as above. Once air dried, 10 µl 
of 400 nM test sample (biotin-tagged RNA) and control samples (non-biotin-tagged RNA, biotin-
tagged control RNA and buffer) were pipetted onto the SA, and incubated for 30 mins at 37 °C in a 
humidified chamber. Slides were washed as above but with PBS in place of PBST and then air 
dried. The slide was blocked with 200 nM bulk RNA for 30 mins at 37 °C in a humidified chamber 
prior to washing as above (with PBS). The slide was then incubated overnight at room 
temperature with 400 nM fluorescently labelled probe RNA in PBS, washed as above (with PBS) 
and air dried.  
2.9.2 Manual RNA array 
2.9.2.1 Preparation of the DNA template slide 
Aliquots (10 µl spots) of 1 mg/ml SA in PBS were pipetted onto NHS-activated slides (Nexterion H, 
Schott), incubated for 30 mins at 37 °C in a humidified chamber, washed three times with 5 ml 
PBST and once with water. To block any remaining active NHS groups 5 ml of 50 mM 
ethanolamine-HCl was incubated over the slide at room temperature for 30 mins prior to 
washing, as described above and then air-dried. Using the slides prepared above, 10 µl of 200 nM 
appropriate biotin-tagged DNA template in PBS and control samples (non-aptamer-encoding DNA 
and buffer) were pipetted onto the SA spots, and incubated for 30 mins at 37 °C in a humidified 
chamber, washed as above and then air-dried. For the purpose of detecting the DNA and ensuring 
the levels of immobilisation are similar for when comparing ROI/ROI-aptamer conjugate printing, 
the DNA was PCR amplified with a 5'-Alexa647 tagged reverse primer to incorporate a 
downstream fluorescent dye label to each DNA molecule which allows the DNA to be detected 
using the Cy5 spectral channel.  
2.9.2.2 Preparing of the RNA capture slide 
Aliquots (10 µl) of either 1 mg/ml SA or 5 mM tobramycin in PBS were pipetted onto NHS-
activated slides (Nexterion H, Schott), incubated for 30 mins at 37 °C in a humidified chamber, 
washed three times with PBST, twice with water, and then air-dried. The slide was incubated in 50 
mM ethanolamine at room temperature for 30 mins prior to washing and drying as described in 
Section 2.9.2.1.  
2.9.3 Automated RNA array 
The Genetix Qarray2 was used to spot molecules of interest (section 7.3) onto slides using a 
375 µm diameter pin in a 50 % humidity, 20 °C. Spot arrangements were as defined using Genetix 
software. 
For slide washing the slides were submerged in 45 ml solution in a 50 ml tube and agitated using a 
Thermo Scientific Spiramix set to maximum speed for the desired time. 
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2.9.4 Use of the Genetix aQuire slide scanner 
Fluorescently labelled on-slide molecules were visualised using the Genetix aQuire scanner. The 
photo multiplier tube (PMT) was adjusted as required to ensure the highest signal possible while 
preventing signal saturation. Data images were processed using ImageQuant software (GE).  
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Chapter 3 
3 Reagent Preparation 
3.1 Introduction 
Reagents were prepared for characterisation studies and method development work. This chapter 
provides the specific details involved in the preparation of the RNAs - U1, MicAstab and MG 
aptamer; sRNAs - MicA, RprA, OxyS, DsrA, Qrr1; mRNAs - ompA, rpoS, hapR and Hfq proteins from 
both E. coli and V. cholerae (EcHfq and VcHfq, respectively). 
3.2 Preparation of nucleic acids 
3.2.1 DNA synthesis 
DNA templates encoding the RNAs were prepared by polymerase chain reaction (PCR) strategies 
detailed in Sections 2.2.1 to 2.2.3. Synthesised DNA templates were compared to standard 
markers (NEB - N0469G and N3233S ) by agarose gel electrophoresis (Section 2.5.4). This showed 
the correct sized products had been made (Figure 3.1 and 3.2) and their purity was sufficient for 
subsequent studies. Details of the example constructs shown in Figures 3.1 and 3.2 are available 
in Table 3.1. A more detailed list of constructs used in this work is included in Appendix 1. Biotin-
labelled DNA was assessed for SA binding by monitoring for retarded gel mobility of formed 
complexes relative to the DNA alone (Figure 3.2). Fluorescently-labelled DNA was detected using 
laser excitation at the dye excitation wavelength and visualised using a suitable fluorescence filter 
(Figure 3.2). Biotin and dye labels were shown to have been successfully incorporated in to the 
DNA (Figure 3.2). 
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Figure 3. 1 DNA template purity and size analysis 
DNA templates (labelled above the lanes) were compared to a standard size marker (lane M) on a 
1.2 % agarose gel, stained with 0.5 μg/ml ethidium bromide and visualised with UV 
transilluminescence. Based on the DNA marker, sample DNA bands corresponded to the expected 
size (Table 3.1). DNA bands are labelled alongside the gel image. 
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Table 3. 1 Details of example DNA constructs 
Construct name Molecular weight DNA length (base pairs) 
ompA (+As) 111703.8 181 
Qrr1_tob 108614.7 176 
MicAstab_tob 91948.6 149 
MicA_tob 93791 152 
MG (malachite green apt) 33861.1 55 
MG_SA 83297 135 
rpoS_SA (step 1 of synthesis) 398423.1 645 
rpoS_SA (full length) 422524.6 684 
Biotin-MicA-alexa647 62247.6 98 
Biotin-MicA_SA-alexa647 111683.5 178 
 
 
3.2.2 RNA synthesis 
RNAs were transcribed in vitro as described in Section 2.3.1. Biotin or dye-labelled RNAs were 
prepared as described in Sections 2.3.2 and 2.3.3. The purified RNAs were analysed by 
denaturing-PAGE (Section 2.5.3) compared to a standard molecular weight marker (NEB - N0364S) 
to assess the quality of the synthesised RNA (Figure 3.3 and 3.4). This showed the correct sized 
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Figure 3. 2 Agarose gel analysis of labelled DNA templates 
MicA and MicA_SA DNA templates were amplified by PCR using 5'-biotin forward and 5'-alexa647 
reverse primers. Agarose gel analysis in parallel with SA capture demonstrated DNA purity as well 
as biotin accessibility. Templates (labelled above the lanes) were compared to a standard size 
marker (lane M) on a 1.8 % agarose gel, stained with 0.5 µg/ml ethidium bromide. The left image 
was scanned with 532 nm laser and green filter allowing visualisation of all ethidium bromide-
bound DNA. The right image was scanned with 643 nm laser and red filter allowing visualisation of 
the alexa647-modified DNA. DNA incubated with and without SA are denoted with a '+' or a '‒', 
respectively, above the lane. The Biotin DNA-SA complex is indicated by the retarded migration of 
the DNA in the '+' lane relative to the '-' lane. SA bound and unbound DNA bands are labelled 
beside the gel for clarity. Based on the DNA marker, sample DNA bands corresponded to the 
expected size (Table 3.1). Marker bands are the same as bottom gels in Figure 3.1. 
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products had been made (Figure 3.3 and 3.4) and their purity was sufficient for subsequent 
studies. Fluorescently-labelled RNA was detected using laser excitation at the dye excitation 
wavelength and visualised using a suitable fluorescence filter (Figure 3.4). Dye labels were shown 
to have been successfully incorporated in to the DNA (Figure 3.4). Details of the example 
constructs shown in Figures 3.3 and 3.4 are available in Table 3.2. A more detailed list of 
constructs used in this work is included in Appendix 1. Unless otherwise stated, all RNAs in this 
work were diluted into experimental buffer, heated to 80 °C and cooled at room temperature for 
5 min to let them fold before use. 
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Figure 3. 3 RNA purity 
RNA transcripts (labelled above the gel) were compared to a standard size marker (lane M) by 8 % 
denaturing PAGE stained with SYBR Gold and visualised with UV transilluminescence. Based on 
the RNA marker, sample RNA bands corresponded to the expected size (Table 3.2). RNA bands are 
labelled alongside the gel image. 
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Table 3. 2 Details of example RNA constructs 
Construct name Molecular weight RNA length (bases) 
MG (malachite green apt) 12521.5 37 
MG_SA 38331.1 118 
MicAstab_tob 42276.1 132 
Qrr1_tob 50863.1 159 
MicA_tob 43480.9 135 
hapR 29134.5 90 
ompA 54647.8 168 
Qrr1 31878.8 99 
ompA (+As) 53315 164 
 
3.3 Protein expression and purification 
3.3.1 E. coli Hfq 
EcHfq was purified as described in Section 2.4.1 using HiTrap Butyl-S FF column chromatography 
(Figure 3.5A and C), followed by size exclusion chromatography (Figure 3.5B and C). SDS-PAGE 
analysis indicated a band corresponding to the monomeric molecular weight of ~ 11 kDa with 
approximately 95 % purity which was deemed sufficient for subsequent studies. Due to the 
SYBR gold 
stain 
Cy3 
fluorescence 
Cy5 
fluorescence 
Dy647 
fluorescence 
SYBR gold 
stain 
h
a
p
R
-C
y3
 
M Q
rr
1
-C
y5
 
o
m
p
A
-C
y3
 
h
a
p
R
-C
y3
 
M Q
rr
1
-C
y5
 
o
m
p
A
-C
y3
 
h
a
p
R
-C
y3
 
M Q
rr
1
-C
y5
 
o
m
p
A
-C
y3
 
M o
m
p
A
(+
A
s)
 
o
m
p
A
-D
y6
4
7
 
M o
m
p
A
(+
A
s)
 
o
m
p
A
-D
y6
4
7
 
300- 
500- 
50- 
80- 
150- 
1000- 
300- 
500- 
50- 
80- 
150- 
1000- 
A B 
Q 
h 
o 
o 
o 
Figure 3. 4 Fluorescently-labelled RNAs 
Fluorescently-labelled RNAs (labelled above the gel) were assessed for fluorescence and correct 
size against a standard size marker (lane M) by 8 % denaturing PAGE. The gels were scanned with 
532 nm laser excitation and green filter or 635 nm laser excitation and red filter for visualisation 
of Cy3/Dy547 or Cy5/Dy647, respectively. Gels were visualised for fluorescence before being 
stained for total RNA with SYBR Gold and scanned with 473 nm laser excitation and blue filter to 
detect SYBR Gold-bound RNA. RNAs are indicated beside the images; o, ompA; h, hapR; Q, Qrr1; 
coloured stars refer to the dye label. A) Internally Cy3/5-labelled RNAs were prepared by IVT. 
Please note when visualising Cy3 fluorescence, Xylene cyanol present in the loading dye can also 
be detected in all 3 sample lanes with a mobility of approximately 80 nt. B) 3' end-labelled RNA 
made by ligation with p-U-U-Dy647 (Section 2.3.4) using T4 RNA ligase. 
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known high stability of the hexameric form, a band corresponding to the hexamer at ~ 66 kDa is 
also visible (Vincent, Henderson, Stone, et al., 2012). The yield of protein from 3 L of E. coli was 
around a satisfactory 18 milligrams.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 V. cholerae Hfq 
VcHfq was expressed (Figure 3.6E) and purified as described in Section 2.4.2 using HisTrap column 
chromatography (Fig 3.A, B and E), followed by Butyl-S column chromatography (Fig 3.6C and E) 
and finally size exclusion chromatography (Fig 3.6D and E). The yield of protein from 3 L of E. coli 
was around a satisfactory 20 milligrams. Following purification, SDS-PAGE analysis indicated 
approximately 95 % purity (Figure 3.6E). A band corresponding to the expected monomeric MW 
of ~ 11 kDa. However due to the known high stability of the hexameric form, a band 
corresponding to the hexamer at ~ 60 kDa is also visible (Vincent, Henderson, Stone, et al., 2012). 
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Figure 3. 5 EcHfq expression and purification 
A) and B) Chromatograms. Blue lines represent absorbance reading at 280 nm, pink line 
represents absorbance reading at 260 nm and green lines represent % of elution buffer. Peaks 
marked with * indicate the fractions collected and relate to the samples analysed by SDS-PAGE in 
C). 
A) HiTrap ButylS FF column. B) Size exclusion S200 column. 
C) SDS-PAGE analysis (composite gel) of samples from purification steps: 1 - Lysate soluble 
protein, 2 - Heat denaturation, 3 - salt precipitation, 4 - Butyl-S from A), 5 - Size exclusion from B). 
EcHfq hexamer has remarkable stability (Vincent, Henderson, Stone, et al., 2012) hence why some 
hexamer persists on SDS-PAGE (purple arrowhead) as well as EcHfq monomer (black arrowhead). 
Lane M, marker. 
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3.3.3 Verification of the function of the purified proteins 
Once EcHfq and VcHfq proteins were successfully purified, an EMSA (Section 2.5.2) was carried 
out to check that the protein was functional by testing it for binding to a well known interaction 
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Figure 3. 6 VcHfq expression and purification 
A) - D) Chromatograms. Blue lines represent absorbance reading at 280 nm, pink line represents 
absorbance reading at 260 nm and green lines represent % of elution buffer. Peaks marked with * 
indicate the fractions collected and relate to the samples analysed by SDS-PAGE in E). 
A) 1st HisTrap column. B) 2nd HisTrap column 2. C) Butyl-S column. D) Size exclusion S200 
column. 
E) SDS-PAGE analysis of samples from purification steps: 1 - Soluble protein without IPTG 
induction, 2 - with IPTG induction, 3 - 1st HisTrap from A), 4 - Thrombin cleavage, 5 - 2nd HisTrap 
from B), 6 - ButylS from C), 7 - Size exclusion from D). VcHfq hexamer has remarkable stability 
hence why some hexamer persists on SDS-PAGE (purple arrowhead) as well as VcHfq monomer 
(black arrowhead). Orange arrowhead indicated His6-tagged VcHfq. Lane M, marker. 
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partner, namely MicA sRNA for EcHfq and Qrr1 sRNA for VcHfq (Figure 3.7A and B, respectively). 
This assay showed both proteins efficiently associated with the sRNA as expected (Fender et al., 
2010; Charlotte A. Henderson et al., 2013; Vincent, Henderson, Ragan, et al., 2012; Vincent, 
Henderson, Stone, et al., 2012). 30 nM Qrr1 RNA was incubated with a titration of VcHfq from 0 
to 50 nM for 30 minutes at room temperature, whilst 30 nM MicA RNA was incubated with a 
titration of EcHfq from 0 to 250 nM under the same conditions. Two MicA-EcHfq complexes were 
observed as is consistent with previous observations (Charlotte A. Henderson et al., 2013) whilst a 
single Qrr1-VcHfq complex was observed, also consistent with previous observations (Vincent, 
Henderson, Ragan, et al., 2012; Vincent, Henderson, Stone, et al., 2012). 
 
 
 
 
 
 
 
 
3.4 Summary 
This chapter illustrates that successful reagent preparation has been achieved and that the RNA 
and protein samples needed for this study were prepared to sufficient purity and in satisfactory 
quantities.  
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Figure 3. 7 EMSA of the Hfq proteins binding to the sRNAs shows the purified proteins are functional 
A) MicA sRNA was incubated with a titration of EcHfq and shows the gradual transition from free 
RNA to the discrete 1:1 and 1:2 complexes of MicA:EcHfq. 
B) Qrr1 sRNA was incubated with a titration of VcHfq and shows the gradual transition from free 
RNA to the discrete 1:1 complex of Qrr1:VcHfq. The binding seen confirms the functionality of the 
Hfq proteins. 
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Chapter 4 
4 sRNA-Hfq Characterisation 
 
4.1 Introduction 
Together, sRNAs and Hfq are known to regulate a wide range of bacterial processes often 
providing a quick response to external stimuli, stresses, and controlling finely tuned virulence 
mechanisms (Gottesman, 2005).  
In E. coli, cellular stresses that compromise the integrity of the bacterial envelope induce the 
transcription of the small non-coding RNA (sRNA) MicA, which interacts with the 5'-untranslated 
region (5'-UTR) of multiple specific messenger RNAs through short sequences of complementarity 
(Udekwu et al., 2005). Recent work by colleagues has shown that Mg2+ regulates the oligomeric 
state of MicA, in parallel with the observation that MicA dimerisation occludes its mRNA binding 
site, suggesting an as yet undiscovered novel mechanism of feedback possibly in response to 
external Mg2+ levels (Henderson, 2012). Whether this response is specific for Mg2+ remains 
unknown and will be considered within this chapter. 
MicA has also been identified to bind to two Hfq hexamers; the binding site for one Hfq hexamer 
having been located to be between stem loops 1 and 2 (Udekwu et al., 2005)(Figure 4.2 A). Whilst 
recent studies support the theory that Hfq binds the 3'-ends of sRNAs (Andrade, Pobre, Matos, & 
Arraiano, 2012), it has also been shown that a single Hfq binding event involves multiple RNA 
determinants (Sauer et al., 2012) hinting that the 3'-end of MicA may also be involved in the 
currently mapped Hfq binding site which is located close to the 3' end. Recent work by colleagues 
has also suggested that the second Hfq binding site on MicA may exist in the 5'-region of the RNA 
before stem loop 1 (Figure 4.2 A) (Henderson, 2012) but further investigation is required and this 
forms the basis of some of the studies in this chapter. 
The 3'-U tail of sRNAs has been implicated in supporting Hfq functionality (Ishikawa, Otaka, Maki, 
Morita, & Aiba, 2012; Otaka et al., 2011; Sauer & Weichenrieder, 2011). However, it is not 
currently known if all sRNAs possess a 3'-U tail due to discrepancies in sequence data and gene 
annotations. There is a general inconsistency shown in the sRNA 3'-end sequences quoted/used 
that appear in the literature of sRNA studies. This is clearly apparent when considering the E. coli 
sRNA OxyS, which regulates the transcription of stress response genes through modulating the 
rpoS sigma factor expression (Altuvia, Weinstein-Fischer, Zhang, Postow, & Storz, 1997)(Table 
4.1). The early work cited in Table 4.1 was instrumental in demonstrating the role of OxyS in a 
cellular context despite the absence of a 3'-U tail. This raises the question of the 
relevance/significance of the 3'-U tail and this will be explored in vitro within this chapter. 
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Table 4. 1 OxyS U tail sequences variation within the scientific literature 
3'-end tail lengths used in RNA studies are listed with references of their use. The structure of the EcoGene 
and 8 U tail constructs can be seen in Figure4.4A and B, respectively. 
OxyS U tail length Reference 
No U tail (Altuvia et al., 1997; Altuvia, Zhang, Argaman, Tiwari, & Storz, 1998) 
1 U tail EcoGene annotation, accession number : EG31116 
2 U tail (Akay, Sarkies, & Miska, 2015; Updegrove & Wartell, 2011) 
8 U tail (Malecka, Strozecka, Sobanska, & Olejniczak, 2015) 
 
Finally, to fully understand Hfq-sRNA binding and the importance of the sRNA 3' tail structural 
data is needed. Currently, high resolution structures of Hfq only include the core N-terminal 
domain (NTD) and lack the CTR, most likely due to its inherent flexibility. This means 
approximately 35 % of the polypeptide chain of Hfq is not visible in X-ray crystallography studies 
to date (Beich-Frandsen, Večerek, Sjöblom, Bläsi, & Djinović-Carugo, 2011). Current RNA bound 
co-crystal structures of Hfq mostly lack the context of a full Hfq-sRNA complex because the CTRs 
are not visible and the RNAs only represent truncations of natural RNA sequences 
(Dimastrogiovanni et al., 2014; Link et al., 2009; Schumacher et al., 2002). With the aim of gaining 
a more relevant insight into Hfq-sRNA binding, this chapter details efforts towards achieving 
atomic resolution data for the high affinity complex of V. cholerae Hfq (VcHfq) and full-length 
Qrr1 sRNA (Vincent, Henderson, Stone, et al., 2012). 
This chapter details the current knowledge of Hfq-sRNA interactions and presents a contribution 
to the field in the form of two peer reviewed publications. 
4.2 Cellular concentrations of Ca2+ do not affect MicA oligomerisation in 
vitro 
MicA has been shown to bind Mg2+ which impacts its structure through promoting dimerisation in 
vitro (Henderson, 2012). The dimer form blocks the site used to pair with the mRNA ompA, 
suggesting Mg2+-induced dimerisation controls MicA functionality in response to internal Mg2+ 
concentrations in vivo. It was observed that Mn2+ - a divalent cation of similar size and charge 
density (Kayestha, Sumati, & Hajela, 1995), often able to substitute for Mg2+ in some experimental 
systems - failed to induce this effect. This could be expected as it is a trace element and 
considered unimportant for RNA folding in vivo (Bowman et al., 2012). Calcium, like Magnesium, 
is a group 2 element, known to bind some biological molecules and exists as a divalent ion with a 
slightly larger ionic radius compared to Mn2+. It was considered relevant to determine whether 
Ca2+ could induce the same dimerisation effect or whether MicA’s response to Mg2+ is specific for 
this ion alone. 
To test this, a sample of MicA was heated to 80 °C for 2 minutes in 10 mM Tris-HCl pH 8.0, 0.5 mM 
EDTA buffer - to remove any ions from the RNA - and then buffer exchanged in to 10 mM Tris-HCl 
pH 8.0, 10 % glycerol by size exclusion with a BioRad biospin p-6 column. 100 nM MicA RNA was 
incubated in the absence and presence of 90 nM CaCl2 (Gangola & Rosen, 1987), and assessed by 
native PAGE (Section 2.5.2) for slower migrating species indicating oligomerisation (Figure 4.1).  
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Absence of MicA dimerisation when in the presence of Ca2+ suggests Mg2+-induced dimerisation in 
vitro is specific and could link to a regulatory sensing role in vivo. This key data supported the 
publication of a paper detailing the Mg2+-MicA findings (Henderson et al., 2013). 
4.3 Exploring the location of the second Hfq binding site on MicA  
MicA has been shown to bind to two Hfq hexamers but whilst the first Hfq binding site has been 
mapped by toeprinting experiments to be in the AU rich single stranded region between stem 
loops 1 and 2 (Udekwu et al., 2005) (Figure 4.2A) the second binding site has been less well 
characterised. Preliminary data by colleagues suggested the second Hfq binding site to be within 
the 5’-region (Henderson, 2012) but by contrast, a later report was published suggesting the 3'-U 
tail is involved in the second binding event (Andrade, Pobre, & Arraiano, 2013). Therefore 
experiments were performed in an attempt to expand the evidence and better define the site of 
the second Hfq binding event. 
Two truncations of the 5’ section of MicA RNA were made which encompass the 5’ single-
stranded region of the first 25 nucleotides and part of the ompA-recognition site (termed 1-25), 
and the same region extended to include the first stem loop which contains the full 
ompA-recognition site (termed 1-47). A schematic detailing these constructs can be seen in Figure 
4.2B and C. The rationale behind these selections came from preliminary data indicating the 5’ 
region contained the second binding site and the knowledge that Hfq is known to have a 
preference for AU rich sequences adjacent to stem loops (Ishikawa et al., 2012). These RNA 
truncates were analysed for Hfq binding by EMSA. If the second Hfq binding event occurs in the 
5'-region, as hypothesised based on preliminary data, only a single Hfq binding event would be 
expected since both truncates lack the known Hfq binding site. 
- + :Ca2+ 
MicA monomer 
Figure 4. 1 MicA does not dimerise in the presence of Ca2+ 
Native PAGE analysis of MicA RNA incubated with absence (-) and presence (+) of 90 nM CaCl2. MicA 
monomer is indicated to the right of the image. There was no apparent band on the gel indicating slower 
migrating MicA oligomers. 
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5’-Dy647 labelled 1-25 and 1-47 RNAs were ordered from Dharmacon and tested for binding to 
Hfq by EMSA (Section 2.5.2).  200 nM RNA was incubated for 30 mins at room temperature with 
Hfq concentrations ranging from 0 to 2 µM and then analysed by native PAGE. As shown in Figure 
4.3, Hfq binding to 1-25 and 1-47 was evident. Whilst there is a single binding event evident for 
1-25, it appears as if there are multiple binding events with the 1-47 construct which would infer 
that part of the 'known' binding site is partially retained (Figure 4.3B). 
 
C 
5' 
B 
A 
D 
ompA mRNA 
Hfq 
Stem loop 1 
Stem loop 2 
Figure 4. 2 MicA truncated constructs used for exploring the possibility of a 5’ second Hfq binding site 
Schematics of secondary structure of: A) MicA full length construct, the Hfq known binding site is indicated 
in violet; The ompA-recognition site is indicated in peach, B) MicA 1-25 and C) MicA 1-47. D) Chemical 
structure of 5’-Dy647-functionalised RNA termini. 
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Hfq binding to 1-47 was seen to have a higher affinity than 1-25 due to initial Hfq binding seen at 
a lower Hfq concentration. However, it was not possible to evaluate the EMSA results beyond 
qualitative analysis because quantification of the smeary bands proved problematic. The apparent 
higher affinity of the 1-47 construct observed in the EMSA could be explained by a need for a 
stem loop to facilitate efficient Hfq binding (Ishikawa et al., 2012) as is present in the 1-47 
construct but absent in the 1-25. The 1-47 construct also retained proficiency for two binding 
events, although these are not well defined by EMSA, potentially due to the stem loop 1 structure 
which is known to undergo structural rearrangement upon initial Hfq binding in which stem loop 1 
is rearranged to expose the partially obscured ompA-recognition site (Henderson et al., 2013; 
Udekwu et al., 2005). The single binding event detected with the 1-25 construct hints that the 5' 
region of MicA contains a Hfq binding site, however the weaker affinity when compared with 1-47 
also suggests that another motif may be involved in Hfq binding that accounts for the difference 
in affinity. 
These results corroborate observations by colleagues that suggest that a second Hfq binding site 
is located within the 5'-region of MicA (Balansethupathy et al., 2014; Henderson, 2012) but 
further investigations are required to define it fully. 
4.4 The 3’ U-tail of OxyS does not impact Hfq binding in vitro 
Much research has been done on the E. coli sRNA OxyS, the sequence of which is annotated in the 
Ecogene database (Jindan Zhou & Rudd, 2013) (accession number: EG31116) as terminating in a 
single 3' Uridine. Despite this, the 3'-end sequence used in previous studies varies greatly (Table 
4.1). Recent work has shown the importance of U-tails (Ishikawa et al., 2012; Otaka et al., 2011; 
Sauer & Weichenrieder, 2011) and Hfq’s preference for binding to poly-U (Kovach, Hoff, Canty, 
Orans, & Brennan, 2014; Schumacher et al., 2002; W. Wang et al., 2011; A. Zhang et al., 2002). Re-
analysis of the genome data (searching downstream region in Ecogene) however showed the 
sequence immediately downstream of the oxyS gene consists of 7 Ts transcribed as Us (Table 4.2) 
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Figure 4. 3 MicA 1-25 and 1-47 constructs both bind to Hfq 
EMSA analysis of Hfq binding to 1-25 and 1-47 MicA constructs. RNA was detected by Dy647 fluorescence. 
Both constructs can be seen to bind Hfq and 1-47 appears to form two distinct complexes. Hfq 
concentrations (µM) are indicated above the relevant lane, free RNA and Hfq complexes are indicated 
beside the gel schematically. Example gels shown of multiple replicates. 
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which could feasibly be included in the OxyS transcript as it follows the commonly accepted 
format of an sRNA where transcription is rho-independently terminated (Gottesman, 2005). 
 
Table 4. 2 EcoGene annotated sequence of oxyS gene with 10 bases downstream sequence 
Annotated sequence is in black and the downstream non-annotated sequence is in blue. 
Link to data origin: http://goo.gl/Uh2bS1 
Coordinate Sequence Position 
4158394 
GAAACGGAGC GGCACCTCTT TTAACCCTTG AAGTCACTGC CCGTTTCGAG 
AGTTTCTCAA CTCGAATAAC TAAAGCCAAC GTGAACTTTT GCGGATCTCC 
AGGATCCGCT 
[1 - 110] 
4158284 TTTTTTTGCC [111 120] 
 
Mfold (Zuker, 2003) analysis was conducted to predict whether OxyS incorporating the extra 7 
non-annotated Uridines would likely form a different structure compared with the known 
structure of OxyS (Figure 4.4A) which could indicate a disagreement of the functional data 
produced thus far on the annotated sequence. However, no such difference was predicted (Figure 
4.4B). It was deemed necessary to investigate whether the presence of the extra 7 Uridines at the 
3’ end of OxyS had an impact on Hfq binding in vitro, which could suggest a similar impact in vivo. 
OxyS RNAs with and without the non-annotated U-tail were synthesised as in Section 2.3.1 (Figure 
4.5). Assessment of Hfq binding was made by EMSA (Figure 4.6) and no obvious difference was 
seen. 
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Figure 4. 4 Structure analysis of OxyS with and without the non-annotated U-tail 
A) Experimentally validated structure of the annotated sequence of OxyS (A. Zhang et al., 2002). B) Mfold 
prediction of the OxyS sequence appended with the additional non-annotated 7 Uridines. Comparison of 
the two indicates there is no predicted difference in the structure. 
Figure 4. 5 Denaturing PAGE analysis of OxyS and OxyS U-tail RNA purity 
OxyS and OxyS U-tail RNA were made by IVT and analysed by denaturing PAGE for purity after reaction 
clean up. Both RNAs were deemed to be of sufficient purity for subsequent EMSA studies. 
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The data here indicates no significant difference in Hfq binding between OxyS constructs with and 
without the non-annotated U-tail in vitro. Recent indications that the U-tail of other sRNAs impact 
Hfq binding were therefore not observed for OxyS. However, the U-tail of OxyS (or lack of) may 
impact ternary complex formation or recruitment of RNases. For example the strong stem loop of 
the terminator has been shown to provide protection against exonuclease degradation (Abe & 
Aiba, 1996). However, the length of the 3'-U tail created before termination is heterogeneous in 
vivo (Reynolds, Bermúdez-Cruz, & Chamberlin, 1992) and read-through transcription (Abe, Abo, & 
Aiba, 1999) produces inactive sRNAs, potentially representing another regulatory process 
controlled by cellular conditions which are yet to be understood (T. Morita, Ueda, Kubo, & Aiba, 
2015). The study which pioneered the U-tail binding hypothesis utilised short U-tail constructs to 
study the affect of U tail length on Hfq binding in vivo (Otaka et al., 2011). Interestingly, 
transcriptional read-through products can be seen in the results which have been demonstrated 
to affect cellular function of the sRNA in vivo (Andrade et al., 2013). It may therefore be the case 
that the affects being measured in short U-tail experiments are as a result of the read-through 
products and not the short U-tail, although this remains to be detailed. 
This key data supported a publication on OxyS-Hfq interactions (Henderson et al., 2013). 
4.5 Structural investigation of Hfq and sRNA 
To define precise molecular interactions, the determination of the structure of full length Hfq 
bound to full length sRNAs is required. So far, EcHfq X-ray crystal structures lack electron density 
for the CTR, most likely due to its flexibility or unstructured nature (Beich-Frandsen et al., 2011; 
Henderson et al., 2013; Vincent, Henderson, Ragan, et al., 2012; Vincent, Henderson, Stone, et al., 
2012) yet it is known that the CTR plays a role in sRNA binding (Salim et al., 2012) (Section 1.3.3). 
Structural information for Hfq-RNA complexes is also limiting with efforts thus far yielding RNA co-
crystal structures with synthetic oligonucleotides which, in comparison to a full length sRNA of 
approximately 100 nt, indicates there is still a lot of Hfq's interaction with RNA yet to be revealed. 
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Figure 4. 6 There is no difference in Hfq binding to OxyS vs OxyS U-tail via EMSA 
EMSA analysis of Hfq binding to OxyS and OxyS U-tail RNAs, stained with SYBR Gold and visualised using UV 
transilluminescence. Hfq concentrations (nM) are indicated above the relevant lanes. The RNA in question is 
indicated below the gel. Free RNA (orange line) and Hfq (violet hexagonal star) complexes are indicated 
schematically beside the gel. Two discreet Hfq complexes are seen for both RNAs and the shifts appear at 
approximately the same Hfq concentrations. 
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An investigation was undertaken with the aim of achieving structural information for full length 
Hfq alone and in complex with a full length sRNA. When considering the aims of this investigation 
it was decided that an ideal interaction to study was V. cholerae Hfq with sRNA Qrr1. The high 
affinity (2.2 nM) of the complex, short CTR (15 residues compared with 30 for E. coli Hfq) and 
existing low resolution structural data showing VcHfq CTRs wrap around Qrr1 (Vincent, 
Henderson, Stone, et al., 2012) make the VcHfq-Qrr1 complex an ideal candidate for 
crystallisation trials. Additionally, the solution scattering experiments highlight that the complex is 
able to be isolated homogenously which would facilitate crystallisation. Attempts were also made 
to crystallise the VcHfq only in an attempt to characterise any differences between bound and 
unbound forms of protein. 
4.5.1 Crystallising VcHfq  
Crystallisation trials of VcHfq were first set up (Section 2.6) for the full length protein. VcHfq was 
added to a variety of commercial screens at different concentrations to gauge its solubilty. The 
initial screens set up with VcHfq at less than ~ 15 mg/ml showed little precipitation which 
prompted further trials at higher protein concentrations. A single condition in the sparse matrix 
screen ‘Structure Screen I & II’ (Molecular Dimensions) yielded full length VcHfq protein crystals in 
the conditions: 0.1 M Na-HEPES pH 7.5, 1.0 M sodium acetate and 0.05 M cadmium sulphate with 
VcHfq at a concentration of 26.6 mg/ml. Unfortunately the crystals that were grown in this 
condition were not single. While not suitable for data collection and structure elucidation, they 
were validated as consisting of protein by in-house source X-ray diffraction (Oxford Diffraction 
Nova diffractometer). 
To optimise the crystallisation conditions for full length VcHfq, a screen was designed to expand 
on the hit conditions with altered pH, sodium acetate and CdSO4 concentrations (see Table 4.3 
and Figure 4.7). The optimisation screen yielded four further hits however, the crystals that grew 
were mostly of poor quality. The crystal with the best morphology is highlighted as 'E7' in Figure 
4.7. This plate-like crystal with a largest dimension of around 100 µm, was single with well-
defined edges, however on closer inspection internal fault lines can be seen. 
Table 4. 3 VcHfq crystallisation optimisation screen 
Grid format of the optimisation screen used to test the effect of buffer pH (left, green), Sodium Acetate 
concentration (top, purple) and CdSO4 concentration (bottom, blue) with the Na-HEPES buffer 
concentration kept constant at 0.1 M, as in the original crystal hit condition. VcHfq protein was added at 
26.6 mg/ml, the same concentration as was used in the original crystal hit condition. The four wells that 
produced crystals are highlighted in red text and their corresponding pictures are shown in Figure 4.7. 
 
[NaAc] (M) 
0.5 0.7 0.9 1.1 1.3 1.5 1.0 
pH 
6.8             
7.0             
7.2             
7.4             
7.6       E7      
7.8       F7      
8.0       G7      
8.2       H7      
 
0.05 0.01 0.03 0.05 0.07 0.09 0.11 
[CdSO4] (M) 
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VcHfq crystals were taken to the Diamond Light Source synchrotron in Oxfordshire to conduct 
diffraction experiments (Figure 4.8). The reflections on the diffraction images appear smeary 
which is likely caused by lattice disorder and there is evidence of ghost reflections indicative of 
multiple lattices (Figure 4.8A). The diffraction is also highly anisotropic, evidenced by the 
directional dependence of diffraction quality which worsens when diffracting at a relative angle 
above 45° (Figure 4.8B and C). Diffraction anisotropy can be attributed to crystal packing 
interactions being more uniform in one direction than another which could be due to the flexible 
CTR (Section 1.3.3), but also the gross crystal morphology, particularly for thin plate-like crystals 
where extracting clean data shooting through the flat edge of the crystal can be very challenging. 
At the anisotropic angle of diffraction, the limit of diffraction in the best direction is ~1.2 Å and 
the worst direction is ~4 Å. 
Figure 4. 7 Custom-made optimisation screen for VcHfq protein crystallisation 
The optimisation screen was set up in a 96 well plate sitting drop format using a Cartesian Honey-Bee X8 
crystallisation robot. Pictures of the four conditions that produced crystals are shown with the grid location 
marked in the corner allowing reference to Table 4.3. The crystals grown were mostly unsuitable for X-ray 
diffraction but 'E7' contained a crystal which was the most suitable produced so far as it is a single crystal 
albeit made of multiple lattices as is indicated by it not being a strict hexagonal shape. 
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Microseed experiments were conducted in an attempt to improve crystal morphology and 
diffraction properties. Microseeding involves smashing protein crystals with a PTFE bead in a tube 
and introducing these ‘seeds’ to crystallisation screens as nucleation points (Luft & DeTitta, 1999). 
Separating nucleation from growth by introducing a nucleation point into an ideal crystal growth 
condition can allow for slow ordered crystal growth (Bergfors, 2003). This technique improves 
crystallisation when spontaneous nucleation is low or crystal morphology is poor (D’Arcy, Villard, 
& Marsh, 2007). Microseeding screens produced several more successful hits in ‘Structure Screen 
I & II’ and other crystallisation screens. However, the morphologies of the crystals that grew were 
similar to the original crystals and were not significantly improved and sadly not sufficient to solve 
the structure. 
4.5.2 Crystallising VcHfq-Qrr1 complex 
Crystallisation trials were set up to try and crystallise VcHfq in a 1:1 complex with Qrr1. Initial 
screens containing VcHfq-Qrr1 complex at 83 µM (protein at 5 mg/ml) produced no crystal hits. 
Most conditions produced precipitation immediately or phase separation indicating low solubility 
of the complex in the conditions tested. Further work on optimising the conditions of the 
crystallisation trials is required to achieve crystallisation.  
4.6 Summary and Conclusions 
E. coli sRNA, MicA has been shown to dimerise in the presence of cellular concentrations of Mg2+ 
(Henderson et al., 2013) which could conceivably be due to the importance of Mg2+ in RNA 
structure. However, this appears not to be a common feature of sRNAs as Mg2+ was observed to 
Figure 4. 8 VcHfq crystal diffraction using the X-ray source at the Diamond Light Source synchrotron in 
Oxfordshire 
The schematic below each diffraction image represents the orientation of the crystal in the X-ray beam at 
that point. The subsequent effect of the orientation on the diffraction quality is revealed as the crystal is 
rotated. A) 0° - The diffraction is reasonably complete but does not have singular reflections. B) 45° - The 
diffraction becomes more anisotropic. C) 90° - The diffraction is severely anisotropic and reflections are 
completely smeared. 
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have no effect over the oligomeric state of OxyS and RprA (Henderson et al., 2013). MicA 
dimerisation had been shown in the presence of Mg2+ but not Mn2+ (Henderson et al., 2013), a 
common analog used in RNA folding experiments but only a trace metal in the cell (Kehres, 
Zaharik, Finlay, & Maguire, 2000). MicA was tested against the cellular concentration of Ca2+ for 
formation of oligomers but this appeared to be ineffective, further suggesting MicA dimerisation 
to be specific to Mg2+. Importantly, the oligomeric state of MIcA was shown to have an effect on 
its proficiency to pair with one of its cognate mRNAs ompA, which indicates a potential 
mechanism of regulation in vivo. There is a speculative link between MicA dimerisation in the 
presence of Mg2+ and MicA's involvement in the regulation of the PhoPQ operon (Van Puyvelde, 
Vanderleyden, & De Keersmaecker, 2015).  MicA is known to directly interact with the phoPQ 
mRNA inhibiting translation and down-regulating members of the PhoPQ regulon which respond 
to changing levels of Mg2+ (Coornaert et al., 2010). 
Investigation into the location of the second Hfq binding event with MicA was conducted using 
two synthetic MicA truncations, namely 1-25 and 1-47 encompassing the single-stranded 
5'-region and the same region including stem loop 1, respectively. The results indicated the 
5'-region played a role in Hfq binding and could therefore be the location of the second binding 
site. However, the different Hfq-binding affinities observed indicated that other elements may be 
involved, such as the remaining ompA-recognition site nucleotides and/or the 3'-U tail. The 3'-U 
tail has previously been suggested to play a role in MicA binding to Hfq (Andrade et al., 2013) 
highlighting the need to verify this further for MicA and other RNAs. 
Analysis of the E. coli genome revealed a poly-uridine stretch downstream of the oxyS gene not 
previously annotated which could hypothetically be (entirely or partially) included in the 
transcribed OxyS as per accepted convention of sRNAs with rho-independent terminators. 
Predicted folding and Hfq binding analysis of this putative full length RNA was compared to the 
annotated OxyS sequence. The prediction was that the structure of OxyS would not change with 
the U-tail and the EMSA showed no difference between OxyS with and without the U-tail when 
binding to Hfq. Despite the suggestion that the U-tail of some sRNAs plays an important role in 
regulation (Andrade et al., 2013) these findings show the U-tail may not be generally important to 
all sRNAs. However, further work on the effect of tertiary complex formation with the two 
constructs may reveal more about the nature of the U-tail for OxyS. Clearly there is a need for 
better definition in sequence data for the active forms of sRNAs with any known variants and 
their respective functions. 
Progress in obtaining detailed structural information for full length VcHfq and its complex with 
Qrr1 was made. Although ideal quality crystals were not achieved, these studies provide a 
platform for future optimisation. It is apparent that crystallisation of structured RNAs is not as 
readily achieved compared with proteins, as indicated by the number of crystal structures in the 
protein data bank (PDB) containing RNA (2285, 2.2 % of total) compared to the total number of 
structures (102851, PDB search on 25/01/2016). Further work on optimising the crystallisation 
process is needed which may be realised through crystallisation aids (S. G. F. Rasmussen et al., 
2011) and RNA crystallisation chaperones (Angelica & Fong, 2008). Recent improvements in 
synthetic antibody fragments (Fab) as RNA crystallisation chaperones (Ravindran, Héroux, & Ye, 
2011) have generated a portable RNA sequence relating to a motif whose recognition by a Fab 
facilitates crystallisation and structural determination (Koldobskaya et al., 2011). Methods also 
exist for creating conformation-specific synthetic antibodies (Paduch et al., 2013) which could be 
used as a crystallisation chaperone for the VcHfq-Qrr1 complex. 
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It may be helpful to identify the best VcHfq-Qrr1 complex by defining the minimal co-complex 
elements required for easier co-crystallisation, as has been shown (Dimastrogiovanni et al., 2014). 
In many instances, despite stable RNA-protein complex formation, crystals of complexes are never 
obtained due inherent RNA and/or protein flexibility. This is usually addressed by creating 
minimal RNA/protein complexes which are more amenable to crystallisation. However, identifying 
the minimal complex can be challenging and requires extensive experimentation. High throughput 
optimisation of RNA-protein complexes for structural analysis involving immobilising a range of 
RNAs (truncates/regions), derived from a specific RNA of interest and screening them for binding 
to a number of proteins, either full length or truncates/specific domains derived from the protein 
of interest would be an exciting prospect and could be used to quickly identify a high affinity, 
minimal complex. Higher-throughput methods for doing this may enhance the chances of gaining 
meaningful data should the approach with full length constructs prove unfruitful. The rest of this 
thesis focuses on developing/expanding effective high-throughput approaches focussed on 
studying RNA interactions.  
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Chapter 5 
5 Labelling RNA for Interaction Studies Using Surface-Based 
Techniques 
 
5.1 Introduction 
RNA is a multifaceted molecule with an ever-expanding repertoire of intra-, inter-molecular and 
ligand-binding functions (Chapter 1). Although RNA can act alone, most frequently its function 
requires interaction with proteins (e.g. RNA chaperones), other nucleic acids and/or small 
molecules. Access to simple tools for probing these interactions, specifically for the 
immobilisation (e.g. to sensor surfaces) and/or detection of RNA, is of increasing importance to 
the study of RNA. 
SPR is a sensitive method that can measure the binding kinetics and affinities of protein, nucleic 
acid or small molecule interactions with partner molecules in real time. SPR requires the 
immobilisation of one molecule (ligand) on the surface of a sensor chip flow cell. Binding is 
monitored in real time through changes in the SPR signal as binding partner molecules (analyte) 
interact with the ligand as they are passed over the surface of the flow cell. A range of 
immobilisation methods, including bioaffinity, have been developed. These commonly involve a 
protein being immobilised as the subject in question. However, in this particular case, RNA is the 
subject of interest. 
A number of approaches currently exist to incorporate bioaffinity tags, such as biotin, into RNA 
molecules. For example, RNA can be chemically synthesised to include the biotin label, but this 
approach is realistically limited to RNAs less than approximately 40 nucleotides in length due to 
the exponential decay in yield with increasing oligonucleotide length (Caruthers, 2011). This 
limitation restricts subsequent interaction studies using tagged RNAs to short, minimal substrates 
containing known binding sites. In place of size-restrictive chemical synthesis, large biotin-labelled 
RNAs can be synthesised by in vitro transcription from a DNA template. For example, including a 
5’-biotin-modified Guanosine analogue alongside the usual GTP within the transcriptional mix 
allows T7 RNA polymerase to synthesise a 5'-biotin tagged RNA (Milligan, Groebe, Witherell, & 
Uhlenbeck, 1987). Alternatively, the 5’ end of the RNA can be chemically modified to incorporate 
a sulfhydryl group, which in turn can react with a haloacetyl-activated biotinylation reagent (Salim 
& Feig, 2010). Nonetheless, attachment of the RNA to the surface via the 5’ end may not be 
suitable when studying interactions involving, or in the vicinity of, the 5’ end of the RNA. 
Therefore, methods to add a biotin tag to the 3’ end of an RNA molecule would be favourable in 
such circumstances. For instance, periodate chemistry can be used to convert the 3’ terminal 
ribose to a dialdehyde; subsequent reaction with biotin-hydrazine yields a 3’-biotinylated RNA 
molecule (Paredes, Evans, & Das, 2011). However, since RNA degradation is a constant threat to 
the researcher, the requirement to subject RNA to multiple, extended, chemical steps may be 
undesirable. Instead, enzymatic approaches can be used. Such approaches include that of T4 DNA 
ligase mediated splinted ligation of two RNA molecules, one of which incorporates a biotin-tag, 
which are hybridised onto a DNA carrier (Kurschat, Müller, Wombacher, & Helm, 2005). 
Unfortunately, the requirement of forming the critical ligation-competent complex, in which the 
two RNA molecules to be ligated are annealed to the DNA splint, reduces the efficiency of this 
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method. Another, more straightforward, enzymatic approach to 3’-end labelling involves T4 RNA 
ligase being used to directly ligate a 5’-adenosyl-pyrophosphate biotin-conjugate to an RNA 
molecule (Cole, Truong, Barone, & McGall, 2004; Richardson & Gumport, 1983) and this is the 
approach that has been explored further in this chapter. 
Methods determined previously by Drs Helen Vincent and Charlotte Henderson (Charlotte Anne 
Henderson, 2012) provided the starting point of biotin-ligation for surface immobilisation 
purposes, as shown schematically in Figure 5.1.  
The aim of this work was to optimise the ligation approach in order to support a surface-based 
interaction study to explore sRNA and mRNA interactions. To do this the importance of the 
nucleotides at the 3’-end of the RNA was investigated. With the tagging approach optimised the 
applicability of surface immobilisation techniques for studying sRNA interactions was explored 
with the goal of realising more high-throughput methods. The results shown in this chapter 
contributed to a peer-reviewed publication (Vincent et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
5.2 A minimum of 3 additional A’s are required at the 3’ end for 
enhanced ligation efficiencies. 
Previous work had shown that negligible yields of biotin-labelled RNA were obtained using the 
standard ligation method (Figure 5.1, Section 2.3.3) but that the yields could be improved 
significantly by adding a stretch of Adenine nucleotides to the 3'-end of the RNA . The preliminary 
data suggested up to 8 As would be sufficient. However, it was unclear whether this beneficiary 
effect could be achieved from appending the RNA with Cs, Gs or Us or the minimum number of 
appended As required to achieve enhanced yields. 
Figure 5. 1 Schematic of the strategy for surface immobilisation of RNAs 
RNA (orange) is prepared by run-off in vitro transcription of the corresponding DNA template (brown). A 
biotinylated Uridine (U-biotin, blue double-pentagon) is then ligated onto the RNA 3'-end by T4 RNA ligase 
(purple). Excess U-biotin was then removed from the labelled RNA using a size exclusion spin column 
leaving it ready for sensor surface immobilisation. Following immobilisation of the biotin labelled RNA to a 
SA-coated (pink) sensor surface (gold), interactions of binding partner molecules (violet) with the 
immobilised RNA can then be undertaken by on-slide probing or SPR analysis. A schematic sensorgram 
illustrative of a binding event for SPR immobilisation is shown. 
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First, to determine the minimum number of A’s that would support enhanced biotin-labelling 
ligation efficiency, MicA was modified to contain an additional 1 to 3 Adenine nucleotides and 
each used as a substrate in the ligation reaction (Section 2.3.3). The addition of 1-3 As were 
demonstrated to have no impact on MicA native structure, as determined by MFold analysis 
(Figure 5.2, panel 1). Ligation reactions analysed by denaturing PAGE (section 2.5.1) showed that a 
A-tail of at least 3 additional As was required to support enhanced biotin-labelling as indicated by 
the presence of a higher MW band corresponding to RNA with U-biotin ligated in the lane for 
MicA+AAA (Figure 5.2, Panel 2, D). MicA WT produced negligible ligation, as was known to be the 
case from preliminary studies performed by colleagues (Charlotte Anne Henderson, 2012). The 1-
2 A tails also produced negligible yields. 
 
 
 
 
 
 
 
 
5.3 The nature of the nucleotides at the 3’ of the RNA is important in 
determining ligation efficiency. 
To explore the effect of different nucleotides at the 3’ end of RNA on ligation efficiencies, MicA 
was appended with 3’ tails comprising 4 additional A’s, G’s C’s or U’s. Mfold analysis of the 
predicted structures indicated that the native structure was retained when appended with G’s, 
U’s and A’s, whist it was lost when C’s were added (Figure 5.3). Consequently C's were not 
Figure 5. 2 Structure prediction and analysis of ligation reactions for MicA with increasing A tail lengths 
Panel 1) Mfold structure prediction analysis of MicA sequences with increasing A-tail lengths, B-D) shows 
no predicted disruption of the native structure shown in A). Panel 2) Data are shown for MicA with 0, 1, 2 
and 3 additional adenine nucleotides appended to the 3’ end (A-D, respectively), as noted beneath the gel. 
Ligation of U-biotin is only seen for MicA with a minimum A-tail of 3 nucleotides in length (Panel 2, D). 
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included. Ligation reactions analysed by denaturing PAGE (section 2.5.1) showed that A-tail 
addition supported enhanced biotin-labelling compared to MicA with a U or G-tail, as indicated by 
the extra band corresponding to the ligation product (Figure 5.3 B, C and D).  
 
 
 
 
 
 
 
 
 
 
Having shown that an A-tail addition results in improved biotin-labelling for MicA, an additional 
sRNA was tested so see if this effect was more generally applicable. In order to maintain Qrr1 
native structure, 8 As were appended to create the A-tail. However, whilst the addition of similar 
length C and U-tails had no effect on Qrr1 native structure, MFold analysis indicated that the 
addition of a G-tail impacted the Qrr1 native structure (Figure 5.4). By analogy to the result for 
MicA, ligation reactions for the Qrr1-modified sRNAs were analysed by denaturing PAGE (section 
2.5.3) and again showed that A-tail addition supported enhanced biotin-labelling compared to 
Qrr1 with C or G-tails (Figure 5.4). Therefore, A-tail addition was seen to be important for high 
ligation efficiencies. Indeed, significant yield increases were obtained for other RNAs with A-tails 
of lengths 4 – 8, in each case the A-tail length was limited by the need to maintain native sRNA 
structure. These findings were in agreement with similar data produced by colleagues (Charlotte 
Anne Henderson, 2012). 
Figure 5. 3 The effect of the 3’-tail of MicA on ligation efficiencies 
Mfold and ligation analysis of MicA with differing 3’ ends: A) Mfold analysis of MicA, provided as a 
comparison to the predicted structures of MicA with U, -G, -A and -C tails B-E). B) Mfold analysis of MicA 
with a U-tail with corresponding ligation reaction gel. C) and D) as for B) but for MicA with G and A-tails 
respectively. E) Mfold analysis of MicA with a C-tail indicating the predicted structure to be disrupted from 
the native form and therefore was not tested experimentally. Ligation was only observed for MicA with a A-
tail D). 
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For future biotin-labelling studies, As were appended to ensure a minimum tail length of 4 
adenines. 
5.4 Preparation of biotin-tagged RNAs for surface immobilisation 
studies using the optimised 3' ligation method 
Using the principles for ligation optimisation identified in Sections 5.2 and 5.3, multiple RNAs 
were biotin tagged for use in later studies. As well as the previous examples of MicA and Qrr1 
shown earlier, another sRNA, OxyS was appended with 4 extra As at the 3' end and showed an 
effective ligation efficiency (Figure 5.5 A). 
The 3' biotin-RNA samples were purified via methods described in section 2.3.3. To confirm the 
purity of the samples and check the accessibility of the biotin tag it was necessary to test for SA 
binding ability. Using an SA capture assay with native gel analysis (in Section 2.3.4) SA binding was 
seen indicating accessibility of the biotin (Figure 5.5B). This indicated that surface-immobilisation 
using the SA-biotin affinity interaction would likely be suitable for 3’-biotin labelled RNAs, thereby 
allowing subsequent surface-bound interaction studies. 
Figure 5. 4 The effect of the 3’-tail of Qrr1 on ligation efficiencies 
As for Figure 5.3, but for Qrr1. In this case, Qrr1 with a G-tail E) was found to disrupt the native predicted 
MFold structure A) and was therefore not tested experimentally. Please note that in C) the Qrr1 (C-tail) RNA 
contains an impurity which is visible on the gel in both the control and ligation reaction samples, but it is 
still possible to observe that no ligation product is generated in the ligation reaction. Ligation was observed 
for Qrr1 with both A D) and U B) tails, but was noticeably more effective for the A-tail D). 
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5.4.1 Strategy for estimating the specific affect of the 3’ biotin tag on sRNA 
interactions 
When studying RNA interactions for which the 3' end is of particular interest as may be the case 
for some sRNAs with Hfq (Otaka et al., 2011), a suitable alternative to biotin-tagging RNA at the 3' 
end would be to tag the 5’ end. RNA tagging at the 5' end would not likely cause steric hindrance 
of binding to the 3' end and may be beneficial for this reason. Therefore, the optimisations for 3'-
biotin tagging by ligation developed in Sections 5.2 and 5.3 informed attempts to produce a 5' 
biotin-tagged RNA to serve as a comparison for 3' end immobilisation. 
The approach for the ligation was to monophosphorylate the RNA by standard methods and 
introduce it in to a T4 RNA ligase reaction with a 5'-biotin substrate, namely: 5' biotin-r(A)4-3' OH. 
The monophosphorylated RNA serves as the donor and the 5'-biotin-r(A)4-OH serves as the 
acceptor. However, all attempts at this ligation reaction were unsuccessful in producing the 
desired ligation product, possibly because the 5'-end of the RNA used (Qrr1) was not an ideal 
substrate for T4 RNA ligase. Consequently, to allows estimation of the specific effect of the 3'-
biotin tag on sRNA binding characteristics it was deemed suitable to compare SPR binding of 
VcHfq to immobilised 3'-biotin Qrr1 with the previously characterised unlabelled Qrr1 binding to 
immobilised VcHfq (Vincent, Henderson, Stone, et al., 2012). 
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Figure 5. 5 Biotin tagging and biotin capture assay of purified 3'-biotin RNAs 
A) OxyS (+As) RNA ligation shows successful biotin-tagging as indicated by the slower migrating band. B) 
Biotin-Qrr1 RNA was incubated with and without an excess of SA and the reaction products were 
subsequently separated by native gel electrophoresis. The biotin-RNA showed a retarded mobility when 
incubated with SA due to the larger size of the SA-biotin RNA complex compared to the biotin-RNA only. 
Qrr1(+As) RNA which contains no biotin was used as a negative control to confirm the retardation in 
mobility is due to specific capture of the biotin by SA. Purified 3'-biotin Qrr1 RNA was over 99 % pure. 
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SPR analysis showed the interaction of VcHfq with immobilised 3'-biotin Qrr1 had a KD of 
approximately 1.5 nM (Figure 5.6), which is in close agreement to the KD published for unlabelled 
Qrr1 binding to immobilised VcHfq of 2.2 nM (Vincent, Henderson, Stone, et al., 2012). The SPR 
data was fit to a 1:1 binding model (Figure 5.6) evaluated to have a Chi2 value of 1.71.  
The Hfq-binding data for both Qrr1 immobilised via the 3'-end and unlabelled Qrr1 free in solution 
closely agreed and indicates that the interaction of Qrr1 with VcHfq is not hindered Qrr1. 
Immobilisation via the 3'-end. For further studies, 3-biotin labelled Qrr1 was used (Sections 5.5 
and 5.6). 
 
 
 
 
 
 
5.5 Surface immobilisation of 3’end biotin-labelled Qrr1 for interaction 
studies via SPRi 
SPRi is a platform for high throughput interaction studies, providing information on kinetic 
processes. Like Biacore, it uses the phenomenon of SPR to monitor biomolecular interactions in 
real time. It measures modifications of the refractive index at the surface of the biochip, which 
can be correlated to mass variations. SPRi advances on SPR technology by visualising the whole of 
the biochip via a video CCD camera. This design enables spots of immobilised molecules to be 
prepared in an array format on the biochips with each active spot providing SPR information 
simultaneously and providing real time difference images across the biochip array surface. 
5.5.1 Preparation of the SPRi array surface and establishing functionality 
Working in collaboration with the developing manufacturers (Horiba Scientific) this study formed 
part of the first efforts to explore this new technology for use in studying RNA interactions. Using 
the well characterised Qrr1-VcHfq interaction used earlier (see Section 5.4.1), immobilisation of 
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Figure 5. 6 SPR binding of VcHfq to immobilised 3'-biotin Qrr1 
Sensorgram data of VcHfq binding to immobilised 3'-biotin Qrr1 is shown in red with the binding model fit 
shown in black. A small schematic illustrating the flow cell arrangement is included (inset). 
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Qrr1 as the ligand in an array was explored before moving on to test Qrr1 functionality through 
VcHfq (analyte) binding. 
During the preliminary experiments of this study it was realised that the recommended self-
assembled monolayer surface (SAM) biochips provided with amine coupled extravidin or coated 
with SA in-house, were not suitable for the immobilisation of biotin-RNAs most likely because of 
insufficient surface loading capacity. The surface used for immobilising the biotin-RNAs needed to 
be a 3D surface - similar to that used in the Biacore SPR experiments - consisting of carboxymethyl 
dextran (CMD) functionalised with NHS esters (Figure 5.7). For the following experiments 
described, a CMD biochip was prepared by coating with extravidin under flow and blocking 
remaining active groups before the immobilisation step in which the biotin-RNA and relevant 
control samples were cycled over the surface using a Continuous Flow Microspotter (SPRi-CFM) 
printer. Once the immobilisation step was completed the experiments were carried out using a 
SPRi-PLEX II system. The greater density of functional groups and capacity of the 3D surface 
together with the cycling immobilisation conditions were the essential changes needed to the 
experimental format to enable the experiments to be a success. More details of the systems used 
and how they work can be found in Section 2.8. 
 
 
 
 
 
 
 
 
 
3’ labelled biotin-Qrr1 spots were immobilised at concentrations between 12.5 nM and 1.4 µM 
with control spots of biotin-antibody, biotin-DNA ss25mer, U-biotin (reagent using to label the 
Qrr1), unlabelled Qrr1 and blank buffer, prepared simultaneously (Figure 5.10A, Table 5.1). 
Table 5. 1 SPRi immobilisation samples and array format 
Array spots featured in binding experiments are coloured; Orange - Qrr1 RNA test, Brown – Biotin-ssDNA 
positive control, Black-Biotin Ab, U-Bi and unlabelled Qrr1 control. 
 1 2 3 4 5 6 7 
a 
1.4 µM 
Qrr1 
12.5 nM 
U-Bi 
300 nM 
U-Bi 
1.4 µM 
U-Bi 
Buffer 
reference 
Buffer 
reference 
100 µM 
25-mer 
ssDNA 
b 
12.5 nM 
Bi-Qrr1 
50 nM Bi-
Qrr1 
100 nM 
Bi-Qrr1 
300 nM 
Bi-Qrr1 
600 nM 
Bi-Qrr1 
1.4 µM 
Bi-Qrr1 
100 µM 
25-mer 
ssDNA 
C 
12.5 nM 
Bi-Qrr1 
50 nM Bi-
Qrr1 
100 nM 
Bi-Qrr1 
300 nM 
Bi-Qrr1 
600 nM 
Bi-Qrr1 
1.4 µM 
Bi-Qrr1 
Biotin-
Antibody 
U
- 
U
- U- U- 
1 2 
3 4 U- Biotin-RNA 
Extravidin 
Carboxymethyl 
dextran 
Gold 
KEY: 
Figure 5. 7 Biochip 3D surface construction 
Schematic and key showing the multiple layers of the CMD SPRi biochip. The gold layer needed for the 
plasmon readings (gold) is coated with carboxymethyl dextran (black) linked to extravidin protein via NHS 
chemistry. The biotin-RNAs were captured in array format. The thickness of the CMD layer can be between 
50 - 200 nm and is suitable for a range of biomolecule interactions due to its low non-specific binding 
characteristics. 
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As a positive control, to test the functionality of the newly made array surface, injection of a 
complementary ssDNA was seen to bind only to the biotin-DNA ss25mer immobilised spots on the 
surface (spots a7 and b7, Table 5.1, Figure 5.8). This confirmed the functionality of the surface for 
studying specific molecular interactions (Figure 5.10).  
 
 
 
 
 
 
 
 
 
Qrr1-VcHfq is known to be a very tight interaction with a KD in the low nanomolar range (Vincent, 
Henderson, Stone, et al., 2012). In order to avoid having to use single-cycle kinetics, as was the 
case with SPR, regeneration conditions were established to allow reuse of the same biochip after 
VcHfq injections and to allow determination of kinetic parameters for the Qrr1-VcHfq interaction 
using a multi-cycle kinetics approach. Firstly, specific VcHfq binding to immobilised Bi-Qrr1 was 
explored. Injection of VcHfq at 4.5 nM over the surface showed binding only to Bi-Qrr1 
immobilised spots on the surface (b1-b6 and c1-c6, Table 5.1, Figure. 5.9 A-1 and 2). No binding to 
control spots was seen. With surface functionality illustrated, the bound VcHfq analyte needed to 
be removed whist not impairing the functionality of the immobilised Qrr1 ligand such that full 
activity was retained. 500 mM NaCl was applied as the regeneration solution between three 
successive injections of VcHfq at 4.5 nM. Analysis of the biotin-Qrr1 spots (immobilised at 1.4 µM) 
showed that the response intensity was maintained with each VcHfq injection: indicating that 
regeneration by 500 mM NaCl does not damage the surface or impact functionality and is 
therefore an appropriate regeneration solution (Figure 5.9).  
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Figure 5. 8 SPRi difference image for ssDNA positive control binding 
SPRi difference images corresponding to A) Beginning of injection. B) ssDNA positive control binding. 
Binding intensity is represented in greyscale (white pixels indicate high signal). Difference image of binding 
reveals that the ssDNA analyte binds only to the two complementary ssDNA ligand spots (a7 and b7). No 
background binding is seen on any other sample spots indicating specific binding. Signal/noise ratio is 
satisfactory. 
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5.5.2 Functional and kinetic analyses of VcHfq binding to immobilised Bi-Qrr1 using 
SPRi 
Having established suitable regeneration conditions which enabled a multi-cycle kinetics 
experiment to be carried out. Functional analysis was undertaken by injecting a range of VcHfq 
sample concentrations over the biochip surface. Upon injecting increasing concentrations of 
VcHfq over the surface, an increase in response, as indicated by the brighter pixel intensity, was 
observed only for biotin-labelled Qrr1 spots with response increase shown in an immobilisation 
concentration dependent manner (Figure 5.10 B). As seen previously (Figure 5.9 A) VcHfq was not 
observed to bind to any of the included controls (Figure 5.10 B). The limit of detection for VcHfq 
binding was observed to be 0.25 nM injected VcHfq protein (Figure 5.10 C). These results 
demonstrate the successful immobilisation of functional biotin-Qrr1 RNA on an SPRi biochip. 
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Figure 5. 9 Verification of regeneration conditions for kinetic analysis 
A) Difference images and sensorgram illustration of: 1 - baseline, 2 - binding, 3 - regeneration and 4 - 
recovery of baseline. B) Densities of bound analyte (with subtraction of the buffer only negative control) 
obtained on biotin-Qrr1 RNA spots immobilised at 1.4 µM after three sequential injections of VcHfq at 4.5 
nM. Biochip surface was regenerated using 500 mM NaCl between injections. Boxes indicate signal averages 
for three injections and error bars indicate the standard deviation of two spots. Retained protein for each 
injection is similar within error margin indicating no loss of binding. 
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Figure 5. 10 VcHfq binding to immobilised biotin-Qrr1 utilising SPRi shows functionality and 
concentration-dependent response 
A) Schematic of SPRi biochip surface showing biotin-Qrr1 concentration range and relative controls, details 
of samples can be found in table 5.1. B) Difference image of array surface observed during injection of 2.5 
nM VcHfq. Binding intensity is represented in greyscale (white pixels indicate high signal). Only biotin-Qrr1 
spots become white, meaning VcHfq interacts specifically with the immobilised biotin-Qrr1 RNA. C) Surface 
coverage (with subtraction of the buffer only negative control) obtained from biotin-Qrr1 RNA spots 
immobilised at increasing concentrations with SPRi-CFM after the injection of a series of concentrations 
(from 0.05 to 5 nM) of VcHfq protein. Boxes indicate signal averages for two spots and error bars for the 
standard deviation. Red box indicates the biotin-Qrr1 concentration spots used in later analysis. 
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Following verification of binding specificity and functionality of the immobilised Bi-Qrr1, a kinetic 
experiment was conducted incorporating the 500 mM NaCl regeneration step between VcHfq 
injections of: 1, 2.5 and 5 nM. Sensorgram data were fitted to a 1:1 binding model using 
ScrubberGen software (Horiba Scientific) indicating a KD of approximately 0.5 nM (Figure 5.11). 
This result is in close agreement with previous observations utilising SPR in which Qrr1 and VcHfq 
affinities (in both analyte and ligand orientations) were calculated as approximately 1.5 and 2 nM. 
The SPRi calculated affinity further corroborates the findings in Section 5.4 that 3’ biotin-
immobilisation of Qrr1 does not impact functionality in terms of VcHfq binding. Furthermore, 
these results demonstrate the first multiplex format for high-throughput RNA interaction studies 
using sensor surface technology. This methodology opens up potential avenues for high 
throughput RNA interaction studies using multiplexing, or array formats. 
 
 
 
 
 
 
 
5.6 Surface-immobilised biotin-RNA on a traditional microarray glass 
slide  
Considering the recent increase in popularity and interest in transcriptomics (Barquist & Vogel, 
2015) the need for high throughput functional analysis is pressing. Having demonstrated that 
biotin-labelled sRNAs can be surface-immobilised in an active form (sections 5.4 and 5.5), the 
potential for microarray slide immobilisation was investigated to explore whether or not higher 
throughput analysis could be possible. 
Using Nexterion H microarray slides, SA was surface-immobilised in spots prior to application of 
biotin-labelled sRNAs, Qrr1 and MicA, as well as controls including non-labelled sRNAs, control 
biotin-labelled sRNA, OxyS and blank spots (Section 2.9.1). The biotin-RNA arrays were probed 
Figure 5. 11 Kinetic analysis of VcHfq interaction with immobilised biotin-Qrr1 RNA 
VcHfq protein was injected at 1 nM (blue kinetic curves), 2.5 nM (red kinetic curves) and 5 nM (green 
kinetic curves). Local fits (orange) of VcHfq protein interactions with immobilised biotin-Qrr1 RNA at 1.4 µM 
using a 1:1 interaction model. 
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with corresponding fluorescently-labelled binding partner mRNA i.e. hapR and ompA for Qrr1 and 
MicA, respectively and visualised (Figure 5.12).  
 
 
 
 
 
 
 
 
 
 
 
When probed with Cy3-labelled mRNA, correct binding to its corresponding immobilised sRNA 
binding partner was observed (i.e. MicA-ompA and Qrr1-hapR). No binding was seen to the 
controls, verifying the specificity of the biotin capture and the binding interactions. These 
promising results indicate that it may be possible to study in high-throughput sRNA-mRNA 
interactions and potentially other RNA-binding partner interactions using RNA-immobilised to 
microarray slides and labelled partner molecules. 
5.7 Summary and Conclusion 
In this chapter, a simple, quick and efficient strategy to biotinylate the 3’ end of biologically 
relevant RNAs has been investigated. 
To achieve high yields of biotin-tagged RNA, it was identified that a tail of four to eight adenine 
nucleotides were required at the 3’ end of the RNAs in order to support the efficient T4 RNA 
Figure 5. 12 Immobilised biotin-sRNA - mRNA binding interactions in microarray format 
Panel A) SA-coated microarray slide with control spots of (1) biotin-OxyS, (2) blank surface, (3) sRNA MicA, 
and test spot of (4) biotin-MicA. The surface was probed with Cy3- labelled ompA RNA. The specific ompA 
interaction with surface-immobilised biotin-MicA is shown by the green spot. 
Panel B) As for A) but in this case the test spot (4) is biotin-Qrr1 and the control sRNA spot (3) is Qrr1. The 
surface was probed with Cy3-labelled hapR RNA. The specific hapR interaction with surface-immobilised 
biotin-Qrr1 is seen by the green spot. C) Schematic representation of the slide interactions. Labels: RNA - 
orange lines, biotin - blue double pentagon, SA - pink, slide surface - gold, probe RNA - green. 
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ligase-mediated addition of a biotinylated Uridine nucleotide. It is possible that the A-tail 
improves access of the RNA chain to the ligase active site. Most likely, the improved ligation 
efficiency is a consequence of the substrate specificity of T4 RNA ligase as the enzyme requires a 
single stranded 3’ terminus and is sensitive to the nature of the 3’ end of the acceptor RNA 
(England & Uhlenbeck, 1978; Romaniuk, McLaughlin, Neilson, & Romaniuk, 1982). Consistent with 
these earlier findings, the data shows that a single stranded A-tail appears to be preferred over C, 
G, or U tails for enhancing the 3’ biotin-ligation efficiency of the structured RNAs tested here 
(Section 5.3). This indicates the additional importance of the nature of the nucleotides comprising 
the single stranded 3’ tail in supporting enhanced yields, enabling the modification of a 
recognised - albeit currently not highly used – approach (Cole et al., 2004; Richardson & Gumport, 
1983) thereby making it more user-friendly and time-efficient.  
For these sRNAs tested here, it was shown that 3’-biotin tagging of RNAs and subsequent 
immobilisation has no detrimental impact on binding to protein or RNA binding partners. Specific 
binding of VcHfq to biotin-tagged sRNA Qrr1 was seen. Similarly, specific pairing of biotin-tagged 
sRNAs with cognate partner mRNAs was observed, demonstrated with Qrr1-hapR and MicA-ompA 
interactions. With the approach validated, the method was exploited in the quantitative analysis 
of VcHfq-Qrr1 interactions on a sensor surface; as shown by SPR and SPRi and for sRNA-mRNA 
pairing with microarray glass slide format. The KDs calculated by sensor surface experiments are in 
keeping with those shown previously in the literature (Vincent, Henderson, Stone, et al., 2012). 
Interestingly, the characterisation of the Qrr1-VcHfq interaction by SPR and SPRi described in this 
chapter indicated 3'-end immobilisation of Qrr1 made no significant difference in binding to VcHfq 
when compared with SPR studies for which Qrr1 was unlabelled. This further corroborates the 
findings in Section 4.4 demonstrating no specific need for Hfq to interact with the U-tail of an 
sRNA. Collectively these findings cannot clearly define the details of the interaction between 
VcHfq and Qrr1 sRNA but they question the validity of the current theory in which Hfq is thought 
to require interaction with an sRNA 3'-U tail for function. The generality of this theory has 
previously been questioned as, to date, direct 3'-end recognition by Hfq has only been 
demonstrated for a few sRNAs (Sauer, 2014). 
Finally, sRNA-mRNA interactions were demonstrated for the first time on microarray format glass 
slides. The interactions were shown to be specific which leads to speculation that RNAs could be 
tested for interactivity with partner mediates in a higher throughput multiplex or microarray 
contexts - of which indications of feasibility have been shown (Figure 5.12). So far, efforts made in 
developing methods to study RNAs have lagged behind that of proteins and other biomolecules 
(see Section 1.4). The reasons for this ultimately involve the sensitivity of RNA to degradation. The 
methods used in Section 5.6 include numerous processing steps, currently prohibitive for 
generating large numbers of RNAs for testing. However, given the need for high-throughput 
methods to explore the interactions currently hidden within transcriptomics data the results 
presented have taken the first steps towards exploring multiplex/array formats capabilities. 
Expanding on this is the focus of the next two chapters.  
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Chapter 6 
6 Functional Multi-RNA Array Generation - Proof of Concept 
 
6.1 Introduction 
Understanding the manner in which two molecules interact lies at the heart of pharmaceutical 
drug development and biological research as a whole. Indeed, RNA-RNA, RNA-protein and RNA-
small molecule interactions are common mechanisms for many biological processes (Cech & 
Steitz, 2014; Coppins et al., 2007; Morris & Mattick, 2014) and it is believed that RNAs represent 
an, as yet, untapped resource in the search for novel pharmaceutical drug targets (Wahlestedt, 
2006). Scientific interest in RNAs has recently been further intensified with the explosion of the 
transcriptomics field, prompting the need for high-throughput analysis techniques in order to 
unravel the network of interactions currently hidden within this data (Rusk, 2014). 
High throughput techniques are therefore needed to study RNA interactions with other RNAs, 
proteins and small molecules. 
Indeed, despite current scientific interest, the study of RNA-interactions to-date has been 
restricted by the instability of RNA, the inability to chemically synthesize large RNAs efficiently 
(Somoza, 2008), coupled with the paucity of available techniques. Recent efforts to address these 
issues have taken the first steps towards developing approaches to support the study of RNA-
interactions in high-throughput format through using on-surface transcription of RNAs that 
remain tethered to their surface-immobilised template DNAs (Buenrostro et al., 2014; Tome et al., 
2014). The RNAs generated were seen to be immobilised to complex surfaces that also included 
bound protein molecules to support effective RNA-surface anchoring. However, the complex 
nature of the RNA-tethered surface, particularly the significant levels of DNA present, can lead to 
issues with non-specific interactions occurring when testing for the specific binding of RNA-
interaction partners. Hence, simplifying the RNA surface is clearly seen to be required. 
Steps towards this goal similarly involve the use of enzymatic transcription of surface-attached 
DNA templates, but in this instance these are directly adjacent to surface-attached RNA primer 
sequences to support synthesis of the RNA complement of the DNA template (Wu et al., 2014). 
Removal of the surface-attached DNA following DNase treatment simplifies the nature of the 
surface; although, given the issues of RNA stability, introducing a post RNA-synthesis treatment 
step increases the risk of impacting the RNA through exposure to degradation agents. 
Furthermore, this method has only been used to generate RNA arrays of ~30mer sequences which 
fail to be a representative size of many prokaryotic, eukaryotic or viral RNAs of functional interest.  
A method is therefore required that is capable of making multiple, different arrays of long 
functional RNA that represent those of interest for interaction studies.  
6.2 The concept of DNA-programmed functional multi-RNA arrays 
To address the current problems this chapter describes the design an exploration of a new 
method that involves the DNA-programmed production of functional multi-RNA arrays that would 
be quick and easy to generate on demand, incorporate a simplified surface that is free of 
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template DNA, and does not require any post RNA-array treatment prior to probing with potential 
binding partners (Figure 6.1). 
The method (Figure 6.1) involves using a template slide containing a DNA array encoding an RNA 
of interest (ROI) fused to an RNA aptamer at the 3’-end. The RNA aptamer facilitates RNA-
tethering to a capture slide surface of immobilised aptamer ligand that is set up facing the 
template slide in a ‘sandwich’ arrangement, containing the IVT reagents in between the two array 
surfaces as the ‘filling’. Once transcribed from their DNA templates, this ‘sandwich’ format 
supports the almost instantaneous immobilisation of only fully synthesised RNAs via the aptamer 
at their 3’ end. The immobilised DNA templates are removed with the template slide and the 
transcription reagents washed away in one step leaving a slide of aptamer-immobilised RNA. With 
each individual spot on the DNA array capable of coding for a different RNA gene, it should be 
possible to generate multi-RNA arrays in a high density format for subsequent high-throughput 
probing with fluorescently labelled binding partners without further handling or treatment of the 
multi-RNA array (explored in Chapter 7). This chapter focuses on proving the concept of this 
method, initially focusing on generating a functional RNA array before expanding to consider 
multi-RNA arrays. 
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6.3 Design of template and capture slide surfaces 
6.3.1 RNA conjugate and capture slide design 
RNA aptamers (from the Latin aptus - fit, and Greek meros - part) are oligoribonucleotide 
molecules that bind to a specific ligand. Although natural aptamers exist as riboswitches, they can 
also be created by selecting them from a large random sequence pool, engineered through 
repeated rounds of in vitro selection by a process called SELEX (systematic evolution of ligands by 
exponential enrichment) to bind to various molecular targets such as ions, small molecules, 
proteins, nucleic acids, and even cells, tissues and organisms (Darmostuk et al., 2015). As such, 
RNA aptamers are useful in biotechnology as they offer molecular recognition properties. In 
addition to their discriminate recognition, RNA aptamers can be completely generated in a test 
tube, and are readily produced by IVT. A number of well-characterised RNA aptamers exist. For 
example the NMR structure of the tobramycin RNA aptamer (tobapt) bound to its molecular 
DNA template format 
Linker sequence 
T7 RNAP promoter 
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Slide of 
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Figure 6. 1 The concept of making DNA-programmed functional multi-RNA arrays 
Schematic representation of the process of making DNA-programmed functional multi-RNA arrays. 
Experimental format, left, illustrates the template slide facing the capture slide. The two slides sandwich an 
IVT mixture which facilitates the production of the RNA which then diffuses to be captured on the opposite 
slide. The RNA array is then ready to be probed with labelled molecules. The sandwich format, centre, 
shows a 'zoomed in' view of the immobilised DNA templates (brown) encoding the RNAs and the 
immobilised ligand (black circles) used to capture the RNA (orange) to the opposite slide. The DNA template 
format, right, illustrates the necessary components incorporated in to the DNA template.  
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target, the aminoglycoside antibiotic tobramycin (tob) (Jiang & Patel, 1998), has been elucidated 
and it has been shown to have low nM interaction affinity (Hamasaki et al., 1998; Y. Wang & 
Rando, 1995). Similarly, the SA RNA aptamer (SAapt) has been extensively characterised and has 
been used for a number of years as a tag for affinity purification via SA binding of 
ribonucleoprotein complexes due to its low nM interaction affinity, its ability to select specifically 
for target from within complex mixtures and binding stability at high NaCl concentrations 
(Srisawat & Engelke, 2002). 
When considering suitable RNA aptamers for use in developing an RNA array technology, Tob and 
SA RNA aptamers were chosen as the ligands (tob and SA) are readily available, inexpensive and 
can be easily surface-immobilised via amine-coupling to NHS-activated slides (Nexterion H; Figure 
6.2). The Nexterion Slide H was chosen for its unique surface properties which impart low non-
specific binding, high loading capacity, straight-forward chemistry for immobilisation of ligands 
whilst preserving their native structure. These features make Nexterion H slides an ideal surface 
for immobilising ligands to support interactions studies of structured RNAs with a range of 
molecules including proteins, nucleic acids and other biomolecules (Harbers et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
6.3.2 Design of ROI-aptamer conjugates using RNA folding programmes 
ROI, selected for use in making DNA-programmed RNA-arrays, were designed to be made fused to 
an aptamer which confers the ability to be selectively immobilised to the tob/SA capture surface 
during 'printing' of the RNA array. The RNAs selected were conjugated to the aptamer via a short 
single stranded linker of approximately 20 nucleotides in length as preliminary data collected in 
the group by Dr Helen Vincent suggested this helped the aptamer and ROI fold independently of 
SA 
SA 
A 
B 
Figure 6. 2 RNA capture slide preparation by immobilisation of aptamer ligands 
Schematic illustration of the immobilisation chemistry of aptamer ligands to the microarray slide. The 
microarray slide is coated in a cross-linked, multi-component polymer layer (purple) activated with N-
Hydroxysuccinimide (NHS) esters to provide covalent immobilisation through primary amine groups. The 
NHS ester reacts with primary amines which is predominantly the 6'-amine position of ring II for tob (Jiang 
& Patel, 1998; Y. Wang & Rando, 1995) as shown in A) and lysine side chains on SA as shown in B) resulting 
in an amide linkage between the ligand and the surface. 
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each other - therefore preserving both aptamer and ROI function - and also providing some 
distance between the slide surface and the ROI for greater accessibility to support subsequent 
probing/interaction studies. 
Two RNA folding programmes were used to predict structures of prospective RNA-linker-aptamer 
combinations, namely Mfold (Zuker, 2003) and RNAfold (Gruber, Bernhart, & Lorenz, 2015). These 
programmes predict RNA structures by energy minimisation using nearest neighbour energy 
parameters and are a common method for predicting the structure of small RNAs without 
experimental data (Hammer & Bassler, 2007). The parameters used with both programmes 
included a temperature setting of 37 °C, as this is the temperature of the IVT reaction and the 
temperature at which the RNAs will fold and bind to the capture surface. All other default 
parameters were used, unless otherwise stated. The folded RNA outputs were then analysed by 
comparison to isolated folded structures of both the aptamer and ROI, and as appropriate, 
verified by known structural information. Typically, the RNA-linker-aptamer combinations with 
the lowest energies were chosen in which the active structures of both the ROI and the aptamer 
were preserved and the linker did not form any structures or interfere with the ROI or aptamer 
conformations. Examples for each MicA conjugates with Tob and SA aptamers are shown in Figure 
6.3 (see Appendix 4 for predictions of other constructs used). The linker sequences were designed 
based on preliminary data obtained by Dr Helen Vincent that approximately 20 nts of repeat 
sequences would allow correct folding. Repeat sequences rather than random sequences were 
found to be successful for keeping the linker single stranded. The linkers never contained Guanine 
because of its ability to form G-C Watson-Crick and G-U wobble base pairs which gave the linker 
undesirable flexibility in forming duplexes. Adenine and Uracil were commonly included because 
of their weak contribution to duplex strength.
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Figure 6. 3 Design of ROI-aptamer conjugate RNAs and prediction of their structures 
RNA structures predicted by folding programmes. The ROI are shown in orange letters with solid black lines indicating base pairs. The linker sequences are shown in green and the 
aptamers in blue. ROI-aptamer conjugate structure predictions show the linker sequences are predicted to allow the ROI, linker and aptamer to fold independently of each other whilst 
retaining correct structures for both aptamer and ROI and remaining single stranded (or double stranded in the case of the ds linker) themselves. The native ROIs were used as a control 
to show that they would also be predicted to fold to the published structures. Predictions were made using the Mfold program (Zuker, 2003) and verified with a second program RNAfold 
(Gruber et al., 2015). 
tob aptamer, ΔG = -
18.00 
(Jiang & Patel, 1998; 
Y. Wang & Rando, 
1995) 
MicA_tob, ΔG = -40.50 
SA aptamer, ΔG = -10.80 
(C Srisawat & Engelke, 2001) 
MicA_SA, ΔG = -45.70 
Key 
sRNA Linker Aptamer 
MicA, ΔG = -22.20 (Udekwu et al., 2005) 
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6.3.3 DNA template design 
The DNA sequences for the ROI/ROI-linker-aptamer were appended with an upstream T7 
bacteriophage RNA polymerase (RNAP) promoter sequence to facilitate their transcription. DNA 
templates were synthesised by TBIO-PCR (Section 2.2.1.2) and subsequently PCR amplified using a 
5'-biotin forward primer to incorporate an upstream biotin moiety (Section 2.2.3) which would 
facilitate its immobilisation to SA slides. The DNA templates were then in vitro transcribed as in 
Section 2.3.1 and the transcription products were assessed for correct size by denaturing gel 
electrophoresis with a size standard marker (Section 2.5.3). 
6.4 Verification of functionality of the aptamer for surface 
immobilisation 
Before proceeding to test whether RNA arrays could be made by the proposed method of 
transcription 'printing' from DNA template slides, the RNA-aptamer conjugates were first in vitro 
transcribed and tested for functionality (Figure 6.4). The ROI-aptamer fusion was tested via a 
simple on-surface binding assay to see if the aptamer successfully conferred the ability to bind the 
ligand and that the interaction between RNA and ligand is specific for the aptamer conjugate with 
low non-specific binding (Figure 6.4 B). The on-slide binding assay in Figure 6.4 B showed specific 
interaction of multiple RNAs to either the tob or SA ligand when fused to the relevant ligand 
aptamer and compared with the non-conjugate RNA. These experiments confirmed functionality 
of the aptamers and proved the concept of using them for immobilisation when appended to an 
ROI. The results therefore confidence in moving forward to test, the proposed RNA array 
sandwich print method. 
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6.5 Preparation of DNA template and RNA capture slides 
For the preparation of the DNA templates and RNA capture slide surfaces a guide was used to 
immobilise the DNA aptamer and ligands in a mirrored arrangement to facilitate alignment when 
arranged for the sandwich IVT. Detailed methods are included in Section 2.9.2. 
Briefly, for both template and capture slides, following the guide spots of 1 µg/µl SA in PBS were 
spotted onto the slides and the slides incubated in a humidified chamber for 30 minutes at 37 °C. 
Spot volumes were varied depending on the number of spots on the slides: 
Volume = x µl 
x=10 if: spot # ≤ 6 
x=5 if: 6 < spot # ≤ 10 spots 
x=0.5 if: 10 < spot # ≤ 48. 
 
Slides were washed 3 x with 5 ml PBST and 1 x with 5 ml filtered dH2O. Slides were covered with 5 
ml of 50 mM ethanolamine-HCl pH 8.5 and incubated for 30 minutes at room temperature. 
Slides were washed as above and dried with pressurised air. 
RprA 
RprA_SA 
ompA_SA 
ompA 
hapR 
hapR_SA Qrr1 hapR_tob 
hapR Qrr1_tob 
A 
Incubate 
and wash 
B 
Schematic key: 
ROI_apt ROI dye label 
Figure 6. 4 Verification that aptamer conjugation conferred binding capability to ROI 
A) Schematic illustrating an experiment in which 400 nM fluorescently labelled ROI and ROI-aptamer RNAs 
were incubated on spots of immobilised aptamer ligand before washing and scanning the slide. 
Schematically only aptamer conjugates are immobilised to the ligand. B) Results of the experiment 
described in A) show specific interactions between ROI-aptamer RNAs and the immobilised ligand indicating 
aptamer presence confers the correct binding activity to the conjugate. The ROIs include sRNAs: RprA and 
Qrr1 and mRNAs: ompA and hapR. SA denotes SAapt conjugated and Tob denotes Tobapt conjugated.  
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For the template slides: 200 nM of biotin-DNA in PBS at the same volume as used for the SA spots 
were pipetted on to the SA spots following the guide and incubated in a humidified chamber for 
30 minutes at 37 °C. 
Slides were washed as above and dried with pressurised air. 
6.6 Generating DNA-programmed RNA arrays 
6.6.1 Sandwich arrangement IVT 
The DNA template slide was placed on top of the RNA capture slide so that the immobilised 
aptamer ligand spots aligned with the immobilised DNA-template spots with both slides facing 
inwards (Figure 6.5). A small piece of parafilm at either end of the slides was used as a spacer to 
prevent the slide surfaces from coming into direct contact. Since the DNA immobilised surface is 
in close proximity to the RNA-binding partner surface the nascent RNA molecule directly 
immobilises to the aptamer ligand on the opposite slide with limited lateral diffusion. 150 μl of 
IVT mix (Table 6.1), supplemented with 0.05 mM Cy3/5 UTP to fluorescently tag the RNA, was 
pipetted between the DNA template and RNA capture slide.  
 
Table 6. 1 Sandwich print IVT mixture 
Reagent volume (µl) [final] 
Nuclease free H2O 111 - 
10 mM each NTPs (20 ×) 7.5 0.5 mM 
10 × transcription buffer 15 1 × 
20 U/µl T7 RNAP (10 ×) 15 2 U/µl 
5 mM CY3/5 UTP 1.5 0.05 mM 
Total 150   
 
The arrangement of the two slides is shown in Figure 6.5. Following incubation at 37°C for 1.5 h in 
a humidified chamber the slides were separated and IVT mix was washed away. The RNA capture 
slide was washed three times with 5 ml PBST, once with 5 ml water and air-dried.  
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6.6.2 Visualisation of the DNA template and RNA capture slides 
The slides were visualised at 550 nm or 650 nm dependent on whether the Cy3 or Cy5 dyes were 
to be detected, respectively (Section 2.9.4). For the initial test of the sandwich IVT arrangement 
method an experiment was performed in which a DNA template array was made by immobilising 
spots of the DNA encoding for the sRNA MicA and the corresponding SA aptamer conjugate 
'MicA_SA' (Figure 6.6 A, top). The DNA array was scanned to ensure all DNA was immobilised in 
equal amounts. Following the sandwich print method, as described above incorporating Cy3-UTP, 
the RNA capture array slide was scanned to detect if and where any RNA was immobilised. 
Fluorescent RNA is detected in spots corresponding to DNA template spots which encode for 
MicA_SA and not for MicA suggesting the MicA is not capable of binding the ligand surface and 
the MicA_SA RNA is correctly structured and binds the ligand surface via the aptamer (Figure 6.6 
A). Figure 6.6 B and C show similar results obtained for other ROIs in which the ROI-aptamer is 
immobilised to the RNA capture slide whereas the ROI is not and this occurs for both Tob and SA 
aptamer/ligand combinations. These results indicate that RNA arrays can be made using this 
method and it was then sought to investigate if they could be made in higher density 
arrangements. 
Immobilised aptamer 
binding ligand e.g. tob 
RNA-capture slide: Slide with spots of immobilised aptamer binding ligand e.g. tob 
DNA-template slide: Slide with spots of immobilised DNA template 
Spacer e.g. 
parafilm 
Immobilised biotin-DNA 
IVT template to SA 
IVT mix -/+ dye-labelled UTP 
Figure 6. 5 Sandwich set up arrangement 
Prepared DNA template slide consist of spots of immobilised SA (pink) which facilitates immobilisation of 
the biotinylated DNA template (brown). On the opposing slide is an array of spots of the aptamer ligand 
(black) which will capture the RNA through the encoded aptamer. The RNA is made by the IVT mixture 
sandwiched between the two slides (light blue) kept apart by two spacers (dark blue). The DNA array 
pattern is aligned to the pattern of the ligand array allowing discrete spots of immobilised RNA to be 
generated. 
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slide 
RNA capture 
slide 
MicA MicA_SA MicA MicA_SA 
A 
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MG_SA 
MGapt U1_SA 
U1 hapR_SA 
hapR 
MicA 
MicA_SA 
rpoS_SA 
rpoS 
MicAstab 
MicAstab_SA 
Qrr1 
Qrr1_tob 
MicA_tob 
MicA 
hapR 
hapR_tob 
MicAstab_tob 
MicAstab 
blank 
U1_tob 
EV71_tob 
blank 
C 
Figure 6. 6 DNA template arrays can be 'printed' with a sandwiched IVT mix to make RNA arrays 
A) Data and schematic of the process of making DNA-programmed RNA arrays. The DNA template slide 
(upper) consists of equal amounts of alexa647 fluorescently labelled DNA templates with and without the 
SA aptamer encoded. After carrying out the sandwich transcription 'print' incorporating Cy3-labelled UTP 
the RNA array slide is scanned (lower) showing Cy3-labelled RNA bound only at the SA spots corresponding 
to the DNA templates encoding the ROI-aptamer conjugate. A schematic of the RNA capture slide surface is 
shown beneath. Further examples of tob aptamer B) and SA aptamer C) labelled RNA arrays. The RNAs 
shown include sRNAs: Qrr1, MicA and a modified MicA known as MicAstab; mRNAs: hapR and rpoS; the viral 
RNA, EV71; truncated Human U1 snRNA and the malachite green aptamer (MGapt). 
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6.6.3 Exploring potential RNA array density 
Initial experiments were conducted with DNA spot sizes of 10 µl aligned to 10 µl ligand spot sizes 
on the RNA capture slide to promote direct capture of the transcribed RNA whilst minimising 
lateral diffusion. However, with a view to allowing the generation of a multi-RNA array, in which 
many unique RNAs are captured on one slide generated from their complementary DNA template 
spots on the facing slide, it was necessary to explore the range of spot sizes that can be used 
successfully. To test this, an experiment similar to that shown in Figure 6.6 A was set up. The DNA 
template array included MicA_tob and MicA control DNA templates immobilised in a range of 
spot sizes from 10 µl to 0.2 µl (pipetting limit) and was set up opposite a corresponding RNA 
capture slide with Tob ligand immobilised in corresponding spot sizes (Figure 6.7 upper 
schematic). The slides were set up using the standard methods described in Section 6. and 6.6.1 
and Cy3-UTP was incorporated in the ‘sandwich’ IVT mix. The RNA array slide was scanned and 
signal was observed for all MicA_tob spot sizes and none of the MicA, suggesting the potential for 
increased higher density array format generation (Figure 6.7). Spot sizes were subsequently used 
in the range of 5 - 0.2 µl 
 
 
 
 
 
 
 
 
  
10 µl 5 µl 2.5 µl 1 µl 0.2 µl 0.5 µl 
MicA 
MicA_tob 
MicA MicA_tob 
MicA MicA_tob 
Figure 6. 7 Exploration of RNA array spot size limit when using manual pipetting 
RNA array slide from a Cy3-UTP labelled sandwich transcription 'print' showing spot size can be reduced 
from 10 µl down to the lowest volume possible to pipette at 0.2 µl. A range of spot sizes were used for both 
DNA template spots and tob spots when preparing the slides for the print as illustrated in the upper 
schematic. The equivalent range of spots for the DNA template with no aptamer encoded were included as 
controls. 
114 
6.7 Generating Multi-RNA Arrays 
Having demonstrated proof of concept for RNA-printing in the sandwich arrangement, facilitating 
surface capture via an RNA-aptamer, steps were taken to generate multi-RNA arrays. Using the 
DNA programmable RNA array method, as above, DNA spots of 5 µl in a higher density format 
were used to generate the RNA arrays shown in Figure 6.8. The same specific immobilisation is 
seen for all aptamer conjugates whilst non-conjugated RNAs do not immobilise. Using 5 µl spots 
was sufficient to get 8 spots (inclusive of controls) on a slide without the problem of lateral 
diffusion. 
 
 
 
 
 
 
 
 
 
 
By exploiting high-affinity aptamer binding and modifying standard IVT techniques it is shown 
here to be possible to generate multi-RNA arrays. Functionality of the RNA aptamer has been 
shown for both SA and tob aptamers. However, the next step is to determine whether the ROI is 
immobilised in such a way as to be functional and available for binding its partner.  
6.8 Probing an ROI on an RNA array 
6.8.1 Investigating ROI functionality with a simple RNA array 
To test the functionality of the printed RNA in array format, appropriate sRNA-mRNA pairs were 
used. Using the methodology for preparing an unlabelled RNA array, as described above and in 
hapR MicAstab_tob MicA Qrr1_tob 
hapR_tob MicAstab MicA_tob Qrr1 MicAstab 
MicA_SA 
blank 
MicAstab_SA 
MicA 
U1_SA 
Figure 6. 8 Multi-RNA array production 
RNA array Cy3-labelled print (left) and Cy5-labelled print (right) shows a range of RNA sequences with and 
without a fusion tob aptamer or SA aptamer respectively, are printed on to immobilised tob or SA 
respectively (schematic above illustrates this). Fluorescent signal from incorporated Cy3/Cy5-UTP 
nucleotides indicate that only the aptamer fusion RNAs bind specifically to the aptamer ligand. 
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section 2.9.2, the MicA-ompA sRNA-mRNA interaction was tested using different buffers and 
concentrations. Figure 6.9 A represents a selection of the conditions tested in which unsuccessful 
binding conditions would show ompA probe bind equally to the control spots and the immobilised 
RNA, as was the case with PBS buffer. However, it was found that the buffer used for the 
transcription of the RNA (TXN) was suitable for specific binding and a range of 400 nM - 800 nM 
probe concentration was established to give sufficient signal. To expand on this further and see 
the comparison of the two different ligand surfaces, the conditions optimised in the previous 
experiment were used for both tob and SA immobilised MicA sRNA arrays (Figure 6.9 B). 
MicA_tob and MicA_SA RNA array spots were prepared, with non-aptamer controls, and probed 
by pipetting 10 µl × 400nm Cy5-labelled ompA mRNA spots over the sRNA array spots before 
washing and scanning. Functionality of the ROI (MicA) was confirmed by specific binding of Cy5-
labelled ompA. 
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MicA MicA_tob MicA MicA_SA 
ompA Cy5 probe ompA Cy5 probe 
A 
C 
MicA 
MicA_SA MicA 
MicA_SA MicA 
MicA_SA 
400 nM in 
TXN buffer 
800 nM in 
TXN buffer 
800 nM in 
PBS 
[Probe] 
& buffer 
ompA 3'-Dy547 
Probe 
B 
SA 
ligand 
Figure 6. 9 Developing conditions for probing RNA arrays for sRNA-mRNA interactions 
A) Schematic for testing the interaction between RNA probes and immobilised RNAs. B) Unlabelled RNA 
arrays probed for interaction with labelled RNA partner (left schematic) using transcription buffer (TXN) and 
PBS indicate TXN buffer is more suitable and the range of 400 - 800 nM is sufficient to see an interaction. C) 
Unlabelled MicA sRNA arrays with and without tob (left) or SA (right) aptamer fusions were printed before 
probing with Cy5 labelled ompA mRNA, washing and visualising. ompA mRNA probe binds to the MicA sRNA 
array with little background binding to the array slide containing aptamer ligand and no RNA. This 
demonstrates the suitability of the RNA array for testing RNA interactions with labelled probes. 
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6.8.2 Exploring the interaction specificity of probing multi-RNA arrays  
Having demonstrated printed RNA functionality for MicA, this test was repeated for a number of 
sRNA-mRNA interactions. Despite testing a number of buffer conditions, non-specific interactions 
were encountered when probing the tob RNA array, which impeded the signal to noise ratio and 
meant the tob surface was not pursued further. However, in the case of the SA RNA capture 
surface, buffer conditions were identified which resolved non-specific probe binding issues. Since 
it was shown that MicA sRNA arrays could be probed with labelled ompA mRNA it was next tested 
to see whether a multi-RNA array could be specifically probed for a single sRNA-mRNA 
interaction. An unlabelled multi-RNA array of immobilised hapR mRNA and MicA sRNA was 
printed with relevant non-aptamer conjugate controls in duplicate. The RNA array slides were 
then probed separately with 10 µl spots of 400 nM Dy547-labelled Qrr1 sRNA or ompA mRNA and 
scanned for fluorescence with the Cy3 channel (Figure 6.10). Both experiments showed specific 
interactions with low background signal demonstrating two sRNA-mRNA interactions and showing 
there is little cross-talk between non-cognate RNAs. Whilst the results showed specific 
interactions there could be seen some speckles on the control spots which are misleading, and 
are not necessarily non-specific binding but just poor washing and therefore highlights that the 
technique still needs to be refined. 
 
 
 
 
 
 
 
6.8.3 Exploring medium density multi-RNA array interaction specificity 
Having defined an appropriate probing buffer for use with SA ligand RNA arrays, the method was 
developed further to demonstrate a greater capability of specific binding with an sRNA-mRNA 
interaction on a 6 RNA multi-RNA array (Figure 6.11). Using 0.2 µl spot size to increase the density 
of spots, 6 unique DNA templates encoding an SA aptamer conjugate RNA were immobilised in 
MicA_SA hapR MicA MicA_SA hapR_SA hapR hapR_SA MicA 
Qrr1 3'-Dy547 ompA 3'-Dy547 
SA 
ligand 
Figure 6. 10 Exploring specificity of sRNA-mRNA interactions probed on a multi-RNA array 
Unlabelled multi RNA arrays of hapR mRNA and MicA sRNA, with respective non-conjugate controls, were 
probed separately with Cy3-labelled Qrr1 and ompA RNA (upper schematic). Both experiments showed 
specific interaction between probe RNA and their RNA binding partner (Qrr1-hapR_SA and ompA-MicA_SA). 
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four repeats on a DNA template array. This was then used to make an unlabelled multi-RNA array 
containing MicA_SA RNA and five other RNAs. The surface was then probed with Cy3-labelled 
ompA mRNA. Once again a specific interaction between immobilised MicA_SA RNA and the ompA 
mRNA probe was seen for all four repeat spots with little background binding to any of the control 
RNAs. This was seen as a significant step towards the high-throughput nature desired whereby 
specific interactions can be deduced from a larger set of RNAs. 
 
 
 
 
 
 
 
6.8.4 Exploring simultaneous probing of RNA array interactions 
Further steps were taken to improve throughput by probing simultaneously with two differently-
labelled RNAs (Figure 6.12). Using 2 µl spot size for sufficient density a DNA array of hapR mRNA 
and MicA sRNA DNA templates with and without the SA aptamer was used to generate a Cy3-
labbled print of the RNA array capture slide as a control to illustrate that significant levels of each 
SA-apt containing RNA were immobilised. This process was repeated to generate an unlabelled 
RNA array and probed simultaneously with a mixture of Cy3-labelled ompA mRNA and Cy5-
labelled Qrr1 sRNA. Specific binding of both RNAs to their immobilised cognate partner RNAs on 
the array surface was seen. This is again a big step forward in demonstrating the capability of the 
method by showing that two experiments can be performed on the same RNA spots in parallel 
allowing higher throughput or the ability to carry out control experiments at the same time as 
interaction testing. 
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Figure 6. 11 Probing multi-RNA arrays to demonstrate probing specificity 
DNA-programmed production of an RNA array of a range of RNAs including mRNAs and small non-coding 
RNAs, all surface tethered via SA aptamers (left schematic). Specific probing of Cy3-labelled mRNA, ompA , 
to partner small non-coding RNA, MicA, is seen (bottom right). Please note that the ‘sandwich’ set up 
arrangement means that the RNA arrays are mirror images of the DNA arrays. 
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6.8.5 Small molecule probing of a multi-RNA array 
Having demonstrated the utility of the RNA array to monitor RNA-RNA interactions, small 
molecule-RNA interactions were explored with a view to expanding the application of the 
technology. Specifically, malachite green (MG), a triphenylmethane dye, interacting with the 
MGapt (Da Costa, Andreiev, & Dieckmann, 2013) was used as a model system and was ideal as the 
dye itself is fluorescent and can report its own binding/presence. The MG-MGapt binding pair is 
additional validation to use as it will demonstrate a synthetic RNA small molecules binding 
interaction. Using the approaches discussed in Section 6.3.2, the DNA encoding the MGapt was 
appended to the SA aptamer via the linkers previously used for the MicA_SA conjugate which 
proved successful (Figure 6.13). As for Section 6.3.2, the MG_SA conjugate structure was 
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Figure 6. 12 Simultaneous probing of a multi-RNA array 
Following production of an RNA array containing SA aptamer immobilised hapR mRNA and small non-coding 
RNA, MicA, probing with Cy5 and Cy3 labelled RNA binding partners - small non-coding RNA Qrr1 and mRNA 
ompA respectively - was conducted (left schematic). The location of Cy5-labelled Qrr1 binding on the RNA 
array was determined following excitation/emission at 650/670nm whilst Cy3-ompA binding was 
determined following excitation/emission at 550/570nm. The top array image is the Cy-labelled RNA array 
generated to confirming presence of the test RNAs only. The composite image below shows specific binding 
of the Qrr1 to its partner mRNA, hapR, whilst ompA is seen to pair to its small non-coding RNA partner 
MicA. Please note that the ‘sandwich’ set up arrangement means that the RNA arrays are mirror images of 
the DNA arrays. 
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predicted alongside the individual domains using Mfold and RNAfold prediction programs to give 
confidence that the structure formed would be correct. DNA template design, synthesis and 
transcription were performed as in Section 6.3.3. 
 
  
 
 
Figure 6. 13 Structure prediction for Malachite Green aptamer (MG) conjugate design 
As for Figure 6.3, the structure is shown with orange letters for the MG RNA aptamer, green letters for the 
linkers and blue letters for the SA aptamer. Solid black lines indicate a base pair. The predicted structure for 
MG, SAapt and MG_SA conjugate are shown for comparison. 
 
To test the small molecule binding interaction a DNA template array was prepared consisting of 
immobilised DNA encoding SAapt conjugates of hapR mRNA, MicA sRNA and MGapt as well as 
hapR and MGapt non-conjugate and no DNA (blank) controls. The DNA template array was used 
to prepare an unlabelled multi-RNA array which was probed with 90 µl of 20 µM MG (Figure 
6.14). A labelled RNA print was also included as a control. Specific binding of MG to the MG_SA 
was observed for all repeats with no non-specific binding, demonstrating the specific interaction 
of a small molecule binding to its target within the context of a multi-RNA array.  
Key 
sRNA Linker Aptamer 
MG_SA 
ΔG = -43.10 
SA aptamer 
ΔG = -10.80 
(C Srisawat 
& Engelke, 
2001) 
MG aptamer 
ΔG = -17.90 
(Baugh, 
Grate, & 
Wilson, 
2000) 
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6.9 Summary/Conclusion/Discussion 
The work in this chapter has demonstrated the utility of this new method to produce functional 
multi-RNA arrays and a patent has been filed to protect the IP of the technology. Using this 
approach, multiple RNAs have been produced in a low-to-medium density RNA array format and 
successfully probed for their interactions with labelled-binding partner molecules. 
When considering the application of this technique, in which its high-throughput manner is key, 
the design of the RNA conjugates with bespoke linker sequences may prove useful for ensuring 
well folded RNAs but may also prove time consuming when considering large libraries of 
sequences. A universal linker sequence would be ideal and a good candidate for this would be the 
linker applied to MicA_SA, MicAstab_SA and MG_SA which proved to work for all three. 
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Figure 6. 14 Demonstration of small molecule specifically binding to its RNA partner within a multi-RNA 
array 
DNA-programmed production of an RNA array of the sRNA MicA, the mRNA hapR and the MGapt, all 
surface tethered via SA aptamers and various controls (left schematic). Specific binding of the small 
molecule MG to the surface-tethered MG_SA conjugate RNA on the multi-RNA array is seen (bottom right). 
As a control a labelled print shows the RNAs immobilised on the RNA array (middle right). Please note that 
the ‘sandwich’ set up arrangement means that the RNA arrays are mirror images of the DNA arrays. 
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When compared to other methods for producing RNA arrays this method has so far demonstrated 
that multi-RNA arrays can be made on relatively non-complex surfaces. From the point of having 
prepared the slides, the RNA arrays can be made and ready to probe in around 100 minutes. 
However, there is plenty of room for optimising something that has not been the main focus of 
the experiments presented. This method holds significant advantage in that the RNA is produced 
and immobilised in one single step and requires only a second processing step after production 
before interaction probing. This simplicity, coupled with the short time the RNA is present before 
being used ensures intact RNA for interaction studies. 
The RNA arrays produced in this work have included RNAs ranging in length from 85-667 nt, RNAs 
both naturally occurring and synthetic; and RNAs that interact with other RNAs, small molecules, 
and proteins (inherently shown through SA-surface immobilisation). 
Collectively, this work has demonstrated the utility of our new method to synthesize functional 
multi-RNA arrays. Using our approach, RNAs representative in size of many prokaryotic, 
eukaryotic or viral RNAs of functional interest, as well as biotechnologically-relevant RNAs such as 
aptamers, have been produced in both low- and medium-density, multi-RNA array format, and 
successfully probed for their specific interactions with fluorescent binding partners, including 
labelled RNAs and the small molecule malachite green. Our method has significant advantages in 
terms of avoiding any requirement to store in vitro transcribed RNAs prior to testing, and the 
associated problems of stability over extended storage times. Furthermore, a single DNA template 
array could potentially generate multiple identical RNA arrays on demand with minimal handling 
required, thereby minimising the cost and time of interaction testing studies. Depending on the 
needs of the researcher, this method could be used on a low throughput scale using standard 
laboratory equipment, whilst use of more specialist equipment opens up avenues for high-
throughput screening of high-density multi-RNA arrays, something considered in the next chapter.  
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Chapter 7 
7 High-throughput RNA array generation - Proof of concept 
 
7.1 Introduction 
For broad usability of the method described in Chapter 6, there is a need to develop high density 
RNA arrays to make the approach relevant to studying the libraries of RNAs which, for example 
would represent the transcriptome of an organism.  
Typical studies could include investigating bacterial sRNAs by immobilising the full complement of 
RNAs of interest on a slide, enabling the simultaneous functional probing of binding interactions 
with labelled potential partner molecules (small molecules, protein, RNAs etc.). E. coli K12 
currently has approximately 4,300 annotated genes of which approximately 60 are annotated 
sRNAs (Jindan Zhou & Rudd, 2013) however, there are many more predicted sRNAs with current 
estimates that E. coli have up to 300 sRNAs with similar numbers predicted for other bacteria 
(Barquist & Vogel, 2015). The aim would therefore be to immobilise a minimum of between 60 
and 300 RNA spots to demonstrate the capability to analyse all known, or known and novel sRNAs 
in parallel. 
Importantly, the need for reduction in RNA spot size and increased density needs to be balanced 
with maintaining a reasonable limit of detection such that weak interactions and/or low 
abundance binding partners will still be detected. Also, the protocol must maintain adequate 
timeliness and simplicity for broad applications, therefore attempts will be made to increase the 
flexibility and automation of the protocol. 
This chapter will explore the adaptation of the protocols and experimental setup described in 
Chapter 6 to allow generation of RNA arrays with increased density whilst maintaining the 
previously described functional integrity.  
7.2 Manual medium-high density printing 
Having successfully proved the functionality of the DNA-programmed multi-RNA array in low-to-
medium density format (Chapter 6), steps were then taken to generate a high density RNA array 
from a high density DNA array. Using the manual methods in Section 6.5, it was previously shown 
that a spot volume of 0.2 µl could be used which gives an approximate spot diameter of 1.5 mm. 
To create a high density array using this method 0.2 µl hapR DNA spots with and without the SA 
aptamer were immobilised to a DNA template slide and was used to print a Cy5-labelled RNA 
array on to an RNA capture array slide aligned to 0.2 µl SA spots, thereby subsequently creating a 
48 spot RNA-array (Figure 7.1). Specific immobilisation of hapR_SA to the SA spots was seen with 
no detectable non-specific immobilisation of the hapR RNA. 
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The decrease in spot size is positively correlated with a decrease in the margin for error in the 
alignment of the DNA template spot and the SA ligand spot, which when the spot size is 
decreased to 1.5 mm, as in Figure 7.1, results in some RNA spots having a gibbous or crescent 
appearance due to imperfect spot alignment. Unfortunately, it is clearly visible that the spot-to-
spot alignment approach is compromised for creating increasingly higher density arrays (Figure 
7.1), suggestive that 1.5 mm spots represent the limit of this manual RNA array generation 
method. Attempts were then made to automate the process with an optimised setup for RNA 
array generation. 
7.3 Automated high density RNA array generation 
To allow applicability to more complex systems, it was necessary to use automated methods with 
an alteration to the slide preparation to allow higher RNA array density production. The following 
methods were used to achieve this. 
7.3.1 Optimisation of the RNA capture slide design 
The current 'spot to spot' arrangement as illustrated in Figure 6.5 becomes problematic when 
attempting a higher density/lower spot size format because the need to align the DNA template 
array with the RNA capture array causes the likelihood for misalignment to increase. When 
attempting production of smaller spot size RNA arrays the array would have spots which were 
'empty' or crescent shape which indicated imperfect alignment (Figure 7.1). Thus, an optimised 
arrangement was proposed and tested as illustrated in Figure 7.2 whereby the RNA capture slide 
with an array of spots of RNA capture ligand was replaced for an RNA capture slide coated in RNA 
capture ligand making the entire slide surface capable of capturing the RNA and eliminating the 
need for array slide alignment.  
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Figure 7. 1 Production of a high density RNA array using manual methods 
A 48 spot DNA template array composed of a pattern of hapR and hapR_SA DNA templates (left, schematic) 
was made by pipetting 0.2 µl. This DNA template array was subsequently used to make a Cy5-labelled multi 
RNA array (left, schematic; right, result). The RNA array slide contains immobilised Cy5-labelled RNA spots 
corresponding to the spots of DNA template which encoded the SA aptamer fusion. Please note that the 
‘sandwich’ set up arrangement means that the RNA arrays are mirror images of the DNA arrays. 
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7.3.2 Preparing the RNA capture array slide 
1 mg/mL SA in PBS was pipetted onto an NHS-activated slides (Nexterion H, Schott), covering the 
entire surface to prevent issues from mis-aligned spots. This was incubated for 30 min at 37 °C in 
a humidified chamber, washed three times with 5 ml PBST and once with 5 ml water. The slide 
was incubated with 5 ml 50 mM ethanolamine-HCl at room temperature for 30 min prior to 
washing, as described above and air-dried.  
7.3.3 Optimisation of the DNA template array slide design - immobilisation of DNA via 
amine coupling 
Oligonucleotide arrays are commonly made by immobilising DNA via amine coupling directly to 
the functionalised slide (Sobek, Aquino, Weigel, & Schlapbach, 2013). The covalent linkage would 
be advantageous since the DNA would be more robustly immobilised and thus could facilitate 
storage of the template slide before use. Additionally, it may then be possible to reuse the slide 
for generation of multiple RNA arrays by a single DNA template array. These benefits, as well as 
removing the SA immobilisation step would make the protocol more flexible. This approach was 
avoided initially because the protocols associated with SA capture of biotinylated DNA are very 
simple to apply, however, amine-coupling was considered more amenable to automation and was 
therefore employed in the initial automation experiment protocols. 
To compensate for the low reactivity of unmodified DNA, an activating linker consisting of a 
flexible chain and reactive amino functional group was included at the upstream 5'-end to 
increase its coupling efficiency to the solid support (Zammatteo et al., 2000). As well as facilitating 
immobilisation, the linker increases the distance between the immobilised DNA and the surface 
and consequently reduces steric hindrance, and improves the conformational flexibility and 
binding of target molecules (Shchepinov, Case-Green, & Southern, 1997). 
The inclusion of an activating linker does not guarantee immobilisation of the DNA by the 5'-end, 
since immobilisation via the linker has to compete with other molecular sites and requires very 
specific experimental conditions to be efficient (Sobek et al., 2013). In the absence of an 
RNA-capture slide: Slide coated with immobilised streptavidin 
Spacer e.g. 
parafilm 
in vitro transcription mix -/+ dye-labelled UTP 
Immobilised 
streptavidin 
Immobilised DNA in 
vitro transcription 
template 
DNA-template slide: Slide with spots of immobilised DNA template 
Figure 7. 2 Sandwich set up arrangement for high density printing 
Prepared DNA template slides consist of spots of DNA template (brown) immobilised by any suitable 
method. On the opposing slide is a coated layer of SA (pink) which will capture the RNA through the 
encoded SA aptamer. The RNA is made by the IVT mixture sandwiched between the two slides (light blue) 
kept apart by two spacers (dark blue). The DNA array pattern no longer needs to be aligned to anything as 
the entire opposing RNA capture slide is capable of tethering the RNA through the encoded SA aptamer. 
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activating linker, covalent immobilisation of DNA to NHS-activated surfaces occurs predominantly 
through deoxyguanosine bases (Millan & Mikkelsen, 1993) and is thought to compromise the 
hybridisation effectiveness of the immobilised nucleic acid (Ghosh & Musso, 1987) and 
consequently is likely to affect its transcription. To avoid immobilising the DNA via the bases 
(Figure 7.3 A, left), an aminohexyl linker (Figure 7.3 A, right) was incorporated in to the DNA by 
PCR amplification (Section 2.2.3). A range of immobilisation conditions were then tested find 
optimal conditions for immobilising DNA templates by the linker only. 
7.3.4 Using DNA with and without a 5’NH2-linker to generate a DNA array  
Sodium phosphate buffer (pH 8.50) at various concentrations is commonly used for NHS reactions 
(Sobek et al., 2013) because it doesn't react with NHS groups. Several buffer concentrations were 
tested to optimise the immobilisation of DNA exclusively via the linker by comparing 
immobilisation of DNA with and without a linker. To facilitate comparison of DNA immobilisation 
levels, a downstream 5'-Alexa Fluor 647 dye was introduced via the reverse primer (Section 2.2.3). 
Immobilisation of the DNA was carried out on Nexterion H slides using a Qarray2 microarray 
spotter (Section 2.9.3). 200 nM DNA with or without linker in concentrations of sodium phosphate 
buffer pH 8.50 from 50 - 400 mM was spotted on to the slide using a 375 µm diameter pin. Runs 
were carried out at 50 % humidity, 20 °C. Spotted slides were incubated for a further 30 mins at 
the end of the run before the remaining NHS groups were blocked using 50 mM ethanolamine-
HCl pH 8.50, incubated at room temperature for 30 mins. Slides were washed using an improved 
protocol which involves washing the slide submerged in a wash solution (Section 2.9.3) which 
removes the opportunity for partial drying during the washing steps and the associated artefact 
signal. The DNA template array was scanned using the Cy5 channel (Figure 7.3B) and the 
fluorescence intensities analysed and quantified with Image Quant software (GE, Figure 7.2C). 
The linker modified DNA was observed to immobilise in greater quantities compared to no linker 
DNA for all buffer concentrations tested. Comparison of the fluorescence intensities at 400 mM 
buffer revealed both DNA samples immobilised at approximately the same level (~60 % intensity) 
indicating that the linker makes no difference and that coupling takes place via the bases, 
whereas comparison of the fluorescence intensities at 50 mM buffer revealed an increase in 
linker-DNA immobilisation and a decrease in no linker-DNA immobilisation (Figure 7.3 C, 
highlighted box). This result suggests that lower concentration buffers favour amine coupling via 
the activating linker over the bases, but do not couple exclusively via the activating linker. Thus, 
the lowest buffer concentration tested (50 mM) was used in subsequent experiments. 
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Figure 7. 3 Comparison of conditions for immobilisation of dye-labelled DNA with and without an 
activating linker, to the template slide via amine coupling 
A) Schematic illustration of the immobilisation of DNA templates with and without an activating linker. B) 
Labelled DNA template encoding MicA_SA was immobilised via amine coupling to a template slide under 
different conditions to test efficiency. DNA with and without an aminohexyl linker was immobilised at a 
range of buffer concentrations at constant pH 8.50. C) Quantification of the DNA spots shown in B) using 
Image Quant software was plotted graphically. Analysis revealed lower buffer concentrations favour 
immobilisation via the aminohexyl linker, whilst higher buffer concentrations favoured coupling via the 
bases. 
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7.4 RNA array generation from covalently immobilised, linker-modified 
DNA template arrays 
Following successful identification of immobilisation conditions for linker-modified DNA to the 
template slide, the optimal conditions for generating RNA arrays from covalent DNA template 
arrays were investigated. Initial experiments revealed that higher amounts of DNA template were 
needed to generate detectable levels of RNA therefore the DNA concentrations used were 
increased relative to those used in earlier experiments. To attempt the generation of automated 
RNA arrays from covalent DNA template arrays a DNA-template slide was constructed using 10 
and 20 µM spots of linker-MicA_SA-Alexa Fluor 647 DNA. The DNA was spotted on the slide as in 
Section 7.3.4. This DNA template slide was used to generate an RNA array using the setup 
illustrated in Figure 7.2 and the transcription mixture shown in Table 6.1 incorporating Cy3-UTP. 
The washing and drying steps used were as in previous experiments with the added 
improvements to washing as detailed in Section 2.9.3. 
The DNA array was scanned prior to RNA array generation using the Cy5 channel and the RNA 
array was scanned following generation using the Cy3 channel. Whilst high density RNA array 
generation was shown to be achievable from covalent DNA arrays (Figure 7.4 A), it was shown to 
be much less efficient than required. The fluorescent signal corresponding to the RNA spots was 
barely detectable above background and thus created a poor signal to noise ratio (Figure 7.4 B). 
Additionally, the presumably lower amounts of RNA transcribed resulted in an increase in spot 
size (700 µm RNA spot diameter vs. 200 µm DNA spot size diameter) which is non-conducive to 
generating high density RNA arrays. 
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The RNA arrays generated using the manual protocols gave more favourable signal/noise ratios 
and thus it was apparent that the automated high density DNA array setup is not sufficiently 
optimised. As mentioned in Section 7.3.3, there are many factors which could potentially affect 
the transcription of the immobilised DNA template such as distance from the slide and steric 
hindrance through base-coupling. To investigate whether these factors may be the cause of the 
poor RNA array signal seen in Figure 7.4 A it was therefore important to directly compare the 
different DNA immobilisation strategies (covalent coupling vs. SA-biotin capture) for efficiency 
and their effects on subsequent generation of RNA arrays to better understand the factors that 
affect high density RNA array generation by automated protocols. 
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Figure 7. 4 Optimisation of DNA concentration and subsequent RNA array generation suggests unsuitable 
nature of amine coupled DNA 
A) A DNA template array containing a range of concentrations of covalently immobilised linker-MicA_SA-
Alexa Fluor 647 DNA (top right) was used to generate a Cy3-labelled RNA array (bottom right) on an SA-
coated slide (left schematic). B) Line plots of the data in A) as indicated by black arrows are shown with 
DNA in red and RNA in green. The plots reveal a narrow profile for the DNA spots but the RNA spots show a 
much wider profile and are not easily distinguishable from the background. Both plots are normalised to 
their respective highest signals. 
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7.5 Comparison of DNA template arrays constructed via amine coupling 
and SA-biotin approaches and their impact on RNA array generation 
7.5.1 DNA template slide construction 
A DNA template array was constructed using automated protocols with linker-MicA_SA-Alexa 
Fluor 647 and biotin-MicA_SA-Alexa Fluor 647 DNA immobilised via the amine-coupling and SA 
capture methods, respectively. To do this, a fresh Nexterion slide H was prepared by immobilising 
8 grids of 2 × 2 spots of 1 mg/ml (16.7 µM tetramer) SA spots. Biotin-DNA was spotted on to the 
same grid and allowed to incubate for 30 minutes before washing whilst linker-DNA was spotted 
to another location in the same 8 grid format and allowed to amine-couple for 30 minutes before 
washing. 
An additional 8 grids of lower concentration SA (1 µM tetramer) were immobilised on which 
biotin-DNA was also incubated. This was to test whether the amount of SA on the template slide 
would affect the amount of RNA immobilised on the RNA capture slide due to 'back-sticking' of 
RNA, effectively depleting the RNA. 200 nM of each DNA template was incubated on the slide on 
their respective grids therefore, direct comparison of their immobilisation efficiencies was 
possible. Automated spotting was achieved using the Qarray2 microarrayer (Section 2.9.3). 
The DNA slide was scanned before RNA array generation using the Cy5 channel. The results 
(Figure 7.5 A, top) showed that the highest fluorescence corresponded to the biotin-DNA 
immobilised on high concentration SA, whilst the lowest fluorescence corresponded to the amine-
coupled linker-DNA. This confirms that the amine-coupling approach is inefficient in immobilising 
high densities of DNA on the template slide. Additionally, the results confirmed that, although the 
1 µM tetrameric SA spots should have still been an excess of SA, there was less fluorescent DNA 
detected indicating that less SA was present or able to capture the biotin-DNA. 
7.5.2 Printing the biotin-DNA slide to generate a high density RNA array 
A fresh Nexterion slide H was coated with 1 mg/ml SA and together with the DNA template slide 
from Section 7.5.1 was used to generate a Cy3-labelled RNA array and scanned using the Cy3 
channel. The results (Figure 7.5 A, bottom) showed that the amine-coupled linker-DNA generated 
the weakest RNA array spots which were effectively undetectable, further confirming the 
inefficiency of this approach. Surprisingly, the biotin-DNA immobilised to lower concentration SA 
spots generated the strongest RNA array spots, whilst the biotin-DNA/excess SA spots generated 
detectable but weak RNA spots. This indicates that RNA back-sticking does occur and depletes the 
RNA immobilised to the RNA capture slide. Surface plots of the DNA and RNA slides (Figure 7.5 B) 
confirmed the RNA array spots corresponding to the biotin-DNA/low SA spots were of the highest 
signal and their profile fit closely to the of the DNA indicating a low increase in spot size. 
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Figure 7. 5 Comparison of DNA template arrays constructed via amine coupling and SA-biotin approaches 
and their impact on RNA array generation 
A) DNA template array scan (upper) and schematic of DNA immobilised by amine-coupling and low/high SA-
biotin capture. RNA array scan (lower) generated by the above DNA template array. 200 nM MicA_SA DNA 
was immobilised by amine coupling via aminohexyl linker (middle) and SA-biotin capture with low (1 µM, 
left) and high (16.7 µM, right) SA. B) Line plots of the data in A) indicated by black arrows. DNA plots (red) 
and RNA plots (green) are normalised to the maximum signal obtainable. RNA plot for amine-coupled 
template is shown on a secondary axis due to the low signal. 
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The amine-coupled linker-DNA approach produced some problematic results which would need 
addressing. The low RNA spot signal can be attributed to either lower amounts of immobilised 
DNA template as seen in Figure 7.5 A (upper middle), the low efficiency of transcription due to the 
immobilisation, or both. 
The lower amounts of linker-DNA immobilised compared to biotin-DNA in Figure 7.5 A (upper) 
could be assigned to surface saturation. The tetrameric SA can in theory increase the 
immobilisation capability of the surface by up to four times. Alternatively the buffer conditions 
used may not be optimal for efficient immobilisation and may require further optimisation. The 
general trend indicated in Figure 7.3 C was that lower Sodium Phosphate buffer concentrations 
were conducive to higher linker-DNA immobilisation. Lowering the buffer concentration further or 
even testing other buffers may increase the efficiency of amine-coupling but may be problematic 
for long term storage of the DNA template. 
The low efficiency of transcription could be due to two reasons. First, as mentioned in Section 
7.3.2, an activating linker was included in the DNA to increase the likelihood of end 
immobilisation however, as observed in Figure 7.3 B and C, immobilisation does not occur 
exclusively via the linker and base-coupling (for which it competes) may inhibit transcription. 
Secondly, the length of the linker included may be insufficient as longer linker length has been 
shown to improve molecular conformation and binding (Shchepinov et al., 1997). As mentioned 
above, optimisation of the immobilisation buffer conditions could eliminate the competition of 
base-coupling facilitating unhindered transcription. Also, a range of linker lengths could be tested 
to discover the optimal length required for efficient transcription. 
The complexities of the linker-DNA amine-coupling approach as outlined above highlight the 
extensive investigation that is likely required for optimisation as an ineffective avenue for 
producing an improved protocol. Thus, the low SA/biotin-DNA approach was chosen for 
subsequent experimental design. 
7.6 Protocol development for preparation of DNA template and RNA 
capture array slides 
7.6.1 Immobilisation of biotin-DNA on SA coated slides and first interaction probed 
on a high-density RNA array 
The results in Section 7.5 indicated that DNA templates immobilised by SA-biotin capture 
produced RNA arrays with higher signal, better signal to noise and satisfactory spot 
profile/diameter. The protocol used in the Section 7.5 involved spotting of SA grids before 
spotting the DNA grids on top. The two steps of automated spotting unnecessarily lengthen the 
protocol and consequently reduce the flexibility of its execution. Also, the 'spot on spot' nature of 
DNA immobilisation caused inconsistencies in signal from one spot to another as is evidenced in 
Figure 7.5 B (left). To improve this protocol, a SA coated slide of which the entire surface is 
capable of capturing the biotin-DNA was trialled in which the DNA template slide was first coated 
with low concentration SA (1 µM) before spotting the biotin-DNA grids (Figure 7.6 A). The RNA 
capture slide design remained unchanged, coated with 1 mg/ml SA (16.7 µM). Additionally, the 
first attempt at probing a high density automated RNA array was performed to verify that the 
amount of RNA being immobilised to the capture slide is detectable with reasonable levels of 
probe (Figure 7.6 C). 
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To test this, a fresh slide H coated with 1 µM SA tetramer was prepared with eight grids of 
patterned biotin-DNA templates spotted on afterwards. This DNA template array was 
subsequently used to generate a Cy3-labelled RNA array and was scanned using the Cy3 channel 
(Figure 7.6 B). The RNA array generated showed satisfactory signal intensity and signal/noise ratio 
on the RNA array spots corresponding to the templates: hapR_SA, MicA_SA and MG_SA, as well 
specific binding as demonstrated by the inclusion of MicA control DNA template, which encodes 
MicA RNA with no aptamer, consequently making it incapable of immobilising to the RNA capture 
slide. This updated setup and protocol allows an RNA array to be generated in a more suitable 
timescale. 
To investigate probing of a high density automated RNA array, an unlabelled RNA array was 
generated using identical DNA template and RNA capture arrays as above with no dye-labelled 
UTP. Following RNA array generation, the RNA-immobilised RNA capture slide was probed with 1 
µM Cy3-Qrr1 RNA overnight at room temperature to observe the interaction with immobilised 
hapR_SA, followed by washing, drying and scanning with the Cy3 channel (Figure 7.6 C). The 
probed RNA array (Figure 7.6 D) showed specific binding of Cy3-Qrr1 to immobilised hapR_SA 
RNA only with satisfactory signal and signal/noise. The automated protocol for generating high-
density RNA arrays appears not to significantly impact the limit of detection and allows for 
detection of specific RNA-RNA interactions. 
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Figure 7. 6 RNA array generation from DNA template arrays constructed on SA coated slides 
A) Schematic illustration of the slide setup demonstrating the SA coated slide used to construct the DNA 
template array. B) RNA array slide generated from biotin-DNA template array on an SA coated slide. RNA 
spots show good signal, signal/noise ratio and the grids are consistent in signal and specific immobilisation 
as demonstrated by the MicA no aptamer control. C) Schematic illustration of unlabelled high-density 
automated RNA array generated and probed with Cy3-Qrr1 for interaction with hapR_SA. D) Unlabelled 
high-density automated RNA array generated and probed with Cy3-Qrr1 for interaction with hapR_SA. The 
Probe successfully showed a specific interaction only with the hapR_SA binding partner. 
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7.6.2 Exploring slide storage - RNA array generation from pre-prepared, frozen-
stored DNA template and RNA capture slides 
An attractive prospect for protocol flexibility would be the ability to stop the protocol mid-way 
through to be resumed later. Preliminary experiments showed that freshly prepared DNA 
template and RNA capture slides stored at room temperature overnight and subsequently used to 
generate an RNA array the following day produced poor quality results. Commercially available SA 
coated slides can be purchased which are stored frozen at -20 °C (Nexterion slide HS) which 
thereby stimulated an investigation into the stability of in house prepared DNA template and RNA 
capture slides when stored frozen at -20 °C.  
To test this, the experiment described in Section 7.6.1 was repeated and interrupted by storing 
the prepared DNA template and RNA capture slides at -20 °C overnight before using them to 
generate a Cy3-labelled RNA array the next day (Figure 7.7 A). The slides were dried following the 
final wash steps as in the protocol and then placed in slide storage boxes in a sealed bag 
containing desiccant beads and stored in a freezer at -20 °C overnight. The following day, the bag 
was allowed to equilibrate to room temperature before opening and assembling the RNA array 
print reaction. The RNA array generated (Figure 7.7 B) was comparable to the one produced from 
fresh slides as shown in Figure 7.6 B. The signal intensity, signal/noise and binding specificity do 
not appear to have been affected significantly if at all. 
To further evaluate the stability of the RNA array capture slide for subsequent probe experiments, 
an unlabelled RNA array was generated using frozen stored DNA template and RNA capture slides 
with the identical 8 grid format used above. The RNA array was then probed with Cy3-labelled 
Qrr1 RNA to observe the interaction with immobilised hapR_SA (Figure 7.7 C) and compared with 
the equivalent result from freshly prepared slides (Figure 7.6 D). The probed RNA array (Figure 7.7 
D) showed specific binding of Cy3-Qrr1 to hapR_SA RNA with comparable signal and signal/noise 
to the equivalent result for RNA arrays generated from freshly prepared slides as shown in Figure 
7.6 D. The extra capability to freeze store the slides for RNA array generation at a later time adds 
a convenient flexibility to the protocol and appears not to impact either RNA array generation 
(Figure 7.7 B) or subsequent probing of the RNA arrays (Figure 7.7 D). 
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Figure 7. 7 RNA array generated from frozen stored DNA template and RNA capture slides. Array quality 
and probing 
A) Schematic illustration of the slide setup. B) Cy3-labelled RNA array slide generated from frozen stored 
DNA template and RNA capture slides, grid pattern included. RNA array quality is comparable to that of 
freshly prepared slides (Figure 7.6 B). C) Schematic illustration of unlabelled RNA array generated from 
frozen stored slides and probed with Cy3-Qrr1 for interaction with hapR_SA. D) Unlabelled RNA array 
generated from frozen stored slides probed with Cy3-Qrr1 for interaction with hapR_SA. 
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7.7 Analysis of high-density RNA arrays generated by automation 
The protocol developed thus far for generating high-density RNA arrays by automation was used 
to create an RNA array containing a large number of spots, representative of an experiment 
exploring the interactions of a large numbers of RNA at once, of which the regularity of the RNA 
spots could be analysed. A labelled-DNA array consisting of 21 grids of 6 × 6 spots was used to 
generate a Cy3-labelled RNA array of 756 spots. This number is over double the amount of sRNAs 
thought to potentially exist in E. coli (Barquist & Vogel, 2015). Each grid of DNA consisted of three 
rows of six spots of biotin-MicA_SA-Alexa Fluor 647 template and three rows of six spots of biotin-
MicA-Alexa Fluor 647 template as a negative control (Figure 7.8 A schematic). 
The DNA array showed consistent immobilisation of both MicA_SA and MicA biotin-DNA 
templates as expected, and the RNA array showed MicA_SA RNA spots only, consistent with 
specific immobilisation of aptamer-fused RNA only (Figure 7.8 A, right). DNA spot profile data 
(Figure 7.8 B, top) are shown in red and were curve-fitted, using least-squares minimisation, to a 
function describing the sum of six Gaussians distributions (one for each peak) with a single 
quadratic baseline correction:- 
 
 
where 𝑓(𝑥) is the fluorescence intensity at position x, and 𝑎𝑖, µ𝑖  and σ𝑖 are the intensity, centre 
and standard deviation, respectively, of spot i. The full-width at half maximum (FWHM) for each 
DNA spot is calculated as:- 
 
The RNA spot profile data (Figure 7.8 B, bottom) are shown in green, and were curve-fitted in an 
equivalent manner to that for the DNA data, i.e. using least-squares minimisation to equation 1 
above. Analysis of the surface plot of the RNA array revealed the spots have an approximate 
Gaussian profile, presumably resulting from the lateral diffusion of the newly-transcribed RNA 
from its template DNA spot before its immobilisation onto a target SA molecule. DNA spots of 
76.3 +/- 8.2 µm FWHM produced RNA spots of 137.1 +/- 5.9 µm FWHM. Considering the original 
DNA template spot separations on the high-density DNA template array, it was evident that this 
arrangement proved sufficient to retain effective separation of the spots of transcribed RNA, thus 
enabling generation of a high-density surface-immobilised RNA array. 
Eq. 2 𝐹𝑊𝐻𝑀 = 2σ 2 ln 2 
𝑓(𝑥) = 𝑎𝑖
6
𝑖=1
exp  −
(𝑥 − µ𝑖)
2
2𝜎𝑖
2  − (𝑚𝑥
2 + 𝑏𝑥 + 𝑐) Eq. 1 
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Figure 7. 8 Production of a high density RNA array from biotin-DNA template slide and surface plot 
analysis 
A) Schematic of the print setup illustrating alternate rows of DNA templates with or without the appended 
SAaptamer and the expected RNA pattern (left). DNA template array consisting of 21 6 x 6 fields of MicA 
and MicA_SA biotin-DNA templates (red, top). RNA capture array consisting only of immobilised MicA_SA 
RNA (green, bottom). B) Surface plots of DNA (red) and corresponding RNA (green) rows (marked by 
arrows). The surface plots are shown with the model fit (dashed lines). 
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7.8 Specific and simultaneous probing of an automated high density 
multi-RNA array  
Having demonstrated that high-density automated RNA arrays can be made to accommodate a 
satisfactory number of spots in a suitable density for a theoretical application of the arrays, an 
attempt to confirm simultaneous probing of a high-density array showing specific RNA-RNA, RNA-
protein and RNA-small molecule interactions was made (Figure 7.9 A).  
A DNA template array containing a 4 x 4 grid arrangement with the spots separated from each 
other by 1100 µm was prepared by automated spotting. Each DNA template array grid contained 
4 replicates each of MicA_SA, ompA_SA, MG_SA and hapR_SA DNA templates (Figure 7.9 B). The 
DNA template array was then used to generate a Cy3-labelled RNA array as a control (Figure 7.9 
C) or, in parallel, an unlabelled RNA array which was subsequently probed overnight at room 
temperature with a mixture of 1 µM Cy3-Qrr1 RNA and 20 µM MG small molecule, after which 
the slide was washed, dried and scanned using the Cy3 and Cy5 channels for Cy3-Qrr1 and MG, 
respectively (Figure 7.9 D).  
Analysis of the Cy3-labelled RNA array revealed equivalent levels of all RNAs were immobilised 
(Figure 7.9 C) producing RNA spots of 133 ± 8 µm FWHM. Specific binding of Cy3-Qrr1 RNA and 
MG was seen to their respective surface immobilised RNA targets (hapR_SA and MG_SA, 
respectively), whilst no signal is seen for MicA or ompA spots, indicating no non-specific binding 
(Figure 7.9 D). The spot profile of the probed slide was plotted graphically for the top two rows of 
the upper 4 x 4 field (Figure 7.9 E), highlighting an increase in fluorescence intensity for specific 
interactions only and yielding probe spots measuring 151 ± 21 µm and 300 ± 98 µm FWHM, for 
MG and Cy3-labelled Qrr1 respectively.  
Probed RNA data were curve-fitted, using least-squares minimization, to a function describing the 
sum of two co-incident Gaussians distributions (one for the main peak, and one for weak signal 
broadening due to diffusion of non-specifically bound probe):- 
where 𝑓(𝑥) is the fluorescence intensity at position x, and 𝑎𝑖, µ and σ𝑖 are the intensity, centre 
and standard deviation, respectively. 
Eq. 3 𝑓(𝑥) = 𝑎𝑖
2
𝑖=1
exp −
(𝑥 − µ)2
2𝜎𝑖
2   
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Figure 7. 9 DNA-directed synthesis and simultaneous probing of a high-density functional multi-RNA array 
Simultaneous probing of a multi-RNA array 
A) Schematic illustration of experimental protocol. B) RNA array grid pattern. C) Cy3-labelled control RNA 
array demonstrating equivalent immobilisation levels of all RNA constructs. D) An unlabelled RNA array 
equivalent to that shown in C) was probed overnight with a mixture of 1 µM Cy3-Qrr1 RNA and 20 µM MG. 
Specific binding of Qrr1 and MG was seen to hapR_SA and MG_SA, respectively. E) Surface plots of the top 
two rows of the upper 4 × 4 grid of the probed slide showed specific increase of fluorescence intensity 
corresponding to specific interactions only. The profile of each spot was separately curve-fitted to a 
Gaussian function and the fit to the data are also shown. 
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7.9 Summary/Conclusion/Discussion 
The work in this chapter has detailed the development of the method described in Chapter 6 for 
generating functional multi-RNA arrays from DNA arrays. This has been achieved by altering the 
slide setup, therefore eliminating the spot-to-spot alignment issues, by automating their 
production at the DNA template slide construction step and consequently by increasing the 
density of the RNA spots whilst maintaining functionality of immobilised RNAs and retaining 
sensitivity of interaction probing experiments. The RNA arrays generated have been shown to be 
capable of displaying specific RNA-RNA, RNA-small molecule and RNA-protein interactions 
(inherent in the immobilisation to the capture slide) and also allowed for simultaneous interaction 
probing. The addition of an optional frozen storage step allows for the protocol to be interrupted 
and increases flexibility without any apparent effect on the RNA array quality as seen by labelled 
RNA array controls and probe experiments. Also, spot to spot variability was demonstrated to be 
low enough to give confidence in reproducibility. 
Consequently, whilst this protocol for generating high-density DNA template arrays can be seen to 
be effective at supporting high-density RNA array generation and subsequent probing, without 
spot-to-spot contamination affecting sensitivity and resolution, it is evident that generation and 
subsequent probing of higher density RNA arrays is likely to be possible. Reduced DNA template 
spot size, coupled with modifications to the transcription component concentrations, reaction 
time and optimisation of the surface-to-surface distance, would likely support higher throughput 
capability.  
The theoretical capacity of the DNA spots on the template slide (of which the capacity of the RNA 
spots on the capture slide is dependant) depends on the spotting parameters used but is quoted 
by the manufacturer to be approximately 50,000 per slide (“SCHOTT Nexterion - Technical 
Support | SCHOTT AG,” n.d.) therefore, when taking into account the slight increase in spot size 
seen for RNA spots relative to their DNA template spots due to the effect of diffusion, the 
maximum number of spots on an RNA array would be in the order of 104. It is important to note 
that the current number of spots achieved on a slide has already reached the order of which 
would be suitable for high-throughput interaction screens (Sections 7.1 and 7.7). 
Given the recent popularity of transcriptomics, RNA and its interactions with proteins, nucleic 
acids and small molecules are the subject of extensive scientific research. RNA represents a 
significant yet mostly unexploited resource in the search for novel pharmaceutical drug targets 
(Vicens & Westhof, 2003; Vicens, 2009). This approach, therefore, has potential to impact both 
academic and industry-based research. RNA arrays could be used for screening an organism's 
transcriptome for interactions with potential ligands. In applications for targeting RNA viruses and 
drug screening, the potential ligands may be agonists or antagonists. The potential ligands may be 
labelled (e.g. radiolabelled or fluorescently labelled) to allow the detection of interactions 
between the RNA molecules and the potential ligands. Alternatively, the interactions may be 
monitored using SPR/SPRi.  
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Chapter 8 
8 Conclusions and Perspectives 
 
8.1 Investigating primary and secondary sRNA structure in binding to 
ions and Hfq 
RNA structure is well known to be affected by ions and often is dependent on ions for correct 
secondary and tertiary structure, and for subsequent function (Cromie, Shi, Latifi, & Groisman, 
2006; Dann et al., 2007). Increasingly diverse roles for RNAs are being discovered in which 
intricate sensing mechanisms utilise the dynamic nature of RNA's structural flexibility for binding, 
catalysis and coding (Breaker, 2009; Johansson, 2009; Strack & Jaffrey, 2013; Webb et al., 2009). 
Together with work from colleagues (Henderson, 2012) a potential mechanism of structural 
feedback based on metal ion availability has been discovered and characterised to be specific for 
Mg2+ and not Ca2+ in vitro (Chapter 4). The mechanism described involves the regulation of the 
oligomeric state of the sRNA, MicA, by Mg2+ concentration and was subsequently published in a 
peer reviewed journal (Henderson et al., 2013). Although it has yet to be proven if this mechanism 
exists in the cell, a potential link with cellular components has already been made (Van Puyvelde 
et al., 2015). 
Whilst current views of Hfq's interaction with sRNAs essentially involves the 3' hydroxyl 
recognition and the U-tail, the research shown here using EMSA analysis and SPR(i) binding 
studies indicate that this may not be equally applicable to all sRNAs or a critical factor when 
studying certain sRNA-Hfq interactions in vitro (see Chapters 4 and 5), specifically, VcHfq was 
identified to bind with similar KD to Qrr1 whether or not it had a free 3'-end. The high affinity 
interaction between Qrr1 and VcHfq made it a suitable complex for crystallography trials. 
Therefore, attempts to structurally characterise the interaction by X-ray crystallography were 
made but were unsuccessful. Current structural analysis of sRNA-Hfq complexes is somewhat out 
of context of a full length sRNA as the RNAs are typically only 8 nt long, stimulating the need for 
more relevant structural data. Only a single example of a co-crystal structure of an sRNA-Hfq 
complex exists although its biological relevance on the arrangement of most sRNA-Hfq complexes 
is questioned by the authors (Section 1.3.3 (Dimastrogiovanni et al., 2014)). Although progress 
was made in crystallising the full length VcHfq protein, above, diffraction quality was low and 
structural elucidation was not possible. Possible reasons for crystallisation issues lie in the flexible 
nature of both the sRNA and the CTR of Hfq which are obstructive to crystallisation. Recent 
advances in crystallisation chaperones may however overcome these problems (Angelica & Fong, 
2008; Koldobskaya et al., 2011) and this would be a potential route for future work. Alternatively, 
advances in cryo electron microscopy have improved the resolution to near atomic resolution 
(Bai, McMullan, & Scheres, 2014) such that a recent snRNP assembly of the yeast spliceosome 
was resolved to 3.7 Å (Nguyen et al., 2016) indicating this method as a potential avenue for future 
sRNA-Hfq structural elucidation. 
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8.2 Biotin tagging method optimisation and subsequent utilisation of 
SPR(i) for RNA interaction studies 
Methods to biophysically characterise RNA interactions can typically be low-throughput however, 
attempts were made to develop a strategy to allow higher throughput screening of interactions 
with sensor surface techniques including SPR and SPRi. As the subject of these studies would be 
the ROI(s) it was pertinent to immobilise the RNA, as opposed to the binding partner, using a 
method that retains accessibility and functionality. To do this, the high affinity interaction of 
biotin-SA was utilised by developing and optimising the method to biotin-tag RNAs at the 3' end 
by ligation with T4 RNA ligase for subsequent immobilisation to SA coated surfaces. Initial efforts 
made by colleagues indicated that the ROIs of this study did not ligate efficiently and that 
appending 3' ends with alternative short sequences would improve yields. The work described in 
Chapter 5 details the optimisation of the number and identity of the nucleotides needed to 
increase the yields of ligation to allow sufficient biotin-tagged RNA for surface immobilisation. 
Ideally 4-8 adenines were added to ROIs and subsequent surface immobilisation studies were 
validated by comparing RNA 3'-end immobilisation to free RNA binding using the Qrr1-VcHfq 
interaction with SPR. Both methods yielded similar KD values indicating no affect on binding by 
immobilising the RNA at the 3'-end as mentioned earlier. 
In an attempt to increase the throughput of these interaction studies SPRi was trialled for sRNA-
Hfq interactions. This technique has not been previously used to study sRNA interactions and has 
not been exploited for RNA studies in general. To develop a protocol for these studies, a 
collaborative effort was made with Horiba Scientific to develop the optimal RNA immobilisation 
conditions for sufficient binding signal. The SPRi approach was validated by using multiple 
controls and again utilising the Qrr1-VcHfq interaction. The data obtained demonstrated the 
specific nature of the interactions and indicated the method as a potentially useful approach in 
higher throughput RNA-partner molecule interaction characterisation 
Additional validation of another approach was sought following the success of the SPRi studies. In 
an attempt to further increase the throughput of interaction studies, a proof of principle 
experiment for sRNA-mRNA interactions was conducted whereby specific sRNA-mRNA pairing was 
observed using traditional microarray format immobilisation of biotin-tagged RNAs to SA coated 
slides. This key result informed this as a potential avenue for investigation in the need for higher 
throughput methods for testing RNA interactions. 
8.3 Development of functional multi-RNA arrays 
During investigation of strategies for high-throughput RNA interaction studies a novel method 
was developed for creating high-density functional RNA interaction arrays. This method involved 
the single step production and immobilisation of functional, nascently folded, label-free RNAs. 
The method was developed initially with low throughput validation of immobilisation of RNAs in 
the correctly folded and functional state. The results demonstrated that RNA of diverse nature 
could be immobilised and specifically probed for correct binding interactions. This was an 
encouraging result that proved the concept of the idea and subsequent efforts were made to 
optimise the throughput of the technique. Whilst there is scope for further improvements, a high 
density RNA array of over 700 spots was achieved on one slide which, when compared to the 
current list of sRNAs in E. coli (approximately 300 known and novel), would allow multiple 
replicates in sRNA interaction experiments. The RNAs immobilised ranged in size from ~80 nt to 
~600 nt in length and included sRNAs, mRNAs, viral RNAs, eukaryotic RNAs and synthetic RNA 
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aptamers; and the interactions shown were between RNA-RNA, RNA-protein (inherent in 
immobilisation) and RNA-small molecule. 
The potential ways for utilising this technique are vast and show promise for future platform 
technology development. 
8.4 Future work for utilising the RNA array 
8.4.1 Applications of the RNA array 
Worldwide, thousands of people die from cholera every year (Faruque, Albert, & Mekalanos, 
1998; World Health Organisation, 2015). The current treatment for cholera is oral administration 
of rehydration salts combined with antibiotics (World Health Organisation, 2015). However, 
resistance to antibiotics is becoming an increasing problem (Faruque et al., 1998; World Health 
Organisation, 2015) and consequently, new antimicrobial approaches are required. Recent studies 
have reported that progression through the V. cholerae infectious cycle is cell density dependent. 
The Quorum Regulatory RNAs (Qrr sRNAs), functioning via the RNA chaperone protein Hfq, are 
pivotal molecular switch components of the V. cholerae cell density dependent virulence pathway 
(Hammer & Bassler, 2007; Jobling & Holmes, 1997; Kovacikova & Skorupski, 2002; Lenz et al., 
2004). The RNA array technology could aid in testing of oligonucleotide mimics that switch off V. 
cholerae virulence via direct targeting of the Qrr sRNAs, thereby supporting inhibitor molecule 
design. 
Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine pleuropneumonia, a 
highly contagious economically important endemic disease of pigs in the UK and worldwide 
(Straw, Zimmerman, D’Allaire, 2013). In 2008 (Zhou, 2008) it was demonstrated that an APP hfq 
mutant was attenuated for virulence in its only known natural host - the pig. Identification of Hfq-
associated sRNAs in APP under growth conditions mimicking infection and subsequent 
identification of mRNA targets controlled by Hfq-associated sRNAs using the RNA array 
technology as a screening and high-throughput interaction testing tool could lead to a novel 
therapeutic strategy for targeting this costly infection. 
8.4.2 Improvements 
Potential avenues for improving the current methodology/arrangement of the RNA array would 
best be directed at further stabilising the immobilisation of the RNA. In the current form, the RNA 
is bound to the surface by a high affinity interaction between the fused aptamer and the 
covalently immobilised aptamer ligand. This interaction has been shown to be sufficient for the 
experimental conditions used in this study. However, a more robust immobilisation would 
facilitate the use of harsher conditions which would potentially remove the bound RNA. 
One method of immobilising the RNA covalently would be to utilise recent advances in non-
natural basepairs (Hirao et al., 2004, 2006). These synthetic nucleotide pairs have been shown to 
site specifically incorporated in to RNAs by IVT with T7 RNAP and have also been used to 
incorporate exogenous chemical groups to functionalise the RNA (Moriyama, Kimoto, Mitsui, 
Yokoyama, & Hirao, 2005; Morohashi, Kimoto, Sato, Kawai, & Hirao, 2012). This approach could 
be exploited to site-specifically incorporate click chemistry groups for the timely covalent coupling 
of the RNA to light activated cognate click chemistry groups on the surface (Orski et al., 2010). 
This approach would facilitate the covalent immobilisation of RNA arrays and have the added 
benefit of negating the need for ROI fusion with exogenous aptamers and linkers, allowing exact 
ROI sequences to be immobilised. 
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8.4.3 Expansion towards a platform technology 
Whilst genomic approaches, such as DNA microarray technology and more recently the 
application of next generation sequencing methods have increased the output of transcriptomic 
studies, proteomics significantly lags behind (Cho, 2007; Mallick & Kuster, 2010). Functional 
protein microarrays, in which hundreds-to-thousands of proteins on one microarray slide can be 
probed for interactions with test binding partner molecules, provide the opportunity for higher 
throughput (Templin et al., 2002). Current methods (Chandra & Srivastava, 2010; Zhu et al., 2001) 
are associated with issues (laborious, time consuming, purity, stability and functionality issues), 
yet these methods remain the gold standard for protein microarray generation (Yang, Guo, Li, 
Zhou, & Tao, 2011). To demonstrate the concept of a covalently-bound functional multi-protein 
microarray it could be possible to combine the RNA array technology with a second sandwich with 
in vitro translation mix containing a novel label that can covalently couple the protein to the 
surface in a uniform orientation upon light activation. Additionally this approach can be utilised to 
directly assay the inhibition of translation by novel compounds and even sRNAs. 
 
 
 
 
 
 
  
Figure 8. 1 Generating functional high density protein arrays from high density RNA arrays 
A sandwich print set-up of an RNA template slide facing the slide to which the protein becomes immobilised 
following in vitro translation. In vitro translation uses reconstituted components with an amber suppressor 
tRNA incorporating a novel, azide-labelled amino acid, illustrated in the grey central panel. The chemical 
processes occurring at the slide surface are also illustrated. 
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The concept of a novel and robust RNA biosensor array capable of simultaneous multi-target 
detection would overcome current limitations of existing approaches and generate a widely 
applicable tool for use in agricultural and aquaculture monitoring, as well as within the broader 
environmental, healthcare and defence domains. To realise the concept of an RNA biosensor 
array it is proposed to combine the RNA array technology with the proven approach of using RNA 
aptamer detectors coupled, via transducers, to RNA aptamer signallers (i.e. RNA biosensors) 
(DasGupta, Shelke, Li, & Piccirilli, 2015; Kellenberger, Chen, Whiteley, Portnoy, & Hammond, 
2015; Kellenberger, Wilson, Sales-Lee, & Hammond, 2013; Nakayama, Luo, Zhou, Dayie, & Sintim, 
2012; Paige et al., 2012; Song et al., 2013; Stojanovic & Kolpashchikov, 2004; Strack, Song, & 
Jaffrey, 2014; You et al., 2015), all stabilised by circularisation of the RNA (Umekage & Kikuchi, 
2009) and tethered to the array surface via a further RNA aptamer-surface interaction (Figure 
8.2). Circularisation is achieved by utilising the permuted intron-exon (PIE) approach, based on 
group I intron self-splicing, to generate circular RNA biosensors and the sequences associated 
with this are highlighted within the DNA template in Figure 8.2. The RNA generated following IVT 
of the DNA template is shown. Once transcribed, the presence of Mg2+ and GTP within the 
transcription reagent mix supports the spontaneous self-splicing reaction of the RNA.  
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Figure 8. 2 Biosensor RNA array concept 
The RNA biosensor component contains an RNA aptamer as a target detector (blue/cyan) coupled, via a 
transducer (red) to a signaller (green). Upon target (blue filled circle) binding to the detector (blue), the 
transducer hybridises (red parallel lines) supporting structuring of the signalling aptamer (green open 
hexagon) such that the signalling molecule (filled green hexagon) can bind, leading to fluorescence (green 
dotted lines). Circularisation (black lines) stabilises the RNA biosensor. Incorporation of a surface 
immobilisation RNA aptamer (black lines) facilitates tethering to a surface-bound molecule (grey). The 
stabilised multi-RNA biosensor array can be generated from a DNA template array using the RNA array 
technology, thus facilitating simultaneous multi-target detection. Fluorescence (green dotted lines) is only 
seen for targets (bottom left , blue and yellow filled circles) binding to corresponding biosensors 
incorporating appropriate detectors (blue and yellow). 
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8.5 Summary 
RNA sequence and structure are important drivers in their molecular interactions and therefore 
dictate their functions. In this work, a potential mechanism of sRNA self-association was shown to 
be specifically mediated by Mg2+. Also, sRNA binding to Hfq was investigated which provided 
insight into the role of the 3'-U tail. Progress into structural characterisation of VcHfq was made 
which has provided a starting point for structural characterisation of the VcHfq-Qrr1 complex. 
Optimisation of a method for biotin-tagging RNAs has led to the utilisation of sensor-surface 
techniques for studying sRNA interactions in low and medium throughput. This approach 
promises to provide detailed interaction data on many RNA samples at once and could facilitate 
the screening of novel RNA binding partners. Additionally, a novel and ideal technique for creating 
functional multi-RNA arrays has been developed. This technique has shown to be capable of 
facilitating the probing of RNA interactions with small molecules, RNAs and proteins. Further use 
of this technique could help define binding partner interactions and provide a tool for researchers 
for general RNA interaction studies. 
This work has contributed to three peer-reviewed publications and one manuscript in 
preparation.  
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Designed DNA templates and associated primer sequences for preparing RNAs
a,b
 
RNA name Sequences 
1. mRNA 
5’UTR 
hapR 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGCTTTAAGTAGCAAATAACAAAATAA
TCATTAGAGCAAAATGCTCAATCAACAACTCAATTGGCAAGGAT
ATACCCCTATGGACGCAT  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; HapR – capitals (90 nt)). 
  Primers: Sense 2 5’- TAATACGACTCACTATAGGGCTTTAAGTAGCAA -3’ 
   Sense 1 5’- 
CTCACTATAGGGCTTTAAGTAGCAAATAACAAAATAA
TCATTAGAGCAAAATGCT -3’ 
   Antisense 
1 
5’- 
ATGCGTCCATAGGGGTATATCCTTGCCAATTGAGTT
GTTGA -3’ 
   Antisense 
2 
5’- 
ATCCTTGCCAATTGAGTTGTTGATTGAGCATTTTGCT
CTAATGATTATTTTGTTA -3’ 
2. MicAstab 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGAAAGACGCGCATTTGTTATCATCATCC
CTGGGAAAGCGAGGCTTTCCCTGGCCACTCACGAGTGGCCTTT
T  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; MicAstab – capitals (71 nt)).  
 
  Primers: Sense 1 5’- 
TAATACGACTCACTATAGAAAGACGCGCATTTGTTAT
CATCATCCCTGGGAAAGCG -3’ 
   Antisense 
1 
5’- 
AAAAGGCCACTCGTGAGTGGCCAGGGAAAGCCTCG
CTTTCCCAGGGATGATGATAAC -3’ 
3. sRNA 
Qrr1 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTGACCCGCAAGGGTCACCTAGCC
AACTGACGTTGTTAGTGAATAATCAATGTTCACAAATAACAGCCA
ATAGACTCATTCTATTGGCTATTTTTTT  
(T7 promoter – bold; Transcriptional start site – bold and underlined; 
Qrr1 – capitals (99 nt)).  
  Primers: Sense 2 5’- 
TAATACGACTCACTATAGGGTGACCCGCAAGGGTCA
C -3’ 
   Sense 1 5’- 
GTGACCCGCAAGGGTCACCTAGCCAACTGACGTTGT
TAGTGAATAATC -3’ 
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RNA name Sequences 
   Antisense 
1 
5’- 
GAATGAGTCTATTGGCTGTTATTTGTGAACATTGATT
ATTCACTAACAACGTCAGTTGGC -3’ 
   Antisense 
2 
5’- 
AAAAAAATAGCCAATAGAATGAGTCTATTGGCTGTTA
TTTGTGAAC -3’ 
4. sRNA 
MicA 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGGAAAGACGCGCATTTGTTATCATC
ATCCCTGAATTCAGAGATGAAATTTTGGCCACTCACGAGTGGCC
TTTT  
(T7 promoter – bold; Transcriptional start site – capital and 
underlined; MicA – capitals (75 nt)).  
  Primers: Sense 1 5’- 
TAATACGACTCACTATAGGGGAAAGACGCGCATTTG
TTATCATCATCCCTGAATTCAGAGATGAA-3’ 
   Antisense 
1 
5’- 
AAAAGGCCACTCGTGAGTGGCCAAAATTTCATCTCT
GAATTCAGGGATGATGATAAC -3’ 
5. MG 
aptamer 
 
DNA 
template: 
Biotin/thiol-                                                             
ctcgagtaatacgactcactataGGATCCCGACTGGCGAGAGCCAGGTA
ACGAATGGATCC 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; MG – capitals (38 nt)).  
  Primers: Sense 1 5’- 
TAATACGACTCACTATAGGATCCCGACTGGCGAGAG
CCAGGTAACGAATGGATCC-3’ 
   Antisense 
1 
5’- 
GGATCCATTCGTTACCTGGCTCTCGCCAGTCGGGAT
CCTATAGTGAGTCGTATTA -3’ 
6. mRNA 
rpoS 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTTCTGAGTCTTCGGGTGAACAGAG
TGCTAACAAAATGTTGCCGAACAACAAGCCAACTGCGACCACG
GTCACAGCGCCTGTAACGGTACCAACAGCAAGCACAACCGAGC
CGACTGTCAGCAGTACATCAACCAGTACGCCTATCTCCACCTG
GCGCTGGCCGACTGAGGGCAAAGTGATCGAAACCTTTGGCGCT
TCTGAGGGGGGCAACAAGGGGATTGATATCGCAGGCAGCAAA
GGACAGGCAATTATCGCGACCGCAGATGGCCGCGTTGTTTATG
CTGGTAACGCGCTGCGCGGCTACGGTAATCTGATTATCATCAAA
CATAATGATGATTACCTGAGTGCCTACGCCCATAACGACACAAT
GCTGGTCCGGGAACAACAAGAAGTTAAGGCGGGGCAAAAAATA
GCGACCATGGGTAGCACCGGAACCAGTTCAACACGCTTGCATT
TTGAAATTCGTTACAAGGGGAAATCCGTAAACCCGCTGCGTTAT
TTGCCGCAGCGATAAATCGGCGGAACCAGGCTTTTGCTTGAAT
GTTCCGTCAAGGGATCACGGGTAGGAGCCACCTTATGAGTCAG
A 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; RpoS – capitals (606 nt)).  
  Primers: Sense 1 5’- 
TAATACGACTCACTATAGGGTTCTGAGTCTTCGGGT
GAACAG-3’ 
   Antisense 
1 
5’- TCTGACTCATAAGGTGGCTCC -3’ 
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RNA name Sequences 
7. mRNA 
5’UTR  
ompA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactatagGGCCAGGGGTGCTCGGCATAAGCCG
AAGATATCGGTAGAGTTAATATTGAGCAGATCCCCCGGTGAAG
GATTTAACCGTGTTATCTCGTTGGAGATATTCATGGCGTATTTTG
GATGATAACGAGGCGCAAAAAATGAAAAAGACAGCTATCGCGA
TTGCAGTGGCA 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; ompA – capitals (167 nt)). 
  Primers: Sense 3 5’- TAATACGACTCACTATAGGGCCAGGGGT -3’ 
   Sense 2 5’- 
CTCACTATAGGGCCAGGGGTGCTCGGCATAAGCCG
AAGATATCGGTAGAGTTAATATTGAGC -3’ 
   Sense 1 5'- 
CCGAAGATATCGGTAGAGTTAATATTGAGCAGATCC
CCCGGTGAAGGATTTAACCGTG -3’ 
   Antisense 
1 
5’- 
CCAAAATACGCCATGAATATCTCCAACGAGATAACA
CGGTTAAATCCTTCACCGGG -3’ 
   Antisense 
2 
5’- 
GTCTTTTTCATTTTTTGCGCCTCGTTATCATCCAAAAT
ACGCCATGAATATCTCCAACG-3’ 
   Antisense 
3 
5’- 
TGCCACTGCAATCGCGATAGCTGTCTTTTTCATTTTT
TGCGCCTCGTTATC -3’ 
8. mRNA 
5’UTR 
hapRTob 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGCTTTAAGTAGCAAATAACAAAATAA
TCATTAGAGCAAAATGCTCAATCAACAACTCAATTGGCAAGGAT
ATACCCCTATGGACGCATaaaaaaaaaaaaaaaaaaaggcttagtatagcga
ggtttagctacactcgtgctgagcc  
 (T7 promoter – bold; Transcriptional start site – capitals and 
underlined; HapR – capitals (90 nt); Linker – italics (19 nt); 
Tobramycin aptamer – lower case, underlined (40 nt)). 
  Primers: Sense 3 5’- TAATACGACTCACTATAGGGCTTTA -3’ 
   Sense 2 5’- 
TAATACGACTCACTATAGGGCTTTAAGTAGCAAATAA
CAAAATAATCATTAGAGCAAAAT -3’ 
   Sense 1 5’- 
CAAATAACAAAATAATCATTAGAGCAAAATGCTCAAT
CAACAACTCAATTGGCAAGGATA -3’ 
   Antisense 
1 
5’- 
CTTTTTTTTTTTTTTTTTTTATGCGTCCATAGGGGTAT
ATCCTTGCCAATTGAGTTGTTG -3’ 
   Antisense 
2 
5’- 
CACGAGTGTAGCTAAACCTCGCTATACTAAGCCTTTT
TTTTTTTTTTTTTTTATGCGTCC -3’ 
   Antisense 
3 
5’- GGCTCAGCACGAGTGTAGCTAAACCTCG -3’ 
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RNA name Sequences 
9. MicAstab_T
ob 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGAAAGACGCGCATTTGTTATCATCATCC
CTGGGAAAGCGAGGCTTTCCCTGGCCACTCACGAGTGGCCTTT
Tatatccccccccccccccccggcttagtatagcgaggtttagctacactcgtgctgagcc  
(T7 promoter – bold; Transcriptional start site – capital and 
underlined; MS – capitals (71 nt); Linker – italics (20 nt); Tobramycin 
binding aptamer (TobApt) – underlined (40 nt)).  
  Primers: Sense 2 5'- 
TAATACGACTCACTATAGAAAGACGCGCATTTGTTAT
CATCATCCCTGGGAAAGCG -3; 
   Sense 1  5'- 
TATCATCATCCCTGGGAAAGCGAGGCTTTCCCTGGC
CACTCACGAGTGGCCTTTTATATC -3’ 
   Antisense 
1 
5’- 
TAAACCTCGCTATACTAAGCCGGGGGGGGGGGGGG
GGATATAAAAGGCCACTCGTGAGTG-3’ 
   Antisense 
2 
5’- 
GGCTCAGCACGAGTGTAGCTAAACCTCGCTATACTA
AGCCGG -3’ 
10. sRNA 
Qrr1Tob 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTGACCCGCAAGGGTCACCTAGCC
AACTGACGTTGTTAGTGAATAATCAATGTTCACAAATAACAGCCA
ATAGACTCATTCTATTGGCTATTTTTTTttttttttttccccccccccggcttagtat
agcgaggtttagctacactcgtgctgagcc  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; Qrr1 – capitals (99 nt); Linker – italics (20 nt); 
Tobramycin binding aptamer (TobApt) – underlined (40 nt)).  
  Primers: Sense 3 5’- TAATACGACTCACTATAGGGTGACCCGCAAG -3’ 
   Sense 2 5’- 
ACTATAGGGTGACCCGCAAGGGTCACCTAGCCAACT
GACGTTGTTAGTGAATAATC -3’ 
   Sense 1 5'- 
CCAACTGACGTTGTTAGTGAATAATCAATGTTCACAA
ATAACAGCCAATAGACTCA -3’ 
   Antisense 
1 
5’- 
GGAAAAAAAAAAAAAAAAATAGCCAATAGAATGAGTC
TATTGGCTGTTATTTGTGA -3’ 
   Antisense 
2 
5’- 
CCTCGCTATACTAAGCCGGGGGGGGGGAAAAAAAA
AAAAAAAAATAGCCAATAGAA-3’ 
   Antisense 
3 
5’- 
GGCTCAGCACGAGTGTAGCTAAACCTCGCTATACTA
AGCCGGG -3’ 
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RNA name Sequences 
11. sRNA 
MicATob 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGGAAAGACGCGCATTTGTTATCATC
ATCCCTGAATTCAGAGATGAAATTTTGGCCACTCACGAGTGGCC
TTTTacacacacacacacacacacggcttagtatagcgaggtttagctacactcgtgctga
gcc  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; MicA – capitals (75 nt); Linker – italics (20 nt); 
Tobramycin binding aptamer (TobApt) – underlined (40 nt)).  
  Primers: Sense 2 5’- 
TAATACGACTCACTATAGGGGAAAGACGCGCATTTG
TTATCATCATCCCTGAATTCAGA -3’ 
   Sense 1 5’- 
TGTTATCATCATCCCTGAATTCAGAGATGAAATTTTG
GCCACTCACGAGTGGCCTTTTAC -3’ 
   Antisense 
1 
5'- 
TAAACCTCGCTATACTAAGCCGTGTGTGTGTGTGTG
TGTGTAAAAGGCCACTCGTGAGTG -3’ 
   Antisense 
2 
5’- 
GGCTCAGCACGAGTGTAGCTAAACCTCGCTATACTA
AGCCGT -3’ 
12. U1Tob 
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTATCCATTGCACTCCGGATGCCtttttt
ttttccccccccccggcttagtatagcgaggtttagctacactcgtcgtgagcc  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; U1 – capitals (25 nt); Linker – italics (20 nt); Tobramycin 
binding aptamer (TobApt) – underlined (40 nt)).  
  Primers: Sense 2 5’- TAATACGACTCACTATAGGGTATCCATTGCACT -3’ 
   Sense 1 5’- 
TCACTATAGGGTATCCATTGCACTCCGGATGCCTTTT
TTTTTTCCC -3’ 
   Antisense 
1 
5'- 
CCTCGCTATACTAAGCCGGGGGGGGGGAAAAAAAA
AAGGCATCCGG -3’ 
   Antisense 
2 
5’- 
GGCTCAGCACGAGTGTAGCTAAACCTCGCTATACTA
AGCCGGG -3’ 
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RNA name Sequences 
13. EV71Tob DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGAGACGATCAATAGCAGGTGTGGCA
CACCAGTCATACCTTGATCAAGCACTTCTGTTTCCCCGGACTGA
GTATCAATAGGCTGCTCGCGCGGCTGAAGGAGAAAACGTTCGT
TACCCGACCAACTACTTCGAGAAGCTTAGTACCACCATGAACGA
GGCAGGGTGTTTCGCTCAGCACAACCCCAGTGTAGATCAGGCT
GATGAGTCACTGCAACCCCCATGGGCGACCATGGCAGTGGCTG
CGTTGGCGGCCTGCCCATGGAGAAATCCATGGGACGCTCTAAT
TCTGACATGGTGTGAAGAGCCTATTGAGCTAGCTGGTAGTCCTC
CGGCCCCTGAATGCGGCTAATCCTAACTGCGGAGCACATGCTC
ACAAACCAGTGGGTGGTGTGTCGTAACGGGCAACTCTGCAACG
GAACCGACTACTTTGGGTGTCCCGTGTTTCCTTTTATTCCTATAT
TGGCTGCTTATGGTGACAATCAAAAAGTTGTTACCATATAGCTAT
TGGATTGGCCATCCGGTGTGCAACAGGGCAATTGTTTACCTATT
TATTGGTTTTGTACCATTATCACTGAAGTCTGTGTCACTCTCAAA
TTCATTTTGACCCTCAACACAATCAAACatgagcacgaatcctaaacctca
aagaaaaaccaaacgtaacaccaaccgtcgcccacaaacctcgactcttctagactctctgg
cttagtatagcgaggtttagctacactcgtgctgagccctctct  
(T7 promoter – bold; transcriptional start site – bold and underlined; 
EV71-IRES – capitals (623 nt); Linker – italics (83 nt); Tobramycin-
binding aptamer (TobApt) – lowercase and underlined (40 nt)). 
  Primers: Sense 1 5’- biotin/thiol-CTCGAGTAATACGACTCACTATAGG -3’ 
   Antisense 
1 
5’- AGAGAGGGCTCAGCACGAGTGTAG -3’ 
14. sRNA 
Qrr1SA 
DNA 
template: 
Biotin/thiol-
cctcgagtaatacgactcactataGGGTGACCCGCAAGGGTCACCTAGCC
AACTGACGTTGTTAGTGAATAATCAATGTTCACAAATAACAGCCA
ATAGACTCATTCTATTGGCTATTTTTTTtttttttttttttttttttttgtgtgaccgacc
agaatcatgcaagtgcgtaagatagtcgcgggccgggcacaca  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; Qrr1 – capitals (99 nt); Linker – italics (26 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (6nt)).  
  Primers: Sense 3 5’- TAATACGACTCACTATAGGGTGACCCGC -3’ 
   Sense 2 5’- 
CTCACTATAGGGTGACCCGCAAGGGTCACCTAGCCA
ACTGACGTTGTTAGTGAATAATCA -3’ 
   Sense 1 5’- 
AACTGACGTTGTTAGTGAATAATCAATGTTCACAAAT
AACAGCCAATAGACTCATTCTAT -3’ 
   Antisense 
1 
5’- 
AAAAAAAAAAAAAAAAAAAAAAAAAAATAGCCAATAG
AATGAGTCTATTGGCTGTTATTT -3’ 
   Antisense 
2 
5’- 
ACTTGCATGATTCTGGTCGGTCACACAAAAAAAAAAA
AAAAAAAAAAAAAAAAATAGCCA -3’ 
   Antisense 
3 
5’- 
TGTGTGCCCGGCCCGCGACTATCTTACGCACTTGCA
TGATTCTGGTCGG -3’ 
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15. MicAstab_S
A 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGAAAGACGCGCATTTGTTATCATCATCC
CTGGGAAAGCGAGGCTTTCCCTGGCCACTCACGAGTGGCCTTT
Tacacacacacacacacacacgcatgcataccgaccagaatcatgcaagtgcgtaagata
gtcgcgggccgggatgcatgc  
(T7 promoter – bold; Transcriptional start site – capital and 
underlined; MicAstab – capitals (72 nt); Linker – italics (28 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (8nt)).  
  Primers: Sense 3 5’- TAATACGACTCACTATAGAAAGACGCGCA -3’ 
   Sense 2 5'- 
ACTCACTATAGAAAGACGCGCATTTGTTATCATCATC
CCTGGGAAAGCGAGG -3’ 
   Sense 1 5'- 
CATCCCTGGGAAAGCGAGGCTTTCCCTGGCCACTCA
CGAGTGGCCTTTTACA -3’ 
   Antisense 
1 
5’- 
GTCGGTATGCATGCGTGTGTGTGTGTGTGTGTGTAA
AAGGCCACTCGTGAGT -3’ 
   Antisense 
2 
5'- 
CCCGCGACTATCTTACGCACTTGCATGATTCTGGTC
GGTATGCATGCGTGTG -3’ 
   Antisense 
3 
5'- GCATGCATCCCGGCCCGCGACTATCTTACGCA -3’ 
16. sRNA 
MicASA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGGAAAGACGCGCATTTGTTATCATC
ATCCCTGAATTCAGAGATGAAATTTTGGCCACTCACGAGTGGCC
TTTTacacacacacacacacacacgcatgcataccgaccagaatcatgcaagtgcgtaa
gatagtcgcgggccgggatgcatgc  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; MicA – capitals (75 nt); Linker – italics (28 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (8 nt)).  
  Primers: Sense 3 5'- 
TAATACGACTCACTATAGGGGAAAGACGCGCATTTG 
-3’ 
   Sense 2 5'- 
GGGGAAAGACGCGCATTTGTTATCATCATCCCTGAA
TTCAGAGATGAAATTT -3’ 
   Sense 1 5'- 
CATCCCTGAATTCAGAGATGAAATTTTGGCCACTCAC
GAGTGGCCTTTTACA -3’ 
   Antisense 
1 
5'- 
GTCGGTATGCATGCGTGTGTGTGTGTGTGTGTGTAA
AAGGCCACTCGTGAGT -3’ 
   Antisense 
2 
5'- 
CCCGCGACTATCTTACGCACTTGCATGATTCTGGTC
GGTATGCATGCGTGTG -3’ 
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   Antisense 
3 
5’- GCATGCATCCCGGCCCGCGACTATCTTACGCA -3’ 
17. U1_SA DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTATCCATTGCACTCCGGATGCCtttttt
tttttttttttttttgtgtgaccgaccagaatcatgcaagtgcgtaagatagtcgcgggccgggcac
aca  
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; U1 – capitals (25 nt); Linker – italics (26 nt); Streptavidin 
binding aptamer (SAApt) – underlined (44 nt); Linker 2 – italics 
underlined (6 nt)).  
  Primers: Sense 2 5’- TAATACGACTCACTATAGGGTATCCATTGCACT -3’ 
   Sense 1 5’- 
CACTATAGGGTATCCATTGCACTCCGGATGCCTTTTT
TTTTTTTTTTTTTTTTG -3’ 
   Antisense 
1 
5’- 
ACTTGCATGATTCTGGTCGGTCACACAAAAAAAAAAA
AAAAAAAAAAGGCATCC -3’ 
   Antisense 
2 
5’- 
TGTGTGCCCGGCCCGCGACTATCTTACGCACTTGCA
TGATTCTGGTCGG -3’ 
18. mRNA 
rpoSSA
§
 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGTTCTGAGTCTTCGGGTGAACAGAG
TGCTAACAAAATGTTGCCGAACAACAAGCCAACTGCGACCACG
GTCACAGCGCCTGTAACGGTACCAACAGCAAGCACAACCGAGC
CGACTGTCAGCAGTACATCAACCAGTACGCCTATCTCCACCTG
GCGCTGGCCGACTGAGGGCAAAGTGATCGAAACCTTTGGCGCT
TCTGAGGGGGGCAACAAGGGGATTGATATCGCAGGCAGCAAA
GGACAGGCAATTATCGCGACCGCAGATGGCCGCGTTGTTTATG
CTGGTAACGCGCTGCGCGGCTACGGTAATCTGATTATCATCAAA
CATAATGATGATTACCTGAGTGCCTACGCCCATAACGACACAAT
GCTGGTCCGGGAACAACAAGAAGTTAAGGCGGGGCAAAAAATA
GCGACCATGGGTAGCACCGGAACCAGTTCAACACGCTTGCATT
TTGAAATTCGTTACAAGGGGAAATCCGTAAACCCGCTGCGTTAT
TTGCCGCAGCGATAAATCGGCGGAACCAGGCTTTTGCTTGAAT
GTTCCGTCAAGGGATCACGGGTAGGAGCCACCTTATGAGTCAG
Attttttttttttttttttatgcatgcaccgaccagaatcatgcaagtgcgtaagatagtcgcgggccg
gggcatgcat 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; RpoS – capitals (606 nt); Linker – italics (26 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (8 nt)).  
  Primers: Sense 1 5’- 
TAATACGACTCACTATAGGGTTCTGAGTCTTCGGGT
GAACAG -3’ 
   Antisense 
1 
5’- 
GATTCTGGTCGGTGCATGCATAAAAAAAAAAAAAAAA
AATCTGACTCATAAGGTGGCTCC -3’ 
   Antisense 
2 
5’- 
ATGCATGCCCCGGCCCGCGACTATCTTACGCACTTG
CATGATTCTGGTCGGTGCATGCAT -3’ 
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19. MG 
aptamerS
A 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGATCCCGACTGGCGAGAGCCAGGTA
ACGAATGGATCCacacacacacacacacacacgcatgcataccgaccagaatcat
gcaagtgcgtaagatagtcgcgggccgggatgcatgc 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; MG – capitals (38 nt); Linker – italics (20 nt); Streptavidin 
binding aptamer (SAApt) – underlined (44 nt); Linker 2 – italics 
underlined (8 nt)).  
  Primers: Sense 2 5’- 
TAATACGACTCACTATAGGATCCCGACTGGCGAGAG
CCAGGTAACGAATGGATC -3’ 
   Sense 1 5’- 
GAGCCAGGTAACGAATGGATCCACACACACACACAC
ACACACGCATGCATACCGA -3’ 
   Antisense 
1 
5’- 
CGGCCCGCGACTATCTTACGCACTTGCATGATTCTG
GTCGGTATGCATGCGTGTG -3’ 
   Antisense 
2 
5’- GCATGCATCCCGGCCCGCGACTATCTT -3’ 
20. mRNA 
5’UTR  
ompASA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactatagGGCCAGGGGTGCTCGGCATAAGCCG
AAGATATCGGTAGAGTTAATATTGAGCAGATCCCCCGGTGAAG
GATTTAACCGTGTTATCTCGTTGGAGATATTCATGGCGTATTTTG
GATGATAACGAGGCGCAAAAAATGAAAAAGACAGCTATCGCGA
TTGCAGTGGCAaataataataataataataatatgcatgcaccgaccagaatcatgca
agtgcgtaagatagtcgcgggccggggcatgcat 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; ompA – capitals (167 nt); Linker – italics (29 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (8 nt)).  
  Primers: Sense 3 5’- 
TAATACGACTCACTATAGGGCCAGGGGTGCTCGGCA
TAAGCCGAAGATATCGGTAGA -3’ 
   Sense 2 5’- 
CATAAGCCGAAGATATCGGTAGAGTTAATATTGAGC
AGATCCCCCGGTGAAGGATTTAACCGT -3’ 
   Sense 1 5’- 
CCGGTGAAGGATTTAACCGTGTTATCTCGTTGGAGA
TATTCATGGCGTATTTTGGATGATAAC -3’ 
   Antisense 
1 
5’- 
TGCAATCGCGATAGCTGTCTTTTTCATTTTTTGCGCC
TCGTTATCATCCAAAATACGCCATGA -3’ 
   Antisense 
2 
5’- 
CTGGTCGGTGCATGCATATTATTATTATTATTATTATT
TGCCACTGCAATCGCGATAGCTGTC -3’ 
   Antisense 
3 
5’- 
ATGCATGCCCCGGCCCGCGACTATCTTACGCACTTG
CATGATTCTGGTCGGTGCATGCATAT -3’ 
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21. mRNA 
5’UTR 
hapRSA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGCTTTAAGTAGCAAATAACAAAATAA
TCATTAGAGCAAAATGCTCAATCAACAACTCAATTGGCAAGGAT
ATACCCCTATGGACGCATaataataataataataataatatgcatgcaccgacca
gaatcatgcaagtgcgtaagatagtcgcgggccggggcatgcat 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; hapR – capitals (90 nt); Linker – italics (29 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (8 nt)).  
  Primers: Sense 3 5’- 
TAATACGACTCACTATAGGGCTTTAAGTAGCAAATAA
CAA -3’ 
   Sense 2 5'- 
TAGGGCTTTAAGTAGCAAATAACAAAATAATCATTAG
AGCAAAATGCTCAATCAA -3’ 
   Sense 1 5'- 
CATTAGAGCAAAATGCTCAATCAACAACTCAATTGGC
AAGGATATACCCCTATGG -3’ 
   Antisense 
1 
5'- 
CATGCATATTATTATTATTATTATTATTATGCGTCCAT
AGGGGTATATCCTTGCC -3’ 
   Antisense 
2 
5'- 
CTTGCATGATTCTGGTCGGTGCATGCATATTATTATT
ATTATTATTATTATGCGT -3’ 
   Antisense 
3 
5'- 
ATGCATGCCCCGGCCCGCGACTATCTTACGCACTTG
CATGATTCTGGTCGGT -3’ 
22. sRNA 
DsrASA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGAACACATCAGATTTCCTGGTGTAA
CGAATTTTTTAAGTGCTTCTTGCTTAAGCAAGTTTCATCCCGACC
CCCTCAGGGTCGGGATTTtttttttttttttttttttagagaccgaccagaatcatgcaag
tgcgtaagatagtcgcgggccgggctcta 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; DsrA – capitals (90 nt); Linker – italics (23 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (5 nt)).  
  Primers: Sense 3 5’- TAATACGACTCACTATAGGGAACAC -3’ 
   Sense 2 5’- 
AATACGACTCACTATAGGGAACACATCAGATTTCCTG
GTGTAACGAATTTTTTAA -3’ 
   Sense 1 5’- 
GATTTCCTGGTGTAACGAATTTTTTAAGTGCTTCTTG
CTTAAGCAAGTTTCATCC -3’ 
   Antisense 
1 
5’- 
AAAAAAAAAAATCCCGACCCTGAGGGGGTCGGGAT
GAAACTTGCTTAAGCAAGAA -3’ 
   Antisense 
2 
5’- 
GCATGATTCTGGTCGGTCTCTAAAAAAAAAAAAAAAA
AAAAAATCCCGACCCTGA -3’ 
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   Antisense 
3 
5’- 
TAGAGCCCGGCCCGCGACTATCTTACGCACTTGCAT
GATTCTGGTCGGTCTC -3’ 
23. sRNA 
RprASA 
DNA 
template: 
Biotin/thiol-
ctcgagtaatacgactcactataGGGACGGTTATAAATCAACATATTGATT
TATAAGCATGGAAATCCCCTGAGTGAAACAACGAATTGCTGTGT
GTAGTCTTTGCCCATCTCCCACGATGGGCTTTTTTTTtttttttttttttttttt
gtgtgaccgaccagaatcatgcaagtgcgtaagatagtcgcgggccgggcacac 
(T7 promoter – bold; Transcriptional start site – capitals and 
underlined; RprA – capitals (109 nt); Linker – italics (23 nt); 
Streptavidin binding aptamer (SAApt) – underlined (44 nt); Linker 2 – 
italics underlined (5 nt)).  
  Primers: Sense 3 5’- 
TAATACGACTCACTATAGGGACGGTTATAAATCAAC -
3’ 
   Sense 2 5’- 
CACTATAGGGACGGTTATAAATCAACATATTGATTTA
TAAGCATGGAAATCCCCTG -3’ 
   Sense 1 5’- 
GATTTATAAGCATGGAAATCCCCTGAGTGAAACAAC
GAATTGCTGTGTGTAGTCTT -3’ 
   Antisense 
1 
5’- 
AAAAAAAAAAAAAGCCCATCGTGGGAGATGGGCAAA
GACTACACACAGCAATTCGT -3’ 
   Antisense 
2 
5’- 
TGATTCTGGTCGGTCACACAAAAAAAAAAAAAAAAAA
AAAAAAAAGCCCATCGTGG -3’ 
   Antisense 
3 
5’- 
GTGTGCCCGGCCCGCGACTATCTTACGCACTTGCAT
GATTCTGGTCGGTCACACA -3’ 
a
All oligonucleotide primers, including those with 5’ and 3’ modified nucleotides, were obtained from 
Invitrogen. 
b
Note the outermost Antisense (reverse) primer was used for preparation of biotin/thiol labelled-DNA 
templates required for generating the DNA array. 
§
 The DNA template for mRNA rpoSSA was prepared using two separate PCR reactions, as required for the 
3’ SAApt  extension. 
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Appendix 2 Extra PCR parameters 
PCR thermal cycler parameters for OxyS 
Temperature (°C) Time (mm:ss) Number of cycles 
95 2:00 1 
95 0:30 
25 59 0:30 
70 0:30 
70 5:00 1 
4 ∞ 1 
 
PCR thermal cycler parameters for Qrr1 
Temperature (°C) Time (mm:ss) Number of cycles 
95 2:00 1 
95 0:20 
25 60 0:10 
70 0:10 
70 1:00 1 
4 ∞ 1 
 
PCR thermal cycler parameters for rpoS_SA 
Temperature (°C) Time (mm:ss) Number of cycles 
95 2:00 1 
95 0:20 
25 60 0:10 
70 0:20 
70 1:00 1 
4 ∞ 1 
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Appendix 3 Hfq sequences 
 
E. coli Hfq 
MAKGQSLQDPFLNALRRERVPVSIYLVNGIKLQGQIESFDQFVILLKNTVSQMVYKHAISTVVPSRPVSHHSNNA
GGGTSSNYHHGSSAQNTSAQQDSEETE 
 
V. cholerae Hfq 
MAKGQSLQDPFLNALRRERIPVSIYLVNGIKLQGQIESFDQFVILLKNTVNQMVYKHAISTVVPARPVSHHSGDR
PASDRPAEKSEE 
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Appendix 4 Extra predicted structures of commonly used RNA constructs 
Uppercase letters represent the sequences of the RNA of interest or the SAapt. Lower case letters represent the linker sequences. 
SAapt RNA of interest RNA of interest fused to SAapt 
 
  
  
hapR_SA 
ΔG =-70.50 
hapR 
ΔG =-10.10 
ompA_SA 
ΔG =-70.50 
ompA 
ΔG =-46.90 
ΔG =-10.80 
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